<SEC-DOCUMENT>0001079973-16-001107.txt : 20160810
<SEC-HEADER>0001079973-16-001107.hdr.sgml : 20160810
<ACCEPTANCE-DATETIME>20160810165019
ACCESSION NUMBER:		0001079973-16-001107
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		52
CONFORMED PERIOD OF REPORT:	20160630
FILED AS OF DATE:		20160810
DATE AS OF CHANGE:		20160810

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Venaxis, Inc.
		CENTRAL INDEX KEY:			0001167419
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				841553387
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33675
		FILM NUMBER:		161822045

	BUSINESS ADDRESS:	
		STREET 1:		1585 S. PERRY STREET
		CITY:			CASTLE ROCK
		STATE:			CO
		ZIP:			80104
		BUSINESS PHONE:		(303) 794-2000

	MAIL ADDRESS:	
		STREET 1:		1585 S. PERRY STREET
		CITY:			CASTLE ROCK
		STATE:			CO
		ZIP:			80104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AspenBio Pharma, Inc.
		DATE OF NAME CHANGE:	20051110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ASPENBIO INC
		DATE OF NAME CHANGE:	20020213
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>appy_10q-063016.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: EDGAR Technology and Business Services Inc.
    Document created using EDGARfilings PROfile 3.6.1.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#ffffff" text="#000000">
<div>
<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Washington, D.C. 20549</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">FORM 10-Q</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">x </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;&#160; QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">For the quarterly period ended June 30, 2016</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">OR</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">o </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;&#160; TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">For the transition period from _________ to __________</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Commission file number: <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>001-33675</u></font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="bedb93ca9f1e451f9ef52929103c7a14" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: black 2px solid" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">VENAXIS, INC.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">(Exact name of registrant as specified in its charter)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: black 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Colorado</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: black 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">84-1553387</div>
</td>
</tr>

<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">(State or other jurisdiction of</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">incorporation or organization)</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">(I.R.S. Employer Identification No.)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="ff13c334024949e0bd177b3577c6fc10" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: black 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">1585 South Perry Street, Castle Rock, Colorado 80104</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">(Address of principal executive offices) (Zip Code)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="dbd9295fbd8d481b9318966562b566ed" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: black 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">(303) 794-2000</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">(Registrant's telephone number, including area code)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &#160;&#160;&#160; Yes&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9746;</font> &#160;&#160; No&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9744;</font></div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). &#160;&#160;&#160; &#160;&#160;&#160; Yes&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9746;</font>&#160;&#160; No&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9744;</font></div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.&#160;&#160;See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act.&#160;&#160;(Check one)</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">Large accelerated filer<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9744;</font> &#160;&#160; Accelerated filer <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9744;</font> &#160;&#160;&#160; Non-accelerated filer <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9744;</font> &#160; Smaller reporting company <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9746;</font></div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). &#160;&#160;&#160; Yes&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9744;</font> &#160;&#160; No&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9746;</font></div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">The number of shares of no par value common stock outstanding as of August 10, 2016 was 3,876,961.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">VENAXIS, INC.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="2979c118ebe9454ba4d4bb19b4213fc7" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 72.6%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 4.08%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">&#160;</td>
<td style="WIDTH: 5.78%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Page</div>
</td>
<td style="WIDTH: 3.36%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 87.81%; VERTICAL-ALIGN: bottom" colspan="4">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">PART I - Financial Information</div>
</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 5.78%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 3.36%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 79.74%; VERTICAL-ALIGN: middle" colspan="3">&#160;</td>
<td style="WIDTH: 12.19%; VERTICAL-ALIGN: middle" colspan="3">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Item 1.</div>
</td>
<td style="WIDTH: 72.6%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Condensed Financial Statements</div>
</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 4.08%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 5.78%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 3.36%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 79.74%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
<td style="WIDTH: 12.19%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 72.6%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Balance Sheets as of&#160;&#160;June 30, 2016 (unaudited) and December 31, 2015</div>
</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 4.08%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 5.78%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">3</div>
</td>
<td style="WIDTH: 3.36%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 79.74%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
<td style="WIDTH: 12.19%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 72.6%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Statements of Operations for the Three and Six Months Ended June 30, 2016 and 2015 (unaudited)</div>
</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 4.08%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 5.78%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">4</div>
</td>
<td style="WIDTH: 3.36%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 79.74%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
<td style="WIDTH: 12.19%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 72.6%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Statements of Cash Flows for the Six Months Ended June 30, 2016 and 2015 (unaudited)</div>
</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 4.08%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 5.78%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">5</div>
</td>
<td style="WIDTH: 3.36%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 79.74%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
<td style="WIDTH: 12.19%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 72.6%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Notes to Condensed Financial Statements (unaudited)</div>
</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 4.08%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 5.78%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">6</div>
</td>
<td style="WIDTH: 3.36%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 79.74%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
<td style="WIDTH: 12.19%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Item 2.</div>
</td>
<td style="WIDTH: 72.6%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Management's Discussion and Analysis of Financial Condition and Results of Operations</div>
</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 4.08%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 5.78%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">16</div>
</td>
<td style="WIDTH: 3.36%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 79.74%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
<td style="WIDTH: 12.19%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Item 3.</div>
</td>
<td style="WIDTH: 72.6%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Quantitative and Qualitative Disclosures About Market Risk</div>
</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 4.08%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 5.78%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">20</div>
</td>
<td style="WIDTH: 3.36%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 79.74%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
<td style="WIDTH: 12.19%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Item 4.</div>
</td>
<td style="WIDTH: 72.6%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Controls and Procedures</div>
</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 4.08%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 5.78%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">21</div>
</td>
<td style="WIDTH: 3.36%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 79.74%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
<td style="WIDTH: 12.19%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 87.81%; VERTICAL-ALIGN: bottom" colspan="4">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">PART II - Other Information</div>
</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 5.78%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 3.36%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 79.74%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
<td style="WIDTH: 12.19%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Item 1.</div>
</td>
<td style="WIDTH: 72.6%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Legal Proceedings</div>
</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 4.08%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 5.78%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">22</div>
</td>
<td style="WIDTH: 3.36%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 79.74%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
<td style="WIDTH: 12.19%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Item 1A.</div>
</td>
<td style="WIDTH: 72.6%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Risk Factors</div>
</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 4.08%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 5.78%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">22</div>
</td>
<td style="WIDTH: 3.36%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 79.74%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
<td style="WIDTH: 12.19%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Item 6.</div>
</td>
<td style="WIDTH: 72.6%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Exhibits</div>
</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 4.08%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 5.78%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">22</div>
</td>
<td style="WIDTH: 3.36%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 79.74%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
<td style="WIDTH: 12.19%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 72.6%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Signatures</div>
</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 4.08%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 3.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 5.78%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">23</div>
</td>
<td style="WIDTH: 3.36%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION AND STATEMENTS</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Certain statements in this Quarterly Report on Form 10-Q, including in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company&#8217;s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential&#8221; or other comparable terminology. Please see the &#8220;Risk Factors&#8221; in Part I, Item 1A of the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2015 for a discussion of certain important factors that relate to forward-looking statements contained in this report. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">PART I &#8212; FINANCIAL INFORMATION</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Item I. Condensed Financial Statements</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Venaxis, Inc.</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Balance Sheets</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="e92f4c46ea7840b2a83d33682e60a84b" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="4"></td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="4"></td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">June 30,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2016</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">(Unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">December 31,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">ASSETS</div>
</td>
<td style="VERTICAL-ALIGN: bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2"></td>
<td style="VERTICAL-ALIGN: bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2"></td>
<td style="VERTICAL-ALIGN: bottom">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Current assets:</div>
</td>
<td style="VERTICAL-ALIGN: bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2"></td>
<td style="VERTICAL-ALIGN: bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2"></td>
<td style="VERTICAL-ALIGN: bottom">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Cash and cash equivalents</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">4,489,809</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">2,012,283</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr style="HEIGHT: 17px">
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Short-term investments (Note 1)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">11,657,412</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">14,147,991</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Prepaid expenses and other current assets (Note 1)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">111,042</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">251,778</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total current assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">16,258,263</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">16,412,052</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="4"></td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="4"></td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Property and equipment, net (Note 2)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">539</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">1,954,496</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="4"></td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="4"></td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Long-term investments (Note 1)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">972,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="4"></td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="4"></td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Other long term assets, net (Notes 1 and 3)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">1,330,714</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">1,523,649</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Total assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">&#160;&#160;17,589,516</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">20,862,197</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">LIABILITIES AND STOCKHOLDERS' EQUITY</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Current liabilities:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Accounts payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">194,599</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">701,064</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Accrued compensation</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">13,408</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">449,873</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Accrued expenses</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">152,602</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">241,882</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Notes and other obligations, current portion (Note 4)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">301,250</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Deferred revenue, current portion (Note 7)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">96,698</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">96,698</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total current liabilities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">457,307</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">1,790,767</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="4"></td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="4"></td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Notes and other obligations, less current portion (Note 4)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">1,838,779</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Deferred revenue, less current portion (Note 7)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">1,113,665</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">1,162,015</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr style="HEIGHT: 12px">
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">1,570,972</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">4,791,561</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Commitments and contingencies (Notes 7 and 9)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="4"></td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="4"></td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Stockholders' equity (Notes 5 and 6):</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;Common stock, no par value, 60,000,000 shares authorized;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,876,961 shares issued and outstanding</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">121,877,347</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">121,653,075</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Accumulated deficit</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">(105,858,803</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">(105,582,439</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total stockholders' equity</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">16,018,544</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">16,070,636</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Total liabilities and stockholders' equity</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">17,589,516</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">20,862,197</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;See Accompanying Notes to Unaudited Condensed Financial Statements</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">3</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div>
<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Venaxis, Inc.</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Statements of Operations</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Three and Six Months Ended June 30</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">(Unaudited)</div>

<table id="1c3004e695ba4e73ac86516e6e769d58" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="4"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="6"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Three Months Ended</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Six Months Ended</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Sales (Note 1)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">24,517</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">35,805</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Cost of sales</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">8,096</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">12,103</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Gross profit</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">16,421</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">23,702</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Other revenue &#8211; fee (Note 7)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">24,174</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">24,174</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">48,349</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">48,349</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Operating expenses:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;Selling, general and administrative</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">822,835</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,482,608</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,852,961</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">3,018,459</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;Research and development</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">73,085</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">552,408</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">445,671</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,260,150</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;Total operating expenses</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">895,920</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">2,035,016</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">2,298,632</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">4,278,609</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;Operating loss</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(871,746</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(1,994,421</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(2,250,283</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(4,206,558</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Other income (expense):</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;Gain on sale of property and equipment (Note 2)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">912</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,920,273</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;Interest expense</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(148</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(24,195</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(25,746</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(49,259</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;Investment (loss) income</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">35,107</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(14,619</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">79,392</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">36,209</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Total other income (expense)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">35,871</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(38,814</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,973,919</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(13,050</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Net loss</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(835,875</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(2,033,235</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(276,364</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(4,219,608</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Basic and diluted net loss per share (Note 1)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(0.22</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(0.52</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(0.07</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(1.09</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Basic and diluted weighted average number of shares outstanding (Note 1)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">3,876,961</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">3,876,961</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">3,876,961</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">3,876,961</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">See Accompanying Notes to Unaudited Condensed Financial Statements</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">4</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Venaxis, Inc.</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Statements of Cash Flows</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Six Months Ended June 30</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">(Unaudited)</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="fa83bf0b12274d418a2038f5cbcb8953" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Cash flows from operating activities:</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Net loss</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(276,364</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(4,219,608</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Adjustments to reconcile net loss to</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; net cash used&#160;in operating activities:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Stock-based compensation for services</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">224,272</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">780,983</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Depreciation and amortization</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">4<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">6</font>,03<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">129,794</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Amortization of license fees</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(48,350</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(48,349</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other non-cash charges</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">168,077</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">4,647</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Gain on sale of property and equipment</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(1,9<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">20,273</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;Change in:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Accounts receivable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(30,260</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Prepaid expenses and other current assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">193,930</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">232,018</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Accounts payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(506,465</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(143,793</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Accrued compensation</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(436,465</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(547,607</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Accrued expenses</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">9,531</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">17,161</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Net cash (used&#160;in) operating activities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(2,546,076</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(3,825,014</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Cash flows from investing activities:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Purchases of short-term investments</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(10,149,937</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(16,216,718</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Sales of short-term investments</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">13,612,516</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">21,652,610</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Proceeds from sale of property and equipment</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,749,484</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Purchases of patent and trademark application costs</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(14,378</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(47,022</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Net cash provided by investing activities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">5,197,685</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">5,388,870</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Cash flows from financing activities:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Repayment of notes payable and other obligations</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(174,083</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(235,935</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Net cash (used in) financing activities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(174,083</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(235,935</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Net change in cash and cash equivalents</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">2,477,526</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,327,921</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Cash and cash equivalents at beginning of period</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">2,012,283</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">3,539,911</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Cash and cash equivalents at end of period</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">4,489,809</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">4,867,832</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Supplemental disclosure of cash flow information:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Cash paid during the period for interest</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">31,362</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">49,740</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Supplemental disclosure of investing information:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Liability payoffs upon property sale</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">2,064,758</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">See Accompanying Notes to Unaudited Condensed Financial Statements</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">5</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Venaxis, Inc.</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Notes to Condensed Financial Statements</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">(Unaudited)</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">INTERIM FINANCIAL STATEMENTS</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The accompanying financial statements of Venaxis, Inc. (the &#8220;Company,&#8221;&#160; &#8220;we,&#8221;&#160;or &#8220;Venaxis&#8221;) have been prepared in accordance with the instructions to quarterly reports on Form 10-Q. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and changes in financial position at June 30, 2016 and for all periods presented have been made. Certain information and footnote data necessary for fair presentation of financial position and results of operations in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted. It is therefore suggested that these financial statements be read in conjunction with the summary of significant accounting policies and notes to financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2015. The results of operations for the period ended June 30, 2016 are not necessarily an indication of operating results for the full year.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Management&#8217;s plans and basis of presentation:</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The Company has experienced recurring losses and negative cash flows from operations.&#160;&#160;At June 30, 2016, the Company had approximate balances of cash and liquid investments of $16,147,000, working capital of $15,801,000, total stockholders&#8217; equity of $16,019,000 and an accumulated deficit of $105,859,000. To date, the Company has in large part relied on equity financing to fund its operations.&#160; The Company expects to continue to incur losses from operations for the near-term and these losses could be significant, as professional and other associated expenses in connection with possible strategic considerations, evaluations and transactions, appendicitis portfolio related expenses, public company and administrative related expenses are incurred. The Company believes that its current working capital position will be sufficient to meet its estimated cash needs into 2017.&#160; The Company is closely monitoring its cash balances, cash needs and expense levels.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">As of January 26, 2016, Venaxis publicly disclosed that it had entered into a series of agreements, including a Master Agreement, for a combination transaction (the &#8220;Strand transaction&#8221;) with Strand Life Sciences Private Limited and its shareholders (&#8220;Strand&#8221;).&#160; Strand is privately-held, and operates clinical reference labs in the U.S. and in India, providing testing and lab services in India and other world-wide markets.&#160; Strand has commercialized a next generation sequencing (NGS) based, targeted, multi-gene, pan-cancer diagnostic panel in select international markets and has engaged in initial commercialization activities in the United States.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">On March 11, 2016, Venaxis and Strand entered into a Mutual Termination Agreement to terminate the series of agreements.&#160; Pursuant to the Mutual Termination Agreement, each of the parties was relieved of any obligations or responsibilities under the Master Agreement and other transaction agreements.&#160; Each party remains responsible for its respective transaction-related expenses.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Following the recent termination of the Strand transaction, the Company has begun evaluating potential strategic alternatives. The Company expects, in the near term, to utilize the primary criteria it has established as it evaluates its next steps and strategic path forward with the goal of maximizing value for its shareholders. As a result of the current market trends and uncertainties, and&#160;the impact on many companies, management believes that there may currently be attractive opportunities available to the Company.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Management&#8217;s strategic assessment includes the following potential options:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">
<table id="c003a99e15fe41bcabea240953a7f4a0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.25pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">&#183;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify">exploring other possible strategic options available to the Company following termination of the Strand transaction;</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">
<table id="f9aa29e3274c4cb8847031f6cd0728ed" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.25pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">&#183;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify">evaluating options to monetize, partner or license the Company's appendicitis product portfolio;</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">
<table id="06d2b190839645a1b482731c2b9c509e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.25pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">&#183;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify">continuing to explore prospective partnering or licensing opportunities with complementary opportunities and technologies; and</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">
<table id="82f7bd38ab934e61acd2cb6dcdcab6e1" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.25pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">&#183;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify">continuing to implement cost control initiatives to conserve cash.</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">As part of the Company&#8217;s process to identify possible strategic partners, several targets were identified that the Company assessed as possibly having a business model that could be interested in discussions with Venaxis for potentially acquiring or licensing the appendicitis assets. Venaxis has made initial contact with several of these parties to gauge their interest level, which initially is more focused on the <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font>2 development assets. Management believes that the estimated potential market for an appendicitis test continues to be significant. If Venaxis is unable to locate a new strategic target, a partner or other third-party interested in advancing development and commercial activities of the Venaxis appendicitis portfolio, the capitalized costs on the Company&#8217;s balance sheet, totaling approximately $371,000, as of June 30, 2016 for the acute appendicitis patents may be deemed impaired.</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">6</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Note 1.&#160;&#160;Significant accounting policies:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Cash, cash equivalents and investments:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The Company considers all highly liquid investments with an original maturity of three months or less at the date of acquisition to be cash equivalents. From time to time, the Company&#8217;s cash account balances exceed the balances as covered by the Federal Deposit Insurance System. The Company has never suffered a loss due to such excess balances.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The Company invests excess cash from time to time in highly-liquid debt and equity investments of highly-rated entities, which are classified as trading securities. Historically, the purpose of the investments has been to fund research and development, product development, FDA clearance-related activities and general corporate purposes. Such amounts are recorded at market values using Level 1 inputs in determining fair value and are generally classified as current, as the Company does not intend to hold the investments beyond twelve months. Investment securities classified as trading are those securities that are bought and held principally for the purpose of selling them in the near term, with the objective of preserving principal and generating profits. These securities are reported at fair value with unrealized gains and losses reported as an element of other (expense) income in current period earnings. The Company&#8217;s Board of Directors has approved an investment policy covering the investment parameters to be followed with the primary goals being the safety of principal amounts and maintaining liquidity. The policy provides for minimum investment rating requirements as well as limitations on investment duration and concentrations. Based upon market conditions, the investment guidelines have been tightened to increase the minimum acceptable investment ratings required for investments and shorten the maximum investment term. As of June 30, 2016, approximately 20% of the investment portfolio was in cash and cash equivalents, which is presented as such on the accompanying balance sheet, and the remaining funds were invested in marketable securities with none individually representing a material amount of the portfolio.&#160; Investments with a scheduled maturity beyond one year are classified as long-term investments on the balance sheet.&#160; To date, the Company&#8217;s cumulative realized market loss from the investments has not been significant.&#160;For the six months ended June 30, 2016 and 2015, there was approximately $11,000 and $16,000, respectively, in management fee expenses.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Fair value of financial instruments:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The Company accounts for financial instruments under Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification Topic (&#8220;ASC&#8221;) 820,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic"> Fair Value Measurements</font>.&#160; This statement defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements.&#160; To increase consistency and comparability in fair value measurements, ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels as follows:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Level 1&#8212; quoted prices (unadjusted) in active markets for identical assets or liabilities;</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Level 2 &#8212; observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Level 3 &#8212; assets and liabilities whose significant value drivers are unobservable.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company&#8217;s market assumptions.&#160; Unobservable inputs require significant management judgment or estimation.&#160; In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy.&#160; In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement.&#160; Such determination requires significant management judgment. There were no financial assets or liabilities measured at fair value, with the exception of cash, cash equivalents and short-term investments as of June 30, 2016 and December 31, 2015.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The carrying amounts of the Company&#8217;s financial instruments (other than cash, cash equivalents and short-term investments as discussed above) approximate fair value because of their variable interest rates and/or short maturities combined with the recent historical interest rate levels.</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">7</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Revenue recognition and accounts receivable:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">We recognized sales of goods under the provisions of ASC 605 and the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) Staff Accounting Bulletin (&#8220;SAB&#8221;) 104, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Revenue Recognition</font>. Future revenue is expected to be generated primarily from the sale of products. Product revenue primarily consists of sales of instrumentation and consumables.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Revenue was recognized when the following four basic criteria were met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred and risk of loss has passed; (iii) the seller&#8217;s price to the buyer is fixed or determinable; and (iv) collectability is reasonably assured.&#160; In international markets, the Company sells its products to distributors or re-sellers, who subsequently resell the products to hospitals. The Company has an agreement with the distributor which provides that title and risk of loss pass to the distributor upon shipment of the products, FOB to the distributor. Revenue is recognized upon shipment of products to the distributor as the products are shipped based on FOB shipping point terms (See Note 8).</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Revenues were recorded less a reserve for estimated product returns and allowances which to date has not been significant. Determination of the reserve for estimated product returns and allowances is based on management&#8217;s analyses and judgments regarding certain conditions. Should future changes in conditions prove management&#8217;s conclusions and judgments on previous analyses to be incorrect, revenue recognized for any reporting period could be adversely affected.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The Company extended credit to customers generally without requiring collateral. As of June 30, 2016 and December 31, 2015, the Company did not have any accounts receivable. During the six months ended June 30, 2016, no sales were recorded.&#160; During the six months ended June 30, 2015, three European-based customers accounted for the total net sales, representing 58%, 28% and 14%, respectively.</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
<font style="FONT-WEIGHT: bold">Recently issued and adopted accounting pronouncements:</font></div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company's financial reporting, the Company undertakes a study to determine the consequences of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company's financial statements properly reflect the change.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">In May 2014, the FASB issued Accounting Standards Update ("ASU") No. 2014-09 "Revenue from Contracts from Customers," which supersedes the revenue recognition requirements in "Revenue Recognition (Topic 605)," and requires entities to recognize revenue in a way that depicts the transfer of potential goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to the exchange for those goods or services. In July 2015, the FASB extended the effective date of ASU 2014-09 by one year, to now be effective for fiscal years, and interim periods beginning after December 15, 2017, and is to be applied retrospectively, with early adoption now permitted for fiscal years and interim periods beginning after December 31, 2015. The Company does not believe the new standard will have a material impact on its operations and financial statements.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Income (loss) per share:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">ASC 260,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic"> Earnings Per Share</font>, requires dual presentation of basic and diluted earnings per share (&#8220;EPS&#8221;) with a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilution. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the entity.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">8</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Basic net earnings (loss) per share includes no dilution and is computed by dividing net earnings (loss) available to shareholders by the weighted average number of common shares outstanding for the period.&#160;Diluted net earnings (loss) per share reflect the potential dilution of securities that could share in the Company&#8217;s earnings (loss).&#160; The effect of the inclusion of the dilutive shares would have resulted in a decrease in loss per share for the three and six months ended June 30, 2016<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> and 2015 respectively</font>.&#160; Accordingly, the weighted average shares outstanding have not been adjusted for dilutive shares for any&#160;period presented.&#160; Outstanding stock options and warrants are not considered in the calculation, as the impact of the potential common shares (totaling approximately 966,000 shares and 776,000 shares for <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">each of </font>the <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">three and </font>six month periods ended June 30, 2016 and 2015, respectively) would be anti-dilutive.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Upon the completion of a special shareholders meeting on March 24, 2016, where such action was approved by shareholders, the Board of Directors authorized a reverse stock split of the Company&#8217;s common stock at a ratio of one-for-eight, whereby each eight shares of common stock were combined into one share of common stock (the &#8220;Reverse Stock Split&#8221;).&#160;&#160;The Reverse Stock Split was implemented and effective on March 31, 2016. All historical references to shares and share amounts in this report have been retroactively revised to reflect the Reverse Stock Split.&#160; A reconciliation of basic and diluted weighted average number of shares outstanding adjusted for the Reverse Stock Split for the period ended June 30, 2016 was 30,990,029 shares on a pre-split basis and 3,876,961 shares on a post-split basis.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Note 2. Property and equipment:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Property and equipment consisted of the following:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="41f4a22cf460475b9b6bb9aa1628d0c2" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">June 30,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2016</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">(Unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">December 31,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Land and improvements</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,107,508</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Building</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">2,589,231</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Building improvements</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">253,526</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Laboratory equipment</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">848,014</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Office and computer equipment</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">64,619</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">318,254</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">64,619</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">5,116,533</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Less accumulated depreciation</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">64,080</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">3,162,037</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">539</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,954,496</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Depreciation expense totaled approximately $400 and $38,000, and $800 and $51,000, for the three and six month periods ended June 30, 2016 and 2015, respectively.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">On February 25, 2016, the Company completed the sale of its corporate headquarters, land, building and certain fixtures and equipment to a third party for a purchase price of approximately $4,000,000.&#160;The sale resulted in a gain of approximately $1,900,000 and generated approximately $1,700,000 in net cash after expenses and mortgage payoffs. The Company is leasing back space in the building under short-term lease agreements that provide office and storage space required for its current level of operations.</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">9</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Note 3.&#160;&#160;Other long-term assets:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Other long-term assets consisted of the following:</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<table id="64e8d8b9b95f4752b2179c5df90115d0" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">June 30,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2016</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">(Unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">December 31,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1; TEXT-INDENT: -18pt">Patents, trademarks and applications, net of&#160;accumulated&#160;amortization of $554,967&#160;and $548,327, respectively</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">943,475</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,136,410</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Goodwill</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">387,239</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">387,239</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,330,714</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,523,649</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The Company capitalizes legal costs and filing fees associated with obtaining patents on its new discoveries. Once the patents have been issued, the Company amortizes these costs over the shorter of the legal life of the patent or its estimated economic life using the straight-line method. Based upon the current status of the above intangible assets, the aggregate amortization expense is estimated to be approximately $81,000 for each of the next five fiscal years. The Company tests intangible assets with finite lives for impairment upon significant changes in the Company&#8217;s business environment. The testing resulted in net patent impairment charges of $34,000 and $5,000, and $168,000 and $5,000, for the three and six month periods ended June 30, 2016 and 2015, respectively.&#160; The impairment charges are related to the Company&#8217;s ongoing analysis of which specific country patents in its portfolio are determined as potentially worth pursuing.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Note 4. Notes and Other Obligations:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Notes payable and other obligations consisted of the following:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="cab9cc4c9e284d67983e6dad9dcaf305" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">June 30,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2016</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">(Unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">December 31,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Mortgage notes</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,997,701</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Other short-term installment obligations</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">142,328</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">2,140,029</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Less current portion</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">301,250</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,838,779</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Mortgage notes:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Prior to the February 2016 sale of the corporate headquarters, the Company had a permanent mortgage on its land and building that was refinanced in May 2013. The mortgage was held by a commercial bank and included a portion guaranteed by the U. S. Small Business Administration (&#8220;SBA&#8221;).&#160; The loan was collateralized by the real property and the SBA portion was also personally guaranteed by a former officer of the Company.&#160;The commercial bank loan terms included a payment schedule based on a fifteen year amortization, with a balloon&#160;maturity at five years. The commercial bank portion had an interest rate fixed at 3.95%, and the SBA portion bore interest at the rate of 5.86%. The commercial bank portion of the loan required total monthly payments of approximately $11,700, which included approximately $4,500 per month in interest. The SBA portion of the loan required total monthly payments of approximately $9,000 through July 2023, which included approximately $3,500 per month in interest and fees in 2016.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">On February 25, 2016, the Company completed the sale of its corporate headquarters, land and building, and also paid off its mortgage obligations.&#160; See Note 2.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Future maturities:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The Company did not have any debt obligations at June 30, 2016.</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">10</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Note 5. Stockholders&#8217; equity:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Upon the completion of a special shareholders meeting on March 24, 2016, where such action was approved by shareholders, the Board of Directors authorized the Reverse Stock Split at a ratio of one-for-eight, whereby each eight shares of common stock were combined into one share of common stock.&#160;&#160;The Reverse Stock Split was implemented and effective on March 31, 2016. All historical references to shares and share amounts in this report have been retroactively revised to reflect the Reverse Stock Split.&#160; Following the Reverse Stock Split, the Company regained its compliance with the Nasdaq minimum bid price requirement, allowing its common stock to continue to be listed on the Nasdaq Capital Market.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Note 6. Stock options and warrants:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Stock options:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The Company currently provides stock-based compensation to employees, directors and consultants, both under the Company's 2002 Stock Incentive Plan, as amended (the "Plan"), and non-qualified options and warrants issued outside of the Plan. During September 2015, the Company's shareholders approved amendments to the Plan to increase the number of shares reserved under the Plan from 459,141 to 709,141. The Company estimates the fair value of the share-based awards on the date of grant using the Black-Scholes option-pricing model (the "Black-Scholes model").&#160;&#160;Using the Black-Scholes model, the value of the award that is ultimately expected to vest is recognized over the requisite service period in the statement of operations.&#160;&#160;Option forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.&#160;&#160;The Company attributes compensation to expense using the straight-line single option method for all options granted.&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The Company&#8217;s determination of the estimated fair value of share-based payment awards on the date of grant is affected by the following variables and assumptions:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="7aab49304acf41eeac694c2470606a6e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 2.98%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">&#183;</div>
</td>
<td style="WIDTH: 97.02%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">Grant date exercise price &#8211; the closing market price of the Company&#8217;s common stock on the date of the grant;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.98%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">&#183;</div>
</td>
<td style="WIDTH: 97.02%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">Estimated option term &#8211; based on historical experience with existing option holders;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.98%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">&#183;</div>
</td>
<td style="WIDTH: 97.02%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Estimated dividend rates &#8211; based on historical and anticipated dividends&#160;over the life of the option;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.98%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">&#183;</div>
</td>
<td style="WIDTH: 97.02%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">Term of the option &#8211; based on historical experience, grants have lives of approximately 3-5 years;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.98%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">&#183;</div>
</td>
<td style="WIDTH: 97.02%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">Risk-free interest rates &#8211; with maturities that approximate the expected life of the options granted;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.98%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">&#183;</div>
</td>
<td style="WIDTH: 97.02%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">Calculated stock price volatility &#8211; calculated over the expected life of the options granted, which is calculated based on the daily closing price of the Company&#8217;s common stock over a period equal to the expected term of the option; and</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.98%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">&#183;</div>
</td>
<td style="WIDTH: 97.02%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Option exercise behaviors &#8211; based on actual and projected employee stock option exercises and forfeitures.</div>
</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The Company recognized total expenses for stock-based compensation during the three and six months ended June 30, 2016 and 2015 which are included in the accompanying statements of operations, in the following categories:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="3f23189dc0764f08aaafe5057d207e44" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Three Months Ended</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="7">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Six Months Ended</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="3"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="3"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="3"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="3"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Selling, general and administrative expenses</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">176,388</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">303,644</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">221,712</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">696,006</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Research and development expenses</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">43,937</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">2,560</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">84,977</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;Total stock-based compensation</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">176,388</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">347,581</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">224,272</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">780,983</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">During the six months ended June 30, 2016 and 2015, respectively, no options were exercised.&#160;&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Stock incentive plan options:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The Company currently provides stock-based compensation to employees, directors and consultants under the Plan.&#160;The Company utilized assumptions in the estimation of fair value of stock-based compensation for the six months ended June 30, 2016 and 2015 as follows:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="fa017df72c9c440bbd4a4dab605ea181" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="3"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="3"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Dividend yield</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">0</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">%</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">0</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">%</div>
</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Expected price volatility</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">99</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">%</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">93</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">%</div>
</td>
</tr>

<tr>
<td style="WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Risk free interest rate</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1.20</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">%</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1.39</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">%</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Expected term</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">5 years</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">5 years</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">11</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">A summary of activity under the Plan for the six months ended June 30, 2016 is presented below:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="8c8d3e82c6d44c82b343752305cdc095" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 38.31%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 12.8%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Shares</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Underlying</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Options</div>
</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 12.79%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Weighted</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Average</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Exercise</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Price</div>
</td>
<td style="WIDTH: 1.02%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 13.81%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Weighted</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Average</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Remaining</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Contractual</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Term (Years)</div>
</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 16.12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Aggregate</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Intrinsic</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Value</div>
</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 38.31%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 12.8%; VERTICAL-ALIGN: bottom" colspan="2">&#160;</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 12.79%; VERTICAL-ALIGN: bottom" colspan="2">&#160;</td>
<td style="WIDTH: 1.02%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 13.81%; VERTICAL-ALIGN: bottom" colspan="3">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 16.12%; VERTICAL-ALIGN: bottom" colspan="3">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 38.31%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Outstanding at January 1, 2016</div>
</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11.73%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">332,560</div>
</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11.72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">35.36</div>
</td>
<td style="WIDTH: 1.02%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" colspan="3">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 16.12%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" colspan="3">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 38.31%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Granted</div>
</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11.73%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">227,000</div>
</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11.72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">2.89</div>
</td>
<td style="WIDTH: 1.02%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 13.81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 16.12%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 38.31%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Exercised</div>
</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11.73%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11.72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">-</div>
</td>
<td style="WIDTH: 1.02%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" colspan="3">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 16.12%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" colspan="3">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 38.31%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Forfeited</div>
</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">(25,445</div>
</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11.72%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">36.30</div>
</td>
<td style="WIDTH: 1.02%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 13.81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 16.12%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" colspan="3">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 38.31%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11.73%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11.72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.02%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" colspan="3">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 16.12%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" colspan="3">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 38.31%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Outstanding at June 30, 2016</div>
</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">534,115</div>
</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11.72%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">21.55</div>
</td>
<td style="WIDTH: 1.02%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11.72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">8.1</div>
</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.24%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 13.82%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">140,740</div>
</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 38.31%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11.73%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11.72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.02%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11.72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.24%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.82%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 38.31%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Exercisable at June 30, 2016</div>
</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">331,427</div>
</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.03%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11.72%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">32.44</div>
</td>
<td style="WIDTH: 1.02%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11.72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">7.1</div>
</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.24%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 13.82%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1">23,870</div>
</td>
<td style="WIDTH: 1.04%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company&#8217;s closing stock price on June 30, 2016 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders, had all option holders been able to, and in fact had, exercised their options on June 30, 2016.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">During the six months ended June 30, 2016, 77,000 options were issued to non-employee directors under the Plan, exercisable at an average of $2.89 per share. The options expire ten years from the date of grant and vest 50% upon on the date of grant, and 25% on each of July 1, 2016 and October 1, 2016.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">During the six months ended June 30, 2016,&#160;150,000 options were issued to officers and employees under the Plan, exercisable at an average of $2.89 per share. The options expire ten years from the date of grant and vest 50% upon each of the six month and the one year anniversary of the grant date.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">During the six months ended June 30, 2015, 43,000 options were issued to non-employee directors under the Plan, exercisable at an average of $15.12 per share. The options expire ten years from the date of grant and vested over one year, based upon 25% on the date of grant, and 25% on each of April 1, 2015, July 1, 2015, and October 1, 2015.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">During the six months ended June 30, 2015,&#160;93,813 options were issued to officers and employees under the Plan, exercisable at an average of $15.12 per share. The options expire ten years from the date of grant and vest over two years with 50% vesting upon six month anniversary of grant date and the remaining balance vesting over the following six quarters in arrears.</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff"><br style="LINE-HEIGHT: 1">
 &#160;</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">During the six months ended June 30, 2016, a total of 25,445 options that were granted under the Plan were forfeited, of which 21,825 were vested and 3,620 were unvested. The vested options were exercisable at an average of $39.81 per share and the unvested options were exercisable at an average of $15.13 per share. During the six months ended June 30, 2015, a total of 24,742 options that were granted under the Plan were forfeited, of which 4,128 were vested and 20,614 were unvested. The vested options were exercisable at an average of $98.56 per share and the unvested options were exercisable at an average of $16.48 per share.</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
 &#160;</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The total fair value of stock options granted to employees, directors and consultants that vested and became exercisable during the six months ended June 30, 2016 and 2015, was approximately&#160;$271,000 and $449,000, respectively.&#160;&#160;&#160;Based upon the Company&#8217;s experience, approximately 80% of the outstanding nonvested stock options, or approximately 162,000 options, are expected to vest in the future, under their terms.</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">12</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">A summary of the activity of nonvested options under the Plan to acquire common shares granted to employees, officers, directors and consultants during the six months ended June 30, 2016 is presented below:</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="a803bc49bdf14c89b8c428d6c75c12ef" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Nonvested Shares</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Nonvested</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Shares</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Underlying</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Options</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Weighted</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Average</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Exercise</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Price</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Weighted</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Average</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Grant Date</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Fair Value</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 58%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Nonvested at January 1, 2016</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">33,336</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">15.54</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">11.41</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 58%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Granted</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">227,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">2.89</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">2.13</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 58%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Vested</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(54,028</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">6.67</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">5.02</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 58%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;&#160;&#160;&#160;&#160;Forfeited</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(3,620</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">15.13</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">10.75</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 58%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 58%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Nonvested at June 30, 2016</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">202,688</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">3.75</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">2.73</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">At June 30, 2016, based upon employee, officer, director and consultant options granted under the Plan to that point, there was approximately $339,000 of additional unrecognized compensation cost related to stock options that will be recorded over a weighted average future period of one year.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Other common stock purchase options and warrants:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">As of June 30, 2016, in addition to the stock incentive plan options discussed above, the Company had outstanding 432,003 non-qualified options and warrants in connection with offering warrants and an officer&#8217;s employment that were not issued under the Plan.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">During the six month periods ended June 30, 2016 and 2015, respectively, no stock options were granted outside of the Plan.&#160; Operating expenses for the six months ended June 30, 2016 and 2015, did not include any value related to stock-based compensation of non-qualified options and warrants.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Following is a summary of outstanding options and warrants that were issued outside of the Plan for the six months ended June 30, 2016:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="c42e36b37b494fd99c6f9c9aaed437d8" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 48.94%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 1.41%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 11.08%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Shares</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Underlying</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Options / Warrants</div>
</td>
<td style="WIDTH: 1.63%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 12.17%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Weighted</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Average</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Exercise</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Price</div>
</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 9.57%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Weighted</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Average</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Remaining</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Contractual</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Term (Years)</div>
</td>
<td style="WIDTH: 1.21%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">&#160;</td>
<td style="WIDTH: 9.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Aggregate</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Intrinsic</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Value</div>
</td>
</tr>

<tr>
<td style="WIDTH: 48.94%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 1.41%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 0.97%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 10.11%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 1.63%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 0.95%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 11.21%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 9.57%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 1.21%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 9.73%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 48.94%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1; BACKGROUND-COLOR: #cceeff">Outstanding at January 1, 2016</div>
</td>
<td style="WIDTH: 1.41%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 0.97%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 10.11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1; BACKGROUND-COLOR: #cceeff">432,003</div>
</td>
<td style="WIDTH: 1.63%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 0.95%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1; BACKGROUND-COLOR: #cceeff">$</div>
</td>
<td style="WIDTH: 11.21%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1; BACKGROUND-COLOR: #cceeff">15.47</div>
</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 9.57%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.21%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 9.73%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 48.94%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">&#160;&#160;&#160;&#160;&#160;Granted</div>
</td>
<td style="WIDTH: 1.41%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 0.97%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 10.11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">-</div>
</td>
<td style="WIDTH: 1.63%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 0.95%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11.21%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">-</div>
</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 9.57%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.21%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 9.73%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 48.94%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1; BACKGROUND-COLOR: #cceeff">&#160;&#160;&#160;&#160;&#160;Exercised</div>
</td>
<td style="WIDTH: 1.41%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 0.97%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 10.11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1; BACKGROUND-COLOR: #cceeff">-</div>
</td>
<td style="WIDTH: 1.63%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 0.95%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11.21%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1; BACKGROUND-COLOR: #cceeff">-</div>
</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 9.57%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.21%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 9.73%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 48.94%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">&#160;&#160;&#160;&#160;&#160;Forfeited</div>
</td>
<td style="WIDTH: 1.41%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 0.97%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 10.11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">-</div>
</td>
<td style="WIDTH: 1.63%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 0.95%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 11.21%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">-</div>
</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 9.57%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.21%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 9.73%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 48.94%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.41%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 0.97%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 10.11%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.63%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 0.95%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 11.21%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 9.57%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.21%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 9.73%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 48.94%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">Outstanding and exercisable at June 30, 2016</div>
</td>
<td style="WIDTH: 1.41%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 0.97%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 10.11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">432,003</div>
</td>
<td style="WIDTH: 1.63%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 0.95%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">$</div>
</td>
<td style="WIDTH: 11.21%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">15.47</div>
</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 9.57%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">1.8</div>
</td>
<td style="WIDTH: 1.21%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1.42%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">$</div>
</td>
<td style="WIDTH: 9.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">-</div>
</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">During the six months ended June 30, 2016 and 2015, no warrants were exercised.&#160; Included at June 30, 2016 in the 432,003 total outstanding options are 429,503 non-compensatory rights, exercisable at an average of $15.40 per common share, expiring through May 2018, granted in connection with public offerings, and 2,500 rights exercisable at $27.36 per common share, expiring December 2018, issued under compensatory arrangements.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company&#8217;s closing stock price on June 30, 2016 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders, had all option holders been able to, and in fact had, exercised their options on June 30, 2016.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">13</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Note 7.&#160;&#160;Animal Health License Agreements:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Effective May 1, 2004, Washington University in St. Louis (&#8220;WU&#8221;) and Venaxis entered into an Exclusive License Agreement (&#8220;WU License Agreement&#8221;), which grants Venaxis exclusive license and right to sublicense WU&#8217;s technology (as defined under the WU License Agreement) for veterinary products worldwide, except where such products are prohibited under U.S. laws for export. The term of the WU License Agreement continues until the expiration of the last of WU&#8217;s patents (as defined in the WU License Agreement) expire.&#160;&#160;Venaxis has agreed to pay minimum annual royalties of $20,000 during the term of the WU License Agreement and such amounts are creditable against future royalties.&#160;&#160;Royalties payable to WU under the WU License Agreement for covered product sales by Venaxis carry a mid-single digit royalty rate and for sublicense fees received by Venaxis&#160;carry a low double-digit royalty rate.&#160;&#160;The WU License Agreement contains customary terms for confidentiality, prosecution and infringement provisions for licensed patents, publication rights, indemnification and insurance coverage.&#160;&#160;The WU License Agreement is cancelable by Venaxis with ninety days advance notice at any time and by WU with sixty days advance notice if Venaxis materially breaches the WU License Agreement and fails to cure such breach.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">In July 2012, the Company entered into an Exclusive License Agreement (the &#8220;License Agreement&#8221;) with Ceva Sant&#233; Animale S.A. (&#8220;Licensee&#8221;), pursuant to which the Company granted the Licensee an exclusive royalty-bearing license, until December 31, 2028, to the Company&#8217;s intellectual property and other assets, including patent rights and know-how, relating to recombinant single chain reproductive hormone technology for use in non-human mammals (the &#8220;Company&#8217;s Animal Health Assets&#8221;). The License Agreement is subject to termination by the Licensee (a) for convenience on 180 days prior written notice, (b) in the Licensee&#8217;s discretion in the event of a sale or other disposal of the Company&#8217;s animal health assets, (c) in the Licensee&#8217;s discretion upon a change in control of the Company, (d) for a material breach of the License Agreement by the Company, or (e) in the Licensee&#8217;s discretion, if the Company becomes insolvent.&#160;&#160;The License Agreement is also terminable by the Company if there is a material breach of the License Agreement by the Licensee, or if the Licensee challenges the Company&#8217;s ownership of designated intellectual property.&#160;&#160;The License Agreement includes a sublicense of the technology licensed to the Company by WU. Under the terms of the WU License Agreement, a portion of license fees and royalties Venaxis receives from&#160;sublicensing agreements will be paid to WU. The obligation for such license fees due to WU is included in accrued expenses at June 30, 2016.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Under the License Agreement, the Licensee obtained a worldwide exclusive license to develop, seek regulatory approval for and offer to sell, market, distribute, import and export luteinizing hormone (&#8220;LH&#8221;) and/or follicle-stimulating hormone (&#8220;FSH&#8221;) products for bovine (cattle), equine and swine in the field of the assistance and facilitation of reproduction in bovine, equine and swine animals.&#160;&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Under the License Agreement, as of June 30, 2016, the following future milestone payments are provided, assuming future milestones are successfully achieved:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">
<table id="46f60b17899a4fa9bf58cf56060ee6de" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">&#8226;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify">Milestone payments, totaling up to a potential of $1.1 million in the aggregate, based on the satisfactory conclusion of&#160;milestones as defined in the License Agreement;</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">
<table id="8e1ce6d41b4048fda8425a4e09cd603d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">&#8226;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify">Potential for milestone payments of up to an additional $2 million for development and receipt of regulatory approval for additional licensed products; and</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">
<table id="718e0784fab44347885ff20fd8c339c0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">&#8226;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify">Royalties, at low double digit rates, based on sales of licensed products.</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Revenue recognition related to the License Agreement and WU License Agreement is based primarily on the Company&#8217;s consideration of ASC 808-10-45, &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Accounting for Collaborative Arrangements.</font>&#8221;&#160;&#160;For financial reporting purposes, the license fees and milestone payments received from the License Agreement, net of the amounts due to third parties, including WU, have been recorded as deferred revenue and are amortized over the term of the License Agreement.&#160;&#160;License fees and milestone revenue totaling a net of approximately $1,500,000 commenced being amortized into income upon the July 2012 date of milestone achievement. As of June 30, 2016, deferred revenue of $96,698 has been classified as a current liability and $1,113,665 has been classified as a long-term liability. The current liability represents the next twelve months&#8217; portion of the amortizable milestone revenue.&#160;During the six months ended June 30, 2016 and 2015, $48,349 was recorded in each period as the amortized license fee revenue arising from the License Agreement.</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">14</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000"><br style="LINE-HEIGHT: 1">
<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font></font><br style="LINE-HEIGHT: 1">
 &#160;</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">A tabular summary of the revenue categories and cumulative amounts of revenue recognition associated with the License Agreement follows:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="f2d1a33d3eb548a2afb87d449627c214" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">Category</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Totals</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 86%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">License fees and milestone amounts paid / achieved</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,920,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 86%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">Third party obligations recorded, including WU</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(363,700</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 86%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">Deferred revenue balance</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,556,300</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 86%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">Revenue amortization to June 30, 2016</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">(345,93<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">7</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 86%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 86%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">Net deferred revenue balance at June 30, 2016</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">$</div>
</td>
<td style="WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">1,210,36<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div>&#160;</div>

<table id="36bc686410dc4269bd2d2dea3cf0710d" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">Commencement of license fees revenue recognition</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Upon signing or receipt</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">Commencement of milestone revenue recognition</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">Upon milestone achievement over then remaining life</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">Original amortization period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1">197 months</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Note 8.&#160;&#160;Commitments and contingencies:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Commitments:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">As of June 30, 2016, the Company had employment agreements with two officers providing aggregate annual minimum commitments totaling&#160;$655,000.&#160;&#160;The agreements automatically renew at the end of each year unless terminated by either party and contain customary confidentiality and benefit provisions.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Venaxis determined in the first quarter of 2016 to begin winding down and ceasing its <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font>1 commercial activities, due to continuing limited sales and losses from the European operations.&#160; This decision also resulted in a reduction of the Company&#8217;s workforce, which was implemented as of January 31, 2016. In February 2016, Venaxis sent notices to its four European distributors informing them of the wind-down and therefore the termination of their distribution agreements. Two of the distributors, linked by common management / ownership, subsequently communicated to Venaxis that they dispute that Venaxis had the right to terminate the agreements. Under the terms of the distribution agreements, such a dispute shall first be attempted to be resolved between management of the parties and then subject to binding arbitration.&#160; The parties are currently attempting to resolve the dispute without arbitration.&#160; Venaxis believes that the distributors&#8217; claims are without merit and any potential settlement or resolution will not be material to the Company&#8217;s financial position.&#160;&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Contingencies:&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">In the ordinary course of business and in the general industry in which the Company is engaged, it is not atypical to periodically receive a third party communication which may be in the form of a notice, threat, or &#8220;cease and desist&#8221; letter concerning certain activities.&#160;&#160;For example, this can occur in the context of the Company&#8217;s pursuit of intellectual property rights.&#160;&#160;This can also occur in the context of operations such as the using, making, having made, selling, and offering to sell products and services, and in other contexts.&#160;&#160;The Company makes rational assessments of each situation on a case-by-case basis as such may arise.&#160;&#160;The Company periodically evaluates its options for trademark positions and considers a full spectrum of alternatives for trademark protection and product branding.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">We are currently not a party to any legal proceedings, the adverse outcome of which would, in our management&#8217;s opinion, have a material adverse effect on our business, financial condition and results of operations.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"></div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"></div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">15</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Management&#8217;s plans and basis of presentation:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The Company has experienced recurring losses and negative cash flows from operations.&#160;&#160;At June 30, 2016, the Company had approximate balances of cash and liquid investments of $16,147,000, working capital of $15,801,000, total stockholders&#8217; equity of $16,019,000 and an accumulated deficit of $105,859,000. To date, the Company has in large part relied on equity financing to fund its operations.&#160; The Company expects to continue to incur losses from operations for the near-term and these losses could be significant, as professional and other associated expenses in connection with possible strategic considerations, evaluations and transactions, appendicitis portfolio related expenses, public company and administrative related expenses are incurred. The Company believes that its current working capital position will be sufficient to meet its estimated cash needs into 2017.&#160; The Company is closely monitoring its cash balances, cash needs and expense levels.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">As of January 26, 2016, Venaxis publicly disclosed that it had entered into a series of agreements, including a Master Agreement, for a combination transaction (the &#8220;Strand transaction&#8221;) with Strand Life Sciences Private Limited and its shareholders (&#8220;Strand&#8221;).&#160; Strand is privately-held, and operates clinical reference labs in the U.S. and in India, providing testing and lab services in India and other world-wide markets.&#160; Strand has commercialized a next generation sequencing (NGS) based, targeted, multi-gene, pan-cancer diagnostic panel in select international markets and has engaged in initial commercialization activities in the United States.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">On March 11, 2016, Venaxis and Strand entered into a Mutual Termination Agreement to terminate the series of agreements.&#160; Pursuant to the Mutual Termination Agreement, each of the parties was relieved of any obligations or responsibilities under the Master Agreement and other transaction agreements.&#160; Each party remains responsible for its respective transaction-related expenses.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Following the recent termination of the Strand transaction, the Company has begun evaluating potential strategic alternatives. The Company expects, in the near term, to utilize the primary criteria it has established as it evaluates its next steps and strategic path forward with the goal of maximizing value for its shareholders. As a result of the current market trends and uncertainties, and&#160;the impact on many companies, management believes that there may currently be attractive opportunities available to the Company.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Management&#8217;s strategic assessment includes the following potential options:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">
<table id="dab7d881d9c9435a81ff0a529a84bd05" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.25pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">&#183;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify">exploring other possible strategic options available to the Company following termination of the Strand transaction;</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">
<table id="25cf1df9bdfc4be78a1c1b05232d2ff4" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.25pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">&#183;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify">evaluating options to monetize, partner or license the Company's appendicitis product portfolio;</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">
<table id="5b50e57ba3dd4d83a93a94dc2288a96b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.25pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">&#183;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify">continuing to explore prospective partnering or licensing opportunities with complementary opportunities and technologies; and</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">
<table id="ffe6b9f218f24e9fbff13cc7512ad767" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.25pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">&#183;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify">continuing to implement cost control initiatives to conserve cash.</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">As part of the Company&#8217;s process to identify possible strategic partners, several targets were identified that the Company assessed as possibly having a business model that could be interested in discussions with Venaxis for potentially acquiring or licensing the appendicitis assets. Venaxis has made initial contact with several of these parties to gauge their interest level, which initially is more focused on the <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font>2 development assets. Management believes that the estimated potential market for an appendicitis test continues to be significant. If Venaxis is unable to locate a new strategic target, a partner or other third-party interested in advancing development and commercial activities of the Venaxis appendicitis portfolio, the capitalized costs on the Company&#8217;s balance sheet, totaling approximately $371,000, as of June 30, 2016 for the acute appendicitis patents may be deemed impaired.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Results of Operations</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Comparative Results for the Six Months Ended June 30, 2016 and 2015</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">No sales were recorded for the six months ended June 30, 2016, as compared to sales of $36,000 in the 2015 period. The 2015 sales resulted from <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font>1 product sales in the EU. Sales of the <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font>1&#160;products have been to customers for initial stocking and market study orders in the EU under commercial development agreements. The decrease in the 2016 period is attributed to the wind-down of the <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font>1 activities.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Cost of sales was zero for the six months ended June 30, 2016 and $12,103 (34% of revenue) for the six months ended June 30, 2015.&#160; The decrease in the 2016 period is attributed to the wind-down of the <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font>1 activities.</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">16</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000"><br>
</font><br style="LINE-HEIGHT: 1">
 &#160;</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">During each of the six month periods ended June 30, 2016 and 2015, $48,000 of license payments under the&#160;Exclusive License Agreement (the &#8220;License Agreement&#8221;) with Ceva Sant&#233; Animale S.A. (&#8220;Licensee&#8221;) was recognized as revenue.&#160;&#160; See further discussion regarding the License Agreement below under the heading &#8220;Liquidity and Capital Resources.&#8221;</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Selling, general and administrative expenses in the six months ended June 30, 2016 totaled $1,853,000, which is an approximately $1,165,000, or 39%, decrease as compared to the 2015 period. Commercialization, marketing and compensation related expenses decreased by approximately $613,000 in the 2016 period as the Company wound down <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font>1 commercialization activities. Stock based compensation also decreased by approximately $474,000 for the six months ended June 30, 2016, as compared to the 2015 period due to fewer options being granted to directors, management and employees.&#160; Legal expenses decreased by $343,000 for the 2016 period<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> due to less legal services on various matters</font>.&#160; A decrease of $152,000 in general operating expenses was due to the winding down of operations.&#160; These decreases were offset by an increase in strategic evaluation costs of approximately $417,000 related to the termination of the Strand transaction and evaluation of possible alternatives.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Research and development expenses in the six months ended June 30, 2016 totaled $446,000, which is an approximately $814,000, or 65%, decrease as compared to the 2015 period.&#160;A decrease of $9<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">69</font>,000 was due primarily to winding down development and commercialization of <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font>2 and <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font>1 operations, including a decrease of $496,000 due to staff reductions.&#160; These decreases were partially offset by an increase in patent impairment costs of approximately $155,000.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Interest expense for the six months ended June 30, 2016 decreased to $26,000, compared to $49,000 in the 2015 period.&#160;The decrease is attributed to the payoff of the mortgage loans through the sale of the land and building in the first quarter of 2016.&#160; For the six months ended June 30, 2016, the Company recorded investment income of approximately $79,000, compared to investment income of $36,000 in the 2015 period.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">On February 25, 2016, the Company completed the sale of its corporate headquarters, land, building and certain fixtures and equipment to a third party at a purchase price of $4,053,000.&#160;The sale resulted in a gain of approximately $1,900,000 and generated approximately $1,700,000 in net cash after expenses and mortgage payoffs. The Company is leasing back space in the building under short-term lease agreements that provide office and storage space required for its current level of operations.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">No income tax benefit was recorded on the net loss for the six months ended June 30, 2016 and 2015, as management was unable to determine that it was more likely than not that such benefit would be realized.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Comparative Results for the Three Months Ended June 30, 2016 and 2015</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">No sales were recorded for the three months ended June 30, 2016, compared to $25,000 in sales in the 2015 period. The 2015 sales resulted from <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font>1 product sales in the EU.&#160; Sales of the <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font>1 System products have been to distributors primarily for initial stocking and market study orders in the EU under commercial development agreements and the timing of sales are generally tied to the distributors&#8217; ordering needs and cycles.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160; The decrease in the 2016 period is attributed to the wind-down of the </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1 activities.</font></div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Cost of sales was zero for the three months ended June 30, 2016 and $8,096 (33% of revenue) for the three months ended June 30, 2015.&#160; The decrease in the 2016 period is attributed to the wind-down of the </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1 activities.</font><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">During each of the three month periods ended June 30, 2016 and 2015, $24,000 of license payments under the License Agreement was recognized as revenue.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Selling, general and administrative expenses in the three months ended June 30, 2016 totaled $823,000, which is an approximately $660,000, or 45%, decrease, compared to the 2015 period. Commercialization, marketing, public and compensation related expenses decreased by approximately $510,000 in the 2016 period as the Company scaled back on its U.S. commercialization activities due to the FDA's January 2015 determination that the Company&#8217;s <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY1</font> Test does not meet the criteria for market clearance as a class II medical device. Legal expenses decreased by $265,000 for the 2016 period<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> due to less legal services on various matters</font>.&#160; These decreases were offset by an increase in strategic evaluation costs of approximately $115,000 as the Company continued to evaluate possible alternatives.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Research and development expenses in the three months ended June 30, 2016 totaled $73,000, which is an approximately $479,000, or 87%, decrease, compared to the 2015 period.&#160;A decrease of $51<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3</font>,000 was due primarily to winding down development and commercialization of <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font>2 and <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font>1 operations, including a decrease of $321,000 due to staff reductions.&#160; These decreases were partially offset by an increase in patent impairment costs of approximately $34,000.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Interest expense for the three months ended June 30, 2016 decreased to $150, compared to $24,000 in the 2015 period.&#160;For the three months ended June 30, 2016, the Company recorded an investment income of approximately $35,000, compared to an investment loss of $15,000 in the 2015 period.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Liquidity and Capital Resources</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">At June 30, 2016, we had working capital of $15,801,000, which included cash, cash equivalents and short-term investments of $16,147,000.&#160;&#160;We reported a net loss of $276,000 during the six months ended June 30, 2016, which included $1,530,000 in non-cash items consisting of stock-based compensation totaling $224,000, depreciation and amortization totaling $46,000, and impairment of patent costs of $168,000, a net of gain on sale of property and equipment totaling $1,920,000, and amortization of license fees totaling $48,000.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">We expect to continue to incur losses from operations for the near-term and these losses could be significant as we incur professional and other associated expenses in connection with the various strategic opportunities that are being evaluated, appendicitis portfolio related expenses, public company and administrative related expenses. We believe that our current working capital position will be sufficient to meet our estimated cash needs into 2017.&#160;We may pursue potential additional financing opportunities.&#160; However, there can be no assurance that we will be able to obtain sufficient additional financing on terms acceptable to us, if at all.&#160;&#160;&#160;We are closely monitoring our cash balances, cash needs and expense levels.&#160;The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that might result in our possible inability to continue as a going concern.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">As a result of the termination of the Strand transaction, the Company is evaluating new strategic alternatives.&#160; If the Company is unable to locate a new strategic target, or a partner or other third-party interested in advancing development and or commercial activities of the Venaxis appendicitis portfolio,&#160; the costs the Company has incurred for the acute appendicitis patents and other development assets may be deemed impaired.&#160;&#160;</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">&#160;</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">In July 2012, the Company entered into the License Agreement with the Licensee, pursuant to which the Company granted the Licensee an exclusive royalty-bearing license, until December 31, 2028, to the Company&#8217;s intellectual property and other assets, including patent rights and know-how, relating to recombinant single chain reproductive hormone technology for use in non-human mammals (the &#8220;Company&#8217;s Animal Health Assets&#8221;). The License Agreement is subject to termination by the Licensee (a) for convenience on 180 days prior written notice, (b) in the Licensee&#8217;s discretion in the event of a sale or other disposal of the Company&#8217;s animal health assets, (c) in the Licensee&#8217;s discretion upon a change in control of the Company, (d) for a material breach of the License Agreement by the Company, or (e) in the Licensee&#8217;s discretion, if the Company becomes insolvent.&#160;&#160;The License Agreement is also terminable by the Company if there is a material breach of the License Agreement by the Licensee, or if the Licensee challenges the Company&#8217;s ownership of designated intellectual property.&#160;The License Agreement includes a sublicense of the technology licensed to the Company by WU. Under the terms of the WU License Agreement, a portion of license fees and royalties Venaxis receives from&#160;sublicensing agreements will be paid to WU. The obligation for such license fees due to WU is included in accrued expenses at June 30, 2016.</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>
</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">17</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>
</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Under the License Agreement, as of June 30, 2016, the following future milestone payments are provided, assuming future milestones are successfully achieved:</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">
<table id="0d2b7a450edf4b1db7f0299cbf10a258" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">&#8226;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify">Milestone payments, totaling up to a potential of $1.1 million in the aggregate, based on the satisfactory conclusion of&#160;milestones as defined in the License Agreement;</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">
<table id="7dbef41048a74161b1bf3c6c5109fa59" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">&#8226;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify">Potential for milestone payments of up to an additional $2 million for development and receipt of regulatory approval for additional licensed products; and</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">
<table id="7c34506cf3e9457abcd0dcc74ffcc102" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 27pt; VERTICAL-ALIGN: top; COLOR: #000000; align: right">&#8226;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify">Royalties, at low double digit rates, based on sales of licensed products.</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The Company periodically enters into generally short-term consulting agreements, which at this time are primarily for assistance with our strategic evaluations.&#160; Such commitments at any point in time may be significant but the agreements typically contain cancellation provisions.</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Prior to the February 2016 sale of its corporate headquarters, the Company had a permanent mortgage on its land and building that was refinanced in May 2013. The mortgage was held by a commercial bank and included a portion guaranteed by the U. S. Small Business Administration (&#8220;SBA&#8221;). The loan was collateralized by the real property and the SBA portion was also personally guaranteed by a former officer of the Company.&#160;The commercial bank loan terms included a payment schedule based on a fifteen year amortization, with a balloon&#160;maturity at five years. The commercial bank portion had an interest rate fixed at 3.95%, and the SBA portion bore interest at the rate of 5.86%. The commercial bank portion of the loan required total monthly payments of approximately $11,700, which included approximately $4,500 per month in interest. The SBA portion of the loan required total monthly payments of approximately $9,000 through July 2023, which included approximately $3,500 per month in interest and fees in 2016.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">On February 25, 2016, the Company completed the sale of its corporate headquarters, land, building and certain fixtures and equipment to a third party at a purchase price of $4,053,000.&#160;The sale resulted in a gain of approximately $1,900,000 and generated approximately $1,700,000 in net cash after expenses and mortgage payoffs. The Company is leasing back space in the building under short-term lease agreements that provide office and storage space required for its current level of operations.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Venaxis determined in the first quarter of 2016 to begin winding down and ceasing its <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font>1 commercial activities, due to continuing limited sales and losses from the European operations.&#160; This decision also resulted in a reduction of the Company&#8217;s workforce, which was implemented as of January 31, 2016. In February 2016, Venaxis sent notices to its four European distributors informing them of the wind-down and therefore the termination of their distribution agreements. Two of the distributors, linked by common management / ownership, subsequently communicated to Venaxis that they dispute that Venaxis had the right to terminate the agreements. Under the terms of the distribution agreements, such a dispute shall first be attempted to be resolved between management of the parties and then subject to binding arbitration.&#160; The parties are currently attempting to resolve the dispute without arbitration.&#160; Venaxis believes that the distributors&#8217; claims are without merit and any potential settlement or resolution will not be material to the Company&#8217;s financial position.&#160;&#160;&#160;&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Due to recent market events that have adversely affected all industries and the economy as a whole, management has placed increased emphasis on monitoring the risks associated with the current environment, particularly the investment parameters of the short-term investments, the recoverability of current assets, the fair value of assets, and the Company&#8217;s liquidity. At this point in time, there has not been a material impact on the Company&#8217;s assets and liquidity. Management will continue to monitor the risks associated with the current environment and their impact on the Company&#8217;s results.</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">18</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Operating Activities</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Net cash consumed by operating activities was $2,546,000 during the six months ended June 30, 2016. Cash was consumed by the loss of $276,000, less non-cash expenses of $438,000 for stock-based compensation, depreciation and amortization, and impairment of patent costs, offset by the gain on sale of property and equipment of $1,920,000 and amortization of license fees totaling $48,000. Decreases in prepaid and other current assets of $194,000 provided cash, primarily related to routine changes in operating activities.&#160;&#160;There was a $933,000 decrease in accounts payable and accrued expenses in the six months ended June 30, 2016, primarily due to the payment of 2015 accrued incentives in early 2016, and a reduction in overall expenses due to the wind-down of the <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">APPY</font>1 activities.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Net cash consumed by operating activities was $3,825,000 during the six months ended June 30, 2015. Cash was consumed by the loss of $4,220,000, less non-cash expenses of $915,000 for stock-based compensation, depreciation and amortization, and other non-cash charges, offset by the amortization of license fees totaling $48,000. The overall decrease in prepaid and other current assets, including accounts receivable, provided cash of $202,000, which is related due primarily to routine changes in operating activities.&#160;&#160;There was a $674,000 decrease in accounts payable and accrued expenses in the six months ended June 30, 2015, primarily due to a decrease in accrued compensation.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Investing Activities</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Net cash inflows from investing activities provided $5,198,000 during the six months ended June 30, 2016. Sales of marketable securities investments totaling approximately $13,613,000 provided cash net of marketable securities purchased totaling approximately $10,150,000.&#160;&#160;A $14,000 use of cash was attributable to additional costs incurred from patent filings.&#160; The sale of the land, building and assets generated approximately $1,749,000 in cash.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Net cash inflows from investing activities provided $5,389,000 during the six months ended June 30, 2015. Sales of marketable securities investments totaled approximately $21,653,000 and marketable securities purchased totaled approximately $16,217,000.&#160;&#160;A $47,000 use of cash was attributable to additional costs incurred from patent filings.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Financing Activities</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Net cash outflows from financing activities consumed $174,000 during the six months ended June 30, 2016 in scheduled payments under debt agreements.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Net cash outflows from financing activities consumed $236,000 during the six months ended June 30, 2015 in scheduled payments under its debt agreements.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Critical Accounting Policies&#160;&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP) requires management to make estimates and assumptions about future events that affect the amounts reported in the financial statements and accompanying notes. Future events and their effects cannot be determined with absolute certainty. Therefore, the determination of estimates requires the exercise of judgment. Actual results inevitably will differ from those estimates, and such differences may be material to the financial statements. The most significant accounting estimates inherent in the preparation of our financial statements include estimates associated with revenue recognition, impairment analysis of intangibles and stock-based compensation.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The Company&#8217;s financial position, results of operations and cash flows are impacted by the accounting policies the Company has adopted. In order to get a full understanding of the Company&#8217;s financial statements, one must have a clear understanding of the accounting policies employed. A summary of the Company&#8217;s critical accounting policies follows:</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Investments</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">:</font>&#160;&#160;&#160;The Company invests excess cash from time to time in highly liquid debt and equity securities of highly rated entities which are classified as trading securities. Such amounts are recorded at market and are generally classified as current, as the Company does not intend to hold the investments beyond twelve months. Such excess funds are invested under the Company&#8217;s investment policy but an unexpected decline or loss could have an adverse and material effect on the carrying value, recoverability or investment returns of such investments. Our Board has approved an investment policy covering the investment parameters to be followed with the primary goals being the safety of principal amounts and maintaining liquidity of the fund. The policy provides for minimum investment rating requirements as well as limitations on investment duration and concentrations.</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">19</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Intangible Assets</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">:</font>&#160;&#160;&#160;Intangible assets primarily represent legal costs and filings associated with obtaining patents on the Company&#8217;s new discoveries.&#160;&#160;The Company amortizes these costs over the shorter of the legal life of the patent or its estimated economic life using the straight-line method.&#160;&#160;The Company tests intangible assets with finite lives upon significant changes in the Company&#8217;s business environment. The testing resulted in $168,000 net patent impairment charges written off during the six month periods ended June 30, 2016 and $5,000 for the six months ended June 30, 2015.</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Long-Lived Assets</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">:</font>&#160;&#160;&#160;The Company records property and equipment at cost. Depreciation of the assets is recorded on the straight-line basis over the estimated useful lives of the assets. Dispositions of property and equipment are recorded in the period of disposition and any resulting gains or losses are charged to income or expense when the disposal occurs. The Company reviews for impairment whenever there is an indication of impairment.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Revenue Recognition</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">:</font>&#160; The Company&#8217;s revenues are recognized when products are shipped or delivered to unaffiliated customers. The Securities and Exchange Commission&#8217;s Staff Accounting Bulletin (SAB) No. 104 provides guidance on the application of GAAP to select revenue recognition issues. The Company has concluded that its revenue recognition policy is appropriate and in accordance with SAB No. 104. Revenue is recognized under sales, license and distribution agreements only after the following criteria are met: (i) there exists adequate evidence of the transactions; (ii) delivery of goods has occurred or services have been rendered; and (iii) the price is not contingent on future activity; and (iv) collectability is reasonably assured.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Stock-based Compensation</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">:</font>&#160;&#160;&#160;ASC 718, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Share-Based Payment</font>, defines the fair-value-based method of accounting for stock-based employee compensation plans and transactions used by the Company to account for its issuances of equity instruments to record compensation cost for stock-based employee compensation plans at fair value as well as to acquire goods or services from non-employees. Transactions in which the Company issues stock-based compensation to employees, directors and consultants and for goods or services received from non-employees are accounted for based on the fair value of the equity instruments issued. The Company utilizes pricing models in determining the fair values of options and warrants issued as stock-based compensation. These pricing models utilize the market price of the Company&#8217;s common stock and the exercise price of the option or warrant, as well as time value and volatility factors underlying the positions.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Recently issued and adopted accounting pronouncements</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">:&#160; </font>The Company has evaluated all recently issued accounting pronouncements and believes such pronouncements do not have a material effect on the Company&#8217;s financial statements.</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">In May 2014, FASB issued Accounting Standards Update ("ASU") No. 2014-09 "Revenue from Contracts from Customers," which supersedes the revenue recognition requirements in "Revenue Recognition (Topic 605)," and requires entities to recognize revenue in a way that depicts the transfer of potential goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to the exchange for those goods or services. In July 2015, the FASB extended the effective date of ASU 2014-09 by one year, to now be effective for fiscal years, and interim periods beginning after December 15, 2017, and is to be applied retrospectively, with early adoption now permitted for fiscal years, and interim periods beginning after December 31, 2015. The Company does not believe that the new standard will have a material impact on its future operations and financial statements.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font></font><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Item&#160;3.&#160;&#160; Quantitative and Qualitative Disclosures About Market Risk</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">General</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">We have limited exposure to market risks from instruments that may impact the Balance Sheets, Statements of Operations, and Statements of Cash Flows. Such exposure is due primarily to changing interest rates.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Interest Rates</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">The primary objective for our investment activities is to preserve principal while maximizing yields without significantly increasing risk. This is accomplished by investing excess cash in highly liquid debt and equity investments of highly rated entities which are classified as trading securities.&#160;&#160;As of June 30, 2016, approximately 20% of the investment portfolio was in cash and cash equivalents with very short-term maturities and therefore not subject to any significant interest rate fluctuations. We have no investments denominated in foreign currencies and therefore our investments are not subject to foreign currency exchange risk.</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">20</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000"><br style="LINE-HEIGHT: 1">
<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font></font><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Item 4.&#160; Controls and Procedures</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Evaluation of Disclosure Controls and Procedures</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Management of the&#160;Company, including the Chief Executive Officer and the&#160;Chief Financial Officer, has conducted an evaluation of the effectiveness&#160;of the Company&#8217;s disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rule 13a-15(e)) as of the last day of the period of the accompanying financial statements.&#160; Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective as of June 30, 2016.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Changes in Internal Control Over Financial Reporting</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">There was no change in the Company&#8217;s internal control over financial reporting that occurred during the fiscal quarter to which this report relates that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">21</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">PART II -&#160;OTHER INFORMATION</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Item 1.&#160;&#160;&#160; Legal Proceedings<br style="LINE-HEIGHT: 1">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">We are not a party to any legal proceedings, the adverse outcome of which would, in our management&#8217;s opinion, have a material adverse effect on our business, financial condition and results of operations.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Item&#160;1A.&#160;&#160;Risk Factors</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">There have been no material changes from the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2015.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Item 6.&#160;&#160;&#160;&#160;&#160;Exhibits</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="c7e00933b26d4637a306483681123d83" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 8.34%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">EXHIBIT</div>
</td>
<td style="WIDTH: 0.18%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 91.48%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">DESCRIPTION</div>
</td>
</tr>

<tr>
<td style="WIDTH: 8.34%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 0.18%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 91.48%; VERTICAL-ALIGN: middle">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 8.34%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">31.1</div>
</td>
<td style="WIDTH: 0.18%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 91.48%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Rule 13a-14(a)/15d-14(a) - Certification of Chief Executive Officer. Filed herewith.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 8.34%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">31.2</div>
</td>
<td style="WIDTH: 0.18%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 91.48%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">Rule 13a-14(a)/15d-14(a) - Certification of Chief Financial Officer. Filed herewith.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 8.34%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">32</div>
</td>
<td style="WIDTH: 0.18%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 91.48%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Section 1350 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. Furnished herewith.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 8.34%; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1">99.1</div>
</td>
<td style="WIDTH: 0.18%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 91.48%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Notice to Corporate Stock Transfer Inc., as Warrant Agent, dated April 1, 2016 (incorporated by reference to Exhibit 99.1 to the Registrant&#8217;s Current Report on Form 8-K, dated March 31, 2016, and filed April 4, 2016).</div>
</td>
</tr>

<tr>
<td style="WIDTH: 8.34%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">101&#160;</div>
</td>
<td style="WIDTH: 0.18%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 91.48%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1">Interactive data files pursuant to Rule 405 of Regulation S-T: (i) the Balance Sheets, (ii) the Statements of Operations, (iii) the Statement of Cash Flows and (iv) the Notes to Condensed Financial Statements.</div>
</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">22</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">SIGNATURES</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="7fbf1f10c84b40148c1c0d139b38e258" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 43.75%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 37.51%; VERTICAL-ALIGN: bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Venaxis, Inc.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">(Registrant)</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
<td style="WIDTH: 18.74%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 43.75%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 6.75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">By:</div>
</td>
<td style="WIDTH: 30.76%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">/s/ Jeffrey G. McGonegal</div>
</td>
<td style="WIDTH: 18.74%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 43.75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Dated: <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BACKGROUND-COLOR: #ffffff">August 10,</font> 2016</div>
</td>
<td style="WIDTH: 6.75%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 49.5%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Jeffrey G. McGonegal,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Chief Financial Officer and duly authorized officer</div>
</td>
</tr>

<tr>
<td style="WIDTH: 43.75%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 6.75%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 30.76%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 18.74%; VERTICAL-ALIGN: top">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">23</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
 &#160;</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex31x1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: EDGAR Technology and Business Services Inc.
    Document created using EDGARfilings PROfile 3.6.1.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#ffffff" text="#000000">
<div>
<div style="LINE-HEIGHT: 1">&#160;</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">EXHIBIT 31.1</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">CERTIFICATION</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>
</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">I, Stephen T. Lundy, certify that:<br style="LINE-HEIGHT: 1">
 &#160;</div>
</div>

<div style="background-color: #ffffff; margin-bottom: 3pt; font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-top: 3pt; line-height: 1; text-indent: 36pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of Venaxis, Inc.;<br style="LINE-HEIGHT: 1">
 &#160;</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
 &#160;</div>
</div>

<div style="background-color: #ffffff; margin-bottom: 3pt; font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-top: 3pt; line-height: 1; text-indent: 36pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;<br style="LINE-HEIGHT: 1">
 &#160;</div>

<div style="background-color: #ffffff; margin-bottom: 3pt; font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-top: 3pt; line-height: 1; text-indent: 36pt;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:<br style="LINE-HEIGHT: 1">
 &#160;</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and<br style="LINE-HEIGHT: 1">
 &#160;</div>
</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
 &#160;</div>
</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="ca56432c408c415a8e4658eeac42f82c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 38.82%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 21.18%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 38.82%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">August 10, 2016</div>
</td>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 21.18%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 38.82%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">/s/ Stephen T. Lundy</div>
</td>
<td style="WIDTH: 21.18%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 38.82%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Stephen T. Lundy, Chief Executive Officer and President</div>
</td>
<td style="WIDTH: 21.18%; VERTICAL-ALIGN: top">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>
</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><img style="HEIGHT: 2px; WIDTH: 2px" src="image24.jpg"></div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #404040; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #404040" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex31x2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: EDGAR Technology and Business Services Inc.
    Document created using EDGARfilings PROfile 3.6.1.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#ffffff" text="#000000">
<div>
<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">EXHIBIT 31.2</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">CERTIFICATION</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
 &#160;</div>
</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">&#160;I, Jeffrey G. McGonegal, certify that:<br style="LINE-HEIGHT: 1">
</div>
</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of Venaxis, Inc.;<br style="LINE-HEIGHT: 1">
 &#160;</div>
</div>

<div style="background-color: #ffffff; margin-bottom: 3pt; font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-top: 3pt; line-height: 1; text-indent: 36pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;<br style="LINE-HEIGHT: 1">
 &#160;</div>

<div style="background-color: #ffffff; margin-bottom: 3pt; font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-top: 3pt; line-height: 1; text-indent: 36pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;<br style="LINE-HEIGHT: 1">
 &#160;</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: 36pt">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:<br style="LINE-HEIGHT: 1">
</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
 &#160;</div>
</div>

<div style="background-color: #ffffff; margin-bottom: 3pt; font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left; margin-top: 3pt; line-height: 1; text-indent: 36pt;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):<br style="LINE-HEIGHT: 1">
 &#160;</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</div>

<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
 &#160;</div>
</div>

<table id="28231cc821c44c8cb834a0a0c61d1854" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 34.52%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 27.38%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 38.1%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 34.52%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">August 10, 2016</div>
</td>
<td style="WIDTH: 27.38%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 38.1%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 34.52%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 27.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">/s/ Jeffrey G. McGonegal</div>
</td>
<td style="WIDTH: 38.1%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 34.52%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 27.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Jeffrey G. McGonegal, Chief Financial Officer</div>
</td>
<td style="WIDTH: 38.1%; VERTICAL-ALIGN: middle">&#160;</td>
</tr>
</table>

<div style="background-color: #ffffff; line-height: 1;"><br style="LINE-HEIGHT: 1">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>ex32.htm
<DESCRIPTION>EXHIBIT 32
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: EDGAR Technology and Business Services Inc.
    Document created using EDGARfilings PROfile 3.6.1.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#ffffff" text="#000000">
<div>
<div style="MARGIN-BOTTOM: 3pt; TEXT-ALIGN: right; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">EXHIBIT 32</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">CERTIFICATION PURSUANT</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">TO 18 U.S.C. SECTION 1350,</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">AS ADOPTED PURSUANT TO</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>
</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 3pt; LINE-HEIGHT: 1; TEXT-INDENT: 36pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In connection with the Quarterly Report on Form 10-Q (the &#8220;Report&#8221;) of Venaxis, Inc. (the &#8220;Company&#8221;) for the quarter ended June 30, 2016, each of the undersigned Stephen T. Lundy and Jeffrey G. McGonegal, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the undersigned&#8217;s knowledge and belief:<br style="LINE-HEIGHT: 1">
</div>
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<table id="5564ae817a2c4731b08249247e04551c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 5.88%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.88%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">(1)</div>
</td>
<td style="WIDTH: 88.24%; VERTICAL-ALIGN: top" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.88%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.88%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">(2)</div>
</td>
<td style="WIDTH: 88.24%; VERTICAL-ALIGN: top" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 37.66%; VERTICAL-ALIGN: bottom" colspan="3">&#160;</td>
<td style="WIDTH: 38.82%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 23.52%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 37.66%; VERTICAL-ALIGN: top" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">August 10, 2016</div>
</td>
<td style="WIDTH: 38.82%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 23.52%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 37.66%; VERTICAL-ALIGN: top" colspan="3">&#160;</td>
<td style="WIDTH: 38.82%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">/s/ Stephen T. Lundy</div>
</td>
<td style="WIDTH: 23.52%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 37.66%; VERTICAL-ALIGN: top" colspan="3">&#160;</td>
<td style="WIDTH: 38.82%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Stephen T. Lundy, Chief Executive Officer and President</div>
</td>
<td style="WIDTH: 23.52%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 37.66%; VERTICAL-ALIGN: top" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">August 10, 2016</div>
</td>
<td style="WIDTH: 38.82%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 23.52%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 37.66%; VERTICAL-ALIGN: top" colspan="3">&#160;</td>
<td style="WIDTH: 38.82%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">/s/ Jeffrey G. McGonegal</div>
</td>
<td style="WIDTH: 23.52%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 37.66%; VERTICAL-ALIGN: top" colspan="3">&#160;</td>
<td style="WIDTH: 38.82%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1">Jeffrey G. McGonegal, Chief Financial Officer</div>
</td>
<td style="WIDTH: 23.52%; VERTICAL-ALIGN: top">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>
</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 3pt; LINE-HEIGHT: 1">*&#160;&#160;*&#160;&#160;*&#160;&#160;*&#160;&#160;*</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>
</div>

<div style="LINE-HEIGHT: 1; BACKGROUND-COLOR: #ffffff">
<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 3pt; LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>

<div style="LINE-HEIGHT: 1"><br style="LINE-HEIGHT: 1">
</div>
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>5
<FILENAME>appy-20160630.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: appy%2D20160630 Final.xfr; Date: 2016%2D08%2D10T18:55:44Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80060000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:appy="http://venaxis.com/20160630">
    <link:schemaRef xlink:href="appy-20160630.xsd" xlink:type="simple" />
    <xbrli:context id="AsOf2015-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C790972">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C790968">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C791670">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_LandAndLandImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C791672">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C791674">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_BuildingAndBuildingImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C791676">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_OtherMachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C791678">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_us-gaap_MortgagesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_NotesPayableToBanksMember_us-gaap_MortgagesMember_custom_NotesPayableToBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">appy:NotesPayableToBankMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_MortgagesMember_custom_UnitedStatesSmallBusinessAdministrationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">appy:UnitedStatesSmallBusinessAdministrationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_us-gaap_MortgagesMember_custom_UnitedStatesSmallBusinessAdministrationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">appy:UnitedStatesSmallBusinessAdministrationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_us-gaap_NotesPayableToBanksMember_us-gaap_MortgagesMember_custom_NotesPayableToBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">appy:NotesPayableToBankMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C792118">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C792117">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_custom_NonqualifiedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:NonqualifiedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-06-30_us-gaap_GeographicConcentrationRiskMember_us-gaap_SalesRevenueNetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-06-30_us-gaap_GeographicConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">appy:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-06-30_us-gaap_GeographicConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">appy:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-06-30_us-gaap_GeographicConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">appy:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:IndependentDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:OfficersAndEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C792015">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C792016">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C792017">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C792018">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C792130">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C792169">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:NonqualifiedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_NonqualifiedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:NonqualifiedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_StockIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C791875">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">us-gaap:EmploymentContractsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-02-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-04-01to2015-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-04-01to2015-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-04-01to2015-06-30_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-08-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-08-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:IndependentDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:OfficersAndEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_NonqualifiedMember_custom_NonCompensatoryRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:NonqualifiedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:NonCompensatoryRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:IndependentDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:IndependentDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:IndependentDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:OfficersAndEmployeesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:OfficersAndEmployeesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:IndependentDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:IndependentDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:IndependentDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember_custom_ShareBasedCompensationAwardTrancheFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:IndependentDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">appy:ShareBasedCompensationAwardTrancheFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:OfficersAndEmployeesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:StockIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:OfficersAndEmployeesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_custom_NonqualifiedMember_custom_NonCompensatoryRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:NonqualifiedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:NonCompensatoryRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-06-30_custom_NonqualifiedMember_custom_CompensatoryRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:NonqualifiedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:CompensatoryRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_NonqualifiedMember_custom_CompensatoryRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001167419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">appy:NonqualifiedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="appy:IssuanceTypeAxis">appy:CompensatoryRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPerShare">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Officers">
      <xbrli:measure>appy:Officers</xbrli:measure>
    </xbrli:unit>
    <us-gaap:ShortTermInvestments contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">14147991</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="C790972" unitRef="USD" decimals="0">11657412</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">251778</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="C790972" unitRef="USD" decimals="0">111042</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">16412052</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="C790972" unitRef="USD" decimals="0">16258263</us-gaap:AssetsCurrent>
    <us-gaap:Assets contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">20862197</us-gaap:Assets>
    <us-gaap:Assets contextRef="C790972" unitRef="USD" decimals="0">17589516</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">701064</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="C790972" unitRef="USD" decimals="0">194599</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">449873</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="C790972" unitRef="USD" decimals="0">13408</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">241882</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="C790972" unitRef="USD" decimals="0">152602</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">1790767</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="C790972" unitRef="USD" decimals="0">457307</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">4791561</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="C790972" unitRef="USD" decimals="0">1570972</us-gaap:Liabilities>
    <us-gaap:CommonStockNoParValue contextRef="AsOf2015-12-31" unitRef="USDPerShare" xsi:nil="true" />
    <us-gaap:CommonStockNoParValue contextRef="C790972" unitRef="USDPerShare" xsi:nil="true" />
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2015-12-31" unitRef="Shares" decimals="INF">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="C790972" unitRef="Shares" decimals="INF">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2015-12-31" unitRef="Shares" decimals="INF">3876961</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="C790972" unitRef="Shares" decimals="INF">3876961</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">121653075</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital contextRef="C790972" unitRef="USD" decimals="0">121877347</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">-105582439</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="C790972" unitRef="USD" decimals="0">-105858803</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">16070636</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C790972" unitRef="USD" decimals="0">16018544</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">20862197</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="C790972" unitRef="USD" decimals="0">17589516</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2015-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="C790972" unitRef="USD" xsi:nil="true" />
    <us-gaap:InvestmentsAndCash contextRef="C790972" unitRef="USD" decimals="0">16147000</us-gaap:InvestmentsAndCash>
    <appy:WorkingCapital contextRef="C790972" unitRef="USD" decimals="0">15801000</appy:WorkingCapital>
    <us-gaap:Depreciation contextRef="C790968" unitRef="USD" decimals="0">51000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">800</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">38000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">400</us-gaap:Depreciation>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="C790968" unitRef="USD" decimals="0">780983</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">224272</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="C792015" unitRef="USD" decimals="0">696006</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="C792016" unitRef="USD" decimals="0">221712</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="C792017" unitRef="USD" decimals="0">84977</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="C792018" unitRef="USD" decimals="0">2560</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">347581</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">176388</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2016-04-01to2016-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember" unitRef="USD" decimals="0">176388</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2016-04-01to2016-06-30_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2015-04-01to2015-06-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember" unitRef="USD" decimals="0">303644</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2015-04-01to2015-06-30_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="0">43937</us-gaap:AllocatedShareBasedCompensationExpense>
    <appy:LicenseAndMilestonePaymentsRevenue contextRef="C790972" unitRef="USD" decimals="0">1920000</appy:LicenseAndMilestonePaymentsRevenue>
    <us-gaap:DeferredCostsCurrentAndNoncurrent contextRef="C790972" unitRef="USD" decimals="0">363700</us-gaap:DeferredCostsCurrentAndNoncurrent>
    <appy:DeferredRevenueAccumulatedRecognition contextRef="C790972" unitRef="USD" decimals="0">345937</appy:DeferredRevenueAccumulatedRecognition>
    <us-gaap:DeferredRevenue contextRef="C790972" unitRef="USD" decimals="0">1210363</us-gaap:DeferredRevenue>
    <us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted contextRef="C791875" unitRef="USD" decimals="0">655000</us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted>
    <appy:NumberOfOfficersUnderEmployementAgreements contextRef="From2016-01-01to2016-06-30" unitRef="Officers" decimals="INF">2</appy:NumberOfOfficersUnderEmployementAgreements>
    <dei:EntityRegistrantName contextRef="From2016-01-01to2016-06-30">Venaxis, Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2016-01-01to2016-06-30">0001167419</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2016-01-01to2016-06-30">10-Q</dei:DocumentType>
    <dei:AmendmentFlag contextRef="From2016-01-01to2016-06-30">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate contextRef="From2016-01-01to2016-06-30">2016-06-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2016-01-01to2016-06-30">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="From2016-01-01to2016-06-30">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2016-01-01to2016-06-30">2016</dei:DocumentFiscalYearFocus>
    <dei:EntityFilerCategory contextRef="From2016-01-01to2016-06-30">Smaller Reporting Company</dei:EntityFilerCategory>
    <us-gaap:LongTermInvestments contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">972000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments contextRef="C790972" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2015-12-31" unitRef="Shares" decimals="INF">3876961</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="C790972" unitRef="Shares" decimals="INF">3876961</us-gaap:CommonStockSharesOutstanding>
    <appy:TotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners contextRef="C790972" unitRef="USD" decimals="0">371000</appy:TotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners>
    <appy:SalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty contextRef="AsOf2016-02-29" unitRef="USD" decimals="0">4000000</appy:SalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2016-01-01to2016-06-30">P197M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2016-08-10" unitRef="Shares" decimals="INF">3876961</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:SecuredDebt contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">1997701</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt contextRef="C790972" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherShortTermBorrowings contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">142328</us-gaap:OtherShortTermBorrowings>
    <us-gaap:OtherShortTermBorrowings contextRef="C790972" unitRef="USD" xsi:nil="true" />
    <us-gaap:NotesPayable contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">2140029</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="C790972" unitRef="USD" xsi:nil="true" />
    <us-gaap:NotesPayableCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">301250</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="C790972" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermNotesPayable contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">1838779</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable contextRef="C790972" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherCommitmentDueInNextTwelveMonths contextRef="C790972" unitRef="USD" decimals="0">20000</us-gaap:OtherCommitmentDueInNextTwelveMonths>
    <appy:PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee contextRef="From2016-01-01to2016-06-30">P180D</appy:PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee>
    <appy:LicenseAgreementMaximumMilestonePayments contextRef="C790972" unitRef="USD" decimals="0">1100000</appy:LicenseAgreementMaximumMilestonePayments>
    <appy:AdditionalMilestoneMaximumPayments contextRef="C790972" unitRef="USD" decimals="0">2000000</appy:AdditionalMilestoneMaximumPayments>
    <appy:DeferredRevenueGross contextRef="C790972" unitRef="USD" decimals="0">1556300</appy:DeferredRevenueGross>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">96698</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="C790972" unitRef="USD" decimals="0">96698</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">1162015</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="C790972" unitRef="USD" decimals="0">1113665</us-gaap:DeferredRevenueNoncurrent>
    <appy:PercentageOfInvestmentPortfolioCashAndCashEquivalent contextRef="C790972" unitRef="Pure" decimals="INF">0.20</appy:PercentageOfInvestmentPortfolioCashAndCashEquivalent>
    <us-gaap:InvestmentIncomeInvestmentExpense contextRef="C790968" unitRef="USD" decimals="0">16000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">11000</us-gaap:InvestmentIncomeInvestmentExpense>
    <appy:WeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit contextRef="From2016-01-01to2016-06-30" unitRef="Shares" decimals="INF">30990029</appy:WeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit>
    <us-gaap:SalesRevenueGoodsNet contextRef="C790968" unitRef="USD" decimals="0">35805</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2016-01-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:SalesRevenueGoodsNet contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">24517</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2016-04-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfGoodsSold contextRef="C790968" unitRef="USD" decimals="0">12103</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="From2016-01-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfGoodsSold contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">8096</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="From2016-04-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GrossProfit contextRef="C790968" unitRef="USD" decimals="0">23702</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2016-01-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GrossProfit contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">16421</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2016-04-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:LicensesRevenue contextRef="C790968" unitRef="USD" decimals="0">48349</us-gaap:LicensesRevenue>
    <us-gaap:LicensesRevenue contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">48349</us-gaap:LicensesRevenue>
    <us-gaap:LicensesRevenue contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">24174</us-gaap:LicensesRevenue>
    <us-gaap:LicensesRevenue contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">24174</us-gaap:LicensesRevenue>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="C790968" unitRef="USD" decimals="0">3018459</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">1852961</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">1482608</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">822835</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="C790968" unitRef="USD" decimals="0">1260150</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">445671</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">552408</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">73085</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses contextRef="C790968" unitRef="USD" decimals="0">4278609</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">2298632</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">2035016</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">895920</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="C790968" unitRef="USD" decimals="0">-4206558</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-2250283</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">-1994421</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-871746</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="C790968" unitRef="USD" decimals="0">49259</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">25746</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">24195</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">148</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeNet contextRef="C790968" unitRef="USD" decimals="0">36209</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">79392</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">-14619</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">35107</us-gaap:InvestmentIncomeNet>
    <us-gaap:NonoperatingIncomeExpense contextRef="C790968" unitRef="USD" decimals="0">-13050</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">1973919</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">-38814</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">35871</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="C790968" unitRef="USD" decimals="0">-4219608</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-276364</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">-2033235</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-835875</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="C790968" unitRef="USDPerShare" decimals="INF">-1.09</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2016-01-01to2016-06-30" unitRef="USDPerShare" decimals="INF">-0.07</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2015-04-01to2015-06-30" unitRef="USDPerShare" decimals="INF">-0.52</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2016-04-01to2016-06-30" unitRef="USDPerShare" decimals="INF">-0.22</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="C790968" unitRef="Shares" decimals="INF">3876961</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2016-01-01to2016-06-30" unitRef="Shares" decimals="INF">3876961</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2015-04-01to2015-06-30" unitRef="Shares" decimals="INF">3876961</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2016-04-01to2016-06-30" unitRef="Shares" decimals="INF">3876961</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:ShareBasedCompensation contextRef="C790968" unitRef="USD" decimals="0">780983</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">224272</us-gaap:ShareBasedCompensation>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="C790968" unitRef="USD" decimals="0">129794</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">46031</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:RecognitionOfDeferredRevenue contextRef="C790968" unitRef="USD" decimals="0">48349</us-gaap:RecognitionOfDeferredRevenue>
    <us-gaap:RecognitionOfDeferredRevenue contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">48350</us-gaap:RecognitionOfDeferredRevenue>
    <us-gaap:OtherNoncashExpense contextRef="C790968" unitRef="USD" decimals="0">4647</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">168077</us-gaap:OtherNoncashExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="C790968" unitRef="USD" decimals="0">30260</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="C790968" unitRef="USD" decimals="0">-232018</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-193930</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="C790968" unitRef="USD" decimals="0">-143793</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-506465</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedSalaries contextRef="C790968" unitRef="USD" decimals="0">-547607</us-gaap:IncreaseDecreaseInAccruedSalaries>
    <us-gaap:IncreaseDecreaseInAccruedSalaries contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-436465</us-gaap:IncreaseDecreaseInAccruedSalaries>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="C790968" unitRef="USD" decimals="0">17161</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">9531</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="C790968" unitRef="USD" decimals="0">-3825014</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-2546076</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="C790968" unitRef="USD" decimals="0">16216718</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">10149937</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments contextRef="C790968" unitRef="USD" decimals="0">21652610</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">13612516</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:RepaymentsOfNotesPayable contextRef="C790968" unitRef="USD" decimals="0">235935</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">174083</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="C790968" unitRef="USD" decimals="0">-235935</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">-174083</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="C790968" unitRef="USD" decimals="0">1327921</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">2477526</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">2012283</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="C790972" unitRef="USD" decimals="0">4489809</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">3539911</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2015-06-30" unitRef="USD" decimals="0">4867832</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestPaid contextRef="C790968" unitRef="USD" decimals="0">49740</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">31362</us-gaap:InterestPaid>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">5116533</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="C790972" unitRef="USD" decimals="0">64619</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="C791670" unitRef="USD" xsi:nil="true" />
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2015-12-31_us-gaap_LandAndLandImprovementsMember" unitRef="USD" decimals="0">1107508</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="C791672" unitRef="USD" xsi:nil="true" />
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2015-12-31_us-gaap_BuildingMember" unitRef="USD" decimals="0">2589231</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="C791674" unitRef="USD" xsi:nil="true" />
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2015-12-31_us-gaap_BuildingAndBuildingImprovementsMember" unitRef="USD" decimals="0">253526</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="C791676" unitRef="USD" xsi:nil="true" />
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2015-12-31_us-gaap_OtherMachineryAndEquipmentMember" unitRef="USD" decimals="0">848014</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="C791678" unitRef="USD" decimals="0">64619</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2015-12-31_us-gaap_OfficeEquipmentMember" unitRef="USD" decimals="0">318254</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">3162037</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="C790972" unitRef="USD" decimals="0">64080</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">1954496</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="C790972" unitRef="USD" decimals="0">539</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">1136410</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="C790972" unitRef="USD" decimals="0">943475</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Goodwill contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">387239</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="C790972" unitRef="USD" decimals="0">387239</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">1523649</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="C790972" unitRef="USD" decimals="0">1330714</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">548327</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="C790972" unitRef="USD" decimals="0">554967</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="C790972" unitRef="USD" decimals="0">81000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="C790972" unitRef="USD" decimals="0">81000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="C790972" unitRef="USD" decimals="0">81000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="C790972" unitRef="USD" decimals="0">81000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="C790972" unitRef="USD" decimals="0">81000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="C790968" unitRef="USD" decimals="0">5000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">168000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="From2015-04-01to2015-06-30" unitRef="USD" decimals="0">5000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">34000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2016-06-30_us-gaap_NotesPayableToBanksMember_us-gaap_MortgagesMember_custom_NotesPayableToBankMember" unitRef="Pure" decimals="INF">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2016-06-30_us-gaap_MortgagesMember_custom_UnitedStatesSmallBusinessAdministrationMember" unitRef="Pure" decimals="INF">0.0586</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <appy:DebtInstrumentAmortizationPeriod contextRef="From2016-01-01to2016-06-30_us-gaap_MortgagesMember">P15Y</appy:DebtInstrumentAmortizationPeriod>
    <appy:DebtInstrumentMaturityPeriod contextRef="From2016-01-01to2016-06-30_us-gaap_MortgagesMember">P5Y</appy:DebtInstrumentMaturityPeriod>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="From2016-01-01to2016-06-30_us-gaap_MortgagesMember_custom_UnitedStatesSmallBusinessAdministrationMember" unitRef="USD" decimals="0">9000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="From2016-01-01to2016-06-30_us-gaap_NotesPayableToBanksMember_us-gaap_MortgagesMember_custom_NotesPayableToBankMember" unitRef="USD" decimals="0">11700</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest contextRef="From2016-01-01to2016-06-30_us-gaap_MortgagesMember_custom_UnitedStatesSmallBusinessAdministrationMember" unitRef="USD" decimals="0">3500</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest contextRef="From2016-01-01to2016-06-30_us-gaap_NotesPayableToBanksMember_us-gaap_MortgagesMember_custom_NotesPayableToBankMember" unitRef="USD" decimals="0">4500</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear contextRef="C790972" unitRef="USD" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="AsOf2015-08-31" unitRef="Shares" decimals="INF">459141</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="AsOf2015-09-01" unitRef="Shares" decimals="INF">709141</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="C792118" unitRef="Shares" decimals="INF">227000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2016-01-01to2016-06-30_custom_NonqualifiedMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember" unitRef="Shares" decimals="INF">77000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember" unitRef="Shares" decimals="INF">150000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember" unitRef="Shares" decimals="INF">43000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember" unitRef="Shares" decimals="INF">93813</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="C792118" unitRef="USDPerShare" decimals="INF">2.89</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2016-01-01to2016-06-30_custom_NonqualifiedMember" unitRef="USDPerShare" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember" unitRef="USDPerShare" decimals="INF">2.89</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember" unitRef="USDPerShare" decimals="INF">2.89</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember" unitRef="USDPerShare" decimals="INF">15.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember" unitRef="USDPerShare" decimals="INF">15.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2016-01-01to2016-06-30_custom_NonqualifiedMember_custom_NonCompensatoryRightsMember" unitRef="USDPerShare" decimals="INF">15.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2016-01-01to2016-06-30_custom_NonqualifiedMember_custom_CompensatoryRightsMember" unitRef="USDPerShare" decimals="INF">27.36</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_us-gaap_MaximumMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_us-gaap_MinimumMember">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" unitRef="Pure" decimals="INF">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" unitRef="Pure" decimals="INF">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" unitRef="Pure" decimals="INF">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" unitRef="Pure" decimals="INF">0.5</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" unitRef="Pure" decimals="INF">0.5</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" unitRef="Pure" decimals="INF">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" unitRef="Pure" decimals="INF">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" unitRef="Pure" decimals="INF">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember_custom_ShareBasedCompensationAwardTrancheFourMember" unitRef="Pure" decimals="INF">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" unitRef="Pure" decimals="INF">0.5</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_OfficersAndEmployeesMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" unitRef="Pure" decimals="INF">0.5</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="C792118" unitRef="Shares" decimals="INF">25445</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="C792117" unitRef="Shares" decimals="INF">24742</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="From2016-01-01to2016-06-30_custom_NonqualifiedMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="C792118" unitRef="Shares" decimals="INF">21825</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="C792117" unitRef="Shares" decimals="INF">4128</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="C792118" unitRef="Shares" decimals="INF">3620</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="C792117" unitRef="Shares" decimals="INF">20614</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="C792118" unitRef="USDPerShare" decimals="INF">39.81</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="C792117" unitRef="USDPerShare" decimals="INF">98.56</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="C792118" unitRef="USDPerShare" decimals="INF">15.13</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="C792117" unitRef="USDPerShare" decimals="INF">16.48</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="C792118" unitRef="USD" decimals="0">271000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="C792117" unitRef="USD" decimals="0">449000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="C792130" unitRef="Shares" decimals="INF">162000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="C792130" unitRef="USD" decimals="0">339000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <appy:ConcentrationRiskNumberOfCustomers contextRef="From2015-01-01to2015-06-30_us-gaap_GeographicConcentrationRiskMember_us-gaap_SalesRevenueNetMember" unitRef="Pure" decimals="INF">3</appy:ConcentrationRiskNumberOfCustomers>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-01-01to2015-06-30_us-gaap_GeographicConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember" unitRef="Pure" decimals="INF">0.58</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-01-01to2015-06-30_us-gaap_GeographicConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember" unitRef="Pure" decimals="INF">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-01-01to2015-06-30_us-gaap_GeographicConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember" unitRef="Pure" decimals="INF">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="C790968" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">1920273</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="From2015-04-01to2015-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">912</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="C790968" unitRef="USD" decimals="0">47022</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">14378</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="C790968" unitRef="USD" decimals="0">5388870</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">5197685</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <appy:BasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis contextRef="From2016-01-01to2016-06-30" unitRef="Shares" decimals="INF">3876961</appy:BasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="C790968" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">1749484</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="C792130" unitRef="Shares" decimals="INF">534115</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="C792169" unitRef="Shares" decimals="INF">432003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2015-12-31_custom_NonqualifiedMember" unitRef="Shares" decimals="INF">432003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2015-12-31_custom_StockIncentivePlanMember" unitRef="Shares" decimals="INF">332560</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2016-06-30_custom_NonqualifiedMember_custom_NonCompensatoryRightsMember" unitRef="Shares" decimals="INF">429503</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2016-06-30_custom_NonqualifiedMember_custom_CompensatoryRightsMember" unitRef="Shares" decimals="INF">2500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="C792118" unitRef="Shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2016-01-01to2016-06-30_custom_NonqualifiedMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="C792130" unitRef="Shares" decimals="INF">331427</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="C792130" unitRef="USDPerShare" decimals="INF">21.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="C792169" unitRef="USDPerShare" decimals="INF">15.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2015-12-31_custom_NonqualifiedMember" unitRef="USDPerShare" decimals="INF">15.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2015-12-31_custom_StockIncentivePlanMember" unitRef="USDPerShare" decimals="INF">35.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="C792118" unitRef="USDPerShare" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2016-01-01to2016-06-30_custom_NonqualifiedMember" unitRef="USDPerShare" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="C792118" unitRef="USDPerShare" decimals="INF">36.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2016-01-01to2016-06-30_custom_NonqualifiedMember" unitRef="USDPerShare" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="C792130" unitRef="USDPerShare" decimals="INF">32.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C792118">P8Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-01-01to2016-06-30_custom_NonqualifiedMember">P1Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="C792118">P7Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="C792130" unitRef="USD" decimals="0">140740</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="C792169" unitRef="USD" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="C792130" unitRef="USD" decimals="0">23870</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="C792130" unitRef="Shares" decimals="INF">202688</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2015-12-31_custom_StockIncentivePlanMember" unitRef="Shares" decimals="INF">33336</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <appy:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice contextRef="C792130" unitRef="USDPerShare" decimals="INF">3.75</appy:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice>
    <appy:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice contextRef="AsOf2015-12-31_custom_StockIncentivePlanMember" unitRef="USDPerShare" decimals="INF">15.54</appy:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="C792118" unitRef="Shares" decimals="INF">54028</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <appy:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice contextRef="C792118" unitRef="USDPerShare" decimals="INF">6.67</appy:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="C792130" unitRef="USDPerShare" decimals="INF">2.73</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2015-12-31_custom_StockIncentivePlanMember" unitRef="USDPerShare" decimals="INF">11.41</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="C792118" unitRef="USDPerShare" decimals="INF">2.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="C792118" unitRef="USDPerShare" decimals="INF">5.02</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue contextRef="C792118" unitRef="USDPerShare" decimals="INF">10.75</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue>
    <appy:VestingPeriodSixMonthAnniversaryPercentOfSharesVesting contextRef="From2016-01-01to2016-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember" unitRef="Pure" decimals="INF">0.25</appy:VestingPeriodSixMonthAnniversaryPercentOfSharesVesting>
    <appy:VestingPeriodSixMonthAnniversaryPercentOfSharesVesting contextRef="From2015-01-01to2015-06-30_custom_StockIncentivePlanMember_custom_IndependentDirectorsMember" unitRef="Pure" decimals="INF">0.25</appy:VestingPeriodSixMonthAnniversaryPercentOfSharesVesting>
    <appy:LicenseFeesAndMilestoneRevenue contextRef="C790972" unitRef="USD" decimals="0">1500000</appy:LicenseFeesAndMilestoneRevenue>
    <appy:LiabilityPayoffsUponPropertySale contextRef="From2016-01-01to2016-06-30" unitRef="USD" decimals="0">2064758</appy:LiabilityPayoffsUponPropertySale>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="C790968" unitRef="Shares" decimals="INF">776000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2016-01-01to2016-06-30" unitRef="Shares" decimals="INF">966000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2015-04-01to2015-06-30" unitRef="Shares" decimals="INF">776000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2016-04-01to2016-06-30" unitRef="Shares" decimals="INF">966000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="C792118">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="C790968" unitRef="Pure" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2016-01-01to2016-06-30" unitRef="Pure" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="C790968" unitRef="Pure" decimals="INF">0.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2016-01-01to2016-06-30" unitRef="Pure" decimals="INF">0.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="C790968" unitRef="Pure" decimals="INF">0.0139</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2016-01-01to2016-06-30" unitRef="Pure" decimals="INF">0.0120</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="C790968">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2016-01-01to2016-06-30">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Note 2. Property and equipment:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Property and equipment consisted of the following:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="a41f4a22cf460475b9b6bb9aa1628d0c2" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;June 30,&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2016&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;(Unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;December 31,&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Land and improvements&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,107,508&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Building&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;2,589,231&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Building improvements&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;253,526&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Laboratory equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;848,014&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Office and computer equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;64,619&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;318,254&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;64,619&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;5,116,533&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Less accumulated depreciation&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;64,080&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;3,162,037&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;539&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,954,496&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Depreciation expense totaled approximately $400 and $38,000, and $800 and $51,000, for the three and six month periods ended June 30, 2016 and 2015, respectively.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;On February 25, 2016, the Company completed the sale of its corporate headquarters, land, building and certain fixtures and equipment to a third party for a purchase price of approximately $4,000,000.&amp;#160;The sale resulted in a gain of approximately $1,900,000 and generated approximately $1,700,000 in net cash after expenses and mortgage payoffs. The Company is leasing back space in the building under short-term lease agreements that provide office and storage space required for its current level of operations.&lt;/div&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Note 3.&amp;#160;&amp;#160;Other long-term assets:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Other long-term assets consisted of the following:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;table id="a64e8d8b9b95f4752b2179c5df90115d0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;June 30,&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2016&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;(Unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;December 31,&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-left: 18pt; text-indent: -18pt"&gt;Patents, trademarks and applications, net of&amp;#160;accumulated&amp;#160;amortization of $554,967&amp;#160;and $548,327, respectively&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;943,475&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,136,410&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Goodwill&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;387,239&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;387,239&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,330,714&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,523,649&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company capitalizes legal costs and filing fees associated with obtaining patents on its new discoveries. Once the patents have been issued, the Company amortizes these costs over the shorter of the legal life of the patent or its estimated economic life using the straight-line method. Based upon the current status of the above intangible assets, the aggregate amortization expense is estimated to be approximately $81,000 for each of the next five fiscal years. The Company tests intangible assets with finite lives for impairment upon significant changes in the Company&amp;#8217;s business environment. The testing resulted in net patent impairment charges of $34,000 and $5,000, and $168,000 and $5,000, for the three and six month periods ended June 30, 2016 and 2015, respectively.&amp;#160; The impairment charges are related to the Company&amp;#8217;s ongoing analysis of which specific country patents in its portfolio are determined as potentially worth pursuing.&lt;/div&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Note 4. Notes and Other Obligations:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Notes payable and other obligations consisted of the following:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="cab9cc4c9e284d67983e6dad9dcaf305" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;June 30,&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2016&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;(Unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;December 31,&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Mortgage notes&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,997,701&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Other short-term installment obligations&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;142,328&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;2,140,029&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Less current portion&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;301,250&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,838,779&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Mortgage notes:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Prior to the February 2016 sale of the corporate headquarters, the Company had a permanent mortgage on its land and building that was refinanced in May 2013. The mortgage was held by a commercial bank and included a portion guaranteed by the U. S. Small Business Administration (&amp;#8220;SBA&amp;#8221;).&amp;#160; The loan was collateralized by the real property and the SBA portion was also personally guaranteed by a former officer of the Company.&amp;#160;The commercial bank loan terms included a payment schedule based on a fifteen year amortization, with a balloon&amp;#160;maturity at five years. The commercial bank portion had an interest rate fixed at 3.95%, and the SBA portion bore interest at the rate of 5.86%. The commercial bank portion of the loan required total monthly payments of approximately $11,700, which included approximately $4,500 per month in interest. The SBA portion of the loan required total monthly payments of approximately $9,000 through July 2023, which included approximately $3,500 per month in interest and fees in 2016.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;On February 25, 2016, the Company completed the sale of its corporate headquarters, land and building, and also paid off its mortgage obligations.&amp;#160; See Note 2.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Future maturities:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company did not have any debt obligations at June 30, 2016.&lt;/div&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Note 5. Stockholders&amp;#8217; equity:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Upon the completion of a special shareholders meeting on March 24, 2016, where such action was approved by shareholders, the Board of Directors authorized the Reverse Stock Split at a ratio of one-for-eight, whereby each eight shares of common stock were combined into one share of common stock.&amp;#160;&amp;#160;The Reverse Stock Split was implemented and effective on March 31, 2016. All historical references to shares and share amounts in this report have been retroactively revised to reflect the Reverse Stock Split.&amp;#160; Following the Reverse Stock Split, the Company regained its compliance with the Nasdaq minimum bid price requirement, allowing its common stock to continue to be listed on the Nasdaq Capital Market.&lt;/div&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Note 6. Stock options and warrants:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Stock options:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company currently provides stock-based compensation to employees, directors and consultants, both under the Company's 2002 Stock Incentive Plan, as amended (the "Plan"), and non-qualified options and warrants issued outside of the Plan. During September 2015, the Company's shareholders approved amendments to the Plan to increase the number of shares reserved under the Plan from 459,141 to 709,141. The Company estimates the fair value of the share-based awards on the date of grant using the Black-Scholes option-pricing model (the "Black-Scholes model").&amp;#160;&amp;#160;Using the Black-Scholes model, the value of the award that is ultimately expected to vest is recognized over the requisite service period in the statement of operations.&amp;#160;&amp;#160;Option forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.&amp;#160;&amp;#160;The Company attributes compensation to expense using the straight-line single option method for all options granted.&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company&amp;#8217;s determination of the estimated fair value of share-based payment awards on the date of grant is affected by the following variables and assumptions:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="aab49304acf41eeac694c2470606a6e" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 2.98%; vertical-align: top"&gt;&#13;&lt;div style="font: 10pt/1 Symbol, serif; color: #000000; text-align: center"&gt;&amp;#183;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 97.02%; vertical-align: top"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Grant date exercise price &amp;#8211; the closing market price of the Company&amp;#8217;s common stock on the date of the grant;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 2.98%; vertical-align: top"&gt;&#13;&lt;div style="font: 10pt/1 Symbol, serif; color: #000000; text-align: center"&gt;&amp;#183;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 97.02%; vertical-align: top"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Estimated option term &amp;#8211; based on historical experience with existing option holders;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 2.98%; vertical-align: top"&gt;&#13;&lt;div style="font: 10pt/1 Symbol, serif; color: #000000; text-align: center"&gt;&amp;#183;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 97.02%; vertical-align: top"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Estimated dividend rates &amp;#8211; based on historical and anticipated dividends&amp;#160;over the life of the option;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 2.98%; vertical-align: top"&gt;&#13;&lt;div style="font: 10pt/1 Symbol, serif; color: #000000; text-align: center"&gt;&amp;#183;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 97.02%; vertical-align: top"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Term of the option &amp;#8211; based on historical experience, grants have lives of approximately 3-5 years;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 2.98%; vertical-align: top"&gt;&#13;&lt;div style="font: 10pt/1 Symbol, serif; color: #000000; text-align: center"&gt;&amp;#183;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 97.02%; vertical-align: top"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Risk-free interest rates &amp;#8211; with maturities that approximate the expected life of the options granted;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 2.98%; vertical-align: top"&gt;&#13;&lt;div style="font: 10pt/1 Symbol, serif; color: #000000; text-align: center"&gt;&amp;#183;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 97.02%; vertical-align: top"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Calculated stock price volatility &amp;#8211; calculated over the expected life of the options granted, which is calculated based on the daily closing price of the Company&amp;#8217;s common stock over a period equal to the expected term of the option; and&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 2.98%; vertical-align: top"&gt;&#13;&lt;div style="font: 10pt/1 Symbol, serif; color: #000000; text-align: center"&gt;&amp;#183;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 97.02%; vertical-align: top"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Option exercise behaviors &amp;#8211; based on actual and projected employee stock option exercises and forfeitures.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;The Company recognized total expenses for stock-based compensation during the three and six months ended June 30, 2016 and 2015 which are included in the accompanying statements of operations, in the following categories:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="f23189dc0764f08aaafe5057d207e44" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Three Months Ended&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="7" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Six Months Ended&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 44%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Selling, general and administrative expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;176,388&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;303,644&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;221,712&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;696,006&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 44%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Research and development expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;43,937&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;2,560&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;84,977&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 44%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 44%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total stock-based compensation&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;176,388&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;347,581&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;224,272&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;780,983&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;During the six months ended June 30, 2016 and 2015, respectively, no options were exercised.&amp;#160;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Stock incentive plan options:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company currently provides stock-based compensation to employees, directors and consultants under the Plan.&amp;#160;The Company utilized assumptions in the estimation of fair value of stock-based compensation for the six months ended June 30, 2016 and 2015 as follows:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="fa017df72c9c440bbd4a4dab605ea181" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Dividend yield&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;0&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;0&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Expected price volatility&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;99&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;93&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Risk free interest rate&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1.20&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1.39&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Expected term&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;5 years&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;5 years&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;A summary of activity under the Plan for the six months ended June 30, 2016 is presented below:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="c8d3e82c6d44c82b343752305cdc095" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="width: 12.8%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Shares&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Underlying&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Options&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="width: 12.79%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Weighted&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Average&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Exercise&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 13.81%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Weighted&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Average&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Remaining&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Contractual&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Term (Years)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 16.12%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Aggregate&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Intrinsic&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Value&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="width: 12.8%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="width: 12.79%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 13.81%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 16.12%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Outstanding at January 1, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.73%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;332,560&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;35.36&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Granted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.73%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;227,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;2.89&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Exercised&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.73%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Forfeited&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.73%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;(25,445&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;36.30&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.73%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Outstanding at June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.73%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;534,115&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;21.55&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;8.1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.24%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 13.82%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;140,740&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.73%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.24%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 13.82%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Exercisable at June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.73%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;331,427&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;32.44&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;7.1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.24%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 13.82%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;23,870&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company&amp;#8217;s closing stock price on June 30, 2016 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders, had all option holders been able to, and in fact had, exercised their options on June 30, 2016.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;During the six months ended June 30, 2016, 77,000 options were issued to non-employee directors under the Plan, exercisable at an average of $2.89 per share. The options expire ten years from the date of grant and vest 50% upon on the date of grant, and 25% on each of July 1, 2016 and October 1, 2016.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;During the six months ended June 30, 2016,&amp;#160;150,000 options were issued to officers and employees under the Plan, exercisable at an average of $2.89 per share. The options expire ten years from the date of grant and vest 50% upon each of the six month and the one year anniversary of the grant date.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;During the six months ended June 30, 2015, 43,000 options were issued to non-employee directors under the Plan, exercisable at an average of $15.12 per share. The options expire ten years from the date of grant and vested over one year, based upon 25% on the date of grant, and 25% on each of April 1, 2015, July 1, 2015, and October 1, 2015.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;During the six months ended June 30, 2015,&amp;#160;93,813 options were issued to officers and employees under the Plan, exercisable at an average of $15.12 per share. The options expire ten years from the date of grant and vest over two years with 50% vesting upon six month anniversary of grant date and the remaining balance vesting over the following six quarters in arrears.&lt;/div&gt;&#13;&#13;&lt;div style="background-color: #ffffff; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13; &amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1; background-color: #ffffff"&gt;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;During the six months ended June 30, 2016, a total of 25,445 options that were granted under the Plan were forfeited, of which 21,825 were vested and 3,620 were unvested. The vested options were exercisable at an average of $39.81 per share and the unvested options were exercisable at an average of $15.13 per share. During the six months ended June 30, 2015, a total of 24,742 options that were granted under the Plan were forfeited, of which 4,128 were vested and 20,614 were unvested. The vested options were exercisable at an average of $98.56 per share and the unvested options were exercisable at an average of $16.48 per share.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13; &amp;#160;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The total fair value of stock options granted to employees, directors and consultants that vested and became exercisable during the six months ended June 30, 2016 and 2015, was approximately&amp;#160;$271,000 and $449,000, respectively.&amp;#160;&amp;#160;&amp;#160;Based upon the Company&amp;#8217;s experience, approximately 80% of the outstanding nonvested stock options, or approximately 162,000 options, are expected to vest in the future, under their terms.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;A summary of the activity of nonvested options under the Plan to acquire common shares granted to employees, officers, directors and consultants during the six months ended June 30, 2016 is presented below:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; text-align: left; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="a803bc49bdf14c89b8c428d6c75c12ef" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Nonvested Shares&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Nonvested&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Shares&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Underlying&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Options&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Weighted&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Average&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Exercise&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Weighted&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Average&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Grant Date&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Fair Value&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 58%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Nonvested at January 1, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;33,336&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;15.54&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;11.41&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 58%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Granted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;227,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;2.89&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;2.13&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 58%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Vested&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;(54,028&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;6.67&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;5.02&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 58%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Forfeited&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;(3,620&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;15.13&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;10.75&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 58%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 58%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Nonvested at June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;202,688&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;3.75&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;2.73&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;At June 30, 2016, based upon employee, officer, director and consultant options granted under the Plan to that point, there was approximately $339,000 of additional unrecognized compensation cost related to stock options that will be recorded over a weighted average future period of one year.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Other common stock purchase options and warrants:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;As of June 30, 2016, in addition to the stock incentive plan options discussed above, the Company had outstanding 432,003 non-qualified options and warrants in connection with offering warrants and an officer&amp;#8217;s employment that were not issued under the Plan.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;During the six month periods ended June 30, 2016 and 2015, respectively, no stock options were granted outside of the Plan.&amp;#160; Operating expenses for the six months ended June 30, 2016 and 2015, did not include any value related to stock-based compensation of non-qualified options and warrants.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Following is a summary of outstanding options and warrants that were issued outside of the Plan for the six months ended June 30, 2016:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="c42e36b37b494fd99c6f9c9aaed437d8" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 48.94%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.41%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="width: 11.08%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Shares&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Underlying&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Options / Warrants&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.63%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="width: 12.17%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Weighted&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Average&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Exercise&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.57%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Weighted&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Average&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Remaining&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Contractual&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Term (Years)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.21%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.73%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Aggregate&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Intrinsic&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Value&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 48.94%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.41%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.97%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 10.11%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.63%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.21%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.57%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.21%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.73%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 48.94%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #cceeff"&gt;Outstanding at January 1, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.41%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.97%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 10.11%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #cceeff"&gt;432,003&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.63%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #cceeff"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11.21%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #cceeff"&gt;15.47&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.57%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.21%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.73%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 48.94%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Granted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.41%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.97%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 10.11%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.63%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.21%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.57%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.21%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.73%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 48.94%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #cceeff"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Exercised&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.41%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.97%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 10.11%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #cceeff"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.63%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.21%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #cceeff"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.57%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.21%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.73%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 48.94%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Forfeited&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.41%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.97%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 10.11%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.63%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.21%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.57%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.21%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.73%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 48.94%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.41%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.97%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 10.11%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.63%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.21%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.57%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.21%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.73%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 48.94%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff"&gt;Outstanding and exercisable at June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.41%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.97%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 10.11%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff"&gt;432,003&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.63%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11.21%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff"&gt;15.47&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.57%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center; background-color: #ffffff"&gt;1.8&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.21%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9.73%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; text-align: left; margin-top: 3pt; line-height: 1"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;During the six months ended June 30, 2016 and 2015, no warrants were exercised.&amp;#160; Included at June 30, 2016 in the 432,003 total outstanding options are 429,503 non-compensatory rights, exercisable at an average of $15.40 per common share, expiring through May 2018, granted in connection with public offerings, and 2,500 rights exercisable at $27.36 per common share, expiring December 2018, issued under compensatory arrangements.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company&amp;#8217;s closing stock price on June 30, 2016 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders, had all option holders been able to, and in fact had, exercised their options on June 30, 2016.&lt;/div&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Note 7.&amp;#160;&amp;#160;Animal Health License Agreements:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Effective May 1, 2004, Washington University in St. Louis (&amp;#8220;WU&amp;#8221;) and Venaxis entered into an Exclusive License Agreement (&amp;#8220;WU License Agreement&amp;#8221;), which grants Venaxis exclusive license and right to sublicense WU&amp;#8217;s technology (as defined under the WU License Agreement) for veterinary products worldwide, except where such products are prohibited under U.S. laws for export. The term of the WU License Agreement continues until the expiration of the last of WU&amp;#8217;s patents (as defined in the WU License Agreement) expire.&amp;#160;&amp;#160;Venaxis has agreed to pay minimum annual royalties of $20,000 during the term of the WU License Agreement and such amounts are creditable against future royalties.&amp;#160;&amp;#160;Royalties payable to WU under the WU License Agreement for covered product sales by Venaxis carry a mid-single digit royalty rate and for sublicense fees received by Venaxis&amp;#160;carry a low double-digit royalty rate.&amp;#160;&amp;#160;The WU License Agreement contains customary terms for confidentiality, prosecution and infringement provisions for licensed patents, publication rights, indemnification and insurance coverage.&amp;#160;&amp;#160;The WU License Agreement is cancelable by Venaxis with ninety days advance notice at any time and by WU with sixty days advance notice if Venaxis materially breaches the WU License Agreement and fails to cure such breach.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;In July 2012, the Company entered into an Exclusive License Agreement (the &amp;#8220;License Agreement&amp;#8221;) with Ceva Sant&amp;#233; Animale S.A. (&amp;#8220;Licensee&amp;#8221;), pursuant to which the Company granted the Licensee an exclusive royalty-bearing license, until December 31, 2028, to the Company&amp;#8217;s intellectual property and other assets, including patent rights and know-how, relating to recombinant single chain reproductive hormone technology for use in non-human mammals (the &amp;#8220;Company&amp;#8217;s Animal Health Assets&amp;#8221;). The License Agreement is subject to termination by the Licensee (a) for convenience on 180 days prior written notice, (b) in the Licensee&amp;#8217;s discretion in the event of a sale or other disposal of the Company&amp;#8217;s animal health assets, (c) in the Licensee&amp;#8217;s discretion upon a change in control of the Company, (d) for a material breach of the License Agreement by the Company, or (e) in the Licensee&amp;#8217;s discretion, if the Company becomes insolvent.&amp;#160;&amp;#160;The License Agreement is also terminable by the Company if there is a material breach of the License Agreement by the Licensee, or if the Licensee challenges the Company&amp;#8217;s ownership of designated intellectual property.&amp;#160;&amp;#160;The License Agreement includes a sublicense of the technology licensed to the Company by WU. Under the terms of the WU License Agreement, a portion of license fees and royalties Venaxis receives from&amp;#160;sublicensing agreements will be paid to WU. The obligation for such license fees due to WU is included in accrued expenses at June 30, 2016.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Under the License Agreement, the Licensee obtained a worldwide exclusive license to develop, seek regulatory approval for and offer to sell, market, distribute, import and export luteinizing hormone (&amp;#8220;LH&amp;#8221;) and/or follicle-stimulating hormone (&amp;#8220;FSH&amp;#8221;) products for bovine (cattle), equine and swine in the field of the assistance and facilitation of reproduction in bovine, equine and swine animals.&amp;#160;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Under the License Agreement, as of June 30, 2016, the following future milestone payments are provided, assuming future milestones are successfully achieved:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; text-align: justify; margin-top: 3pt; line-height: 1"&gt;&#13;&lt;table id="a46f60b17899a4fa9bf58cf56060ee6de" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top; color: #000000"&gt;&amp;#8226;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: auto; vertical-align: top; color: #000000; text-align: justify"&gt;Milestone payments, totaling up to a potential of $1.1 million in the aggregate, based on the satisfactory conclusion of&amp;#160;milestones as defined in the License Agreement;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; text-align: justify; margin-top: 3pt; line-height: 1"&gt;&#13;&lt;table id="a8e1ce6d41b4048fda8425a4e09cd603d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top; color: #000000"&gt;&amp;#8226;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: auto; vertical-align: top; color: #000000; text-align: justify"&gt;Potential for milestone payments of up to an additional $2 million for development and receipt of regulatory approval for additional licensed products; and&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; text-align: justify; margin-top: 3pt; line-height: 1"&gt;&#13;&lt;table id="a718e0784fab44347885ff20fd8c339c0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top; color: #000000"&gt;&amp;#8226;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: auto; vertical-align: top; color: #000000; text-align: justify"&gt;Royalties, at low double digit rates, based on sales of licensed products.&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Revenue recognition related to the License Agreement and WU License Agreement is based primarily on the Company&amp;#8217;s consideration of ASC 808-10-45, &amp;#8220;&lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt;Accounting for Collaborative Arrangements.&lt;/font&gt;&amp;#8221;&amp;#160;&amp;#160;For financial reporting purposes, the license fees and milestone payments received from the License Agreement, net of the amounts due to third parties, including WU, have been recorded as deferred revenue and are amortized over the term of the License Agreement.&amp;#160;&amp;#160;License fees and milestone revenue totaling a net of approximately $1,500,000 commenced being amortized into income upon the July 2012 date of milestone achievement. As of June 30, 2016, deferred revenue of $96,698 has been classified as a current liability and $1,113,665 has been classified as a long-term liability. The current liability represents the next twelve months&amp;#8217; portion of the amortizable milestone revenue.&amp;#160;During the six months ended June 30, 2016 and 2015, $48,349 was recorded in each period as the amortized license fee revenue arising from the License Agreement.&lt;/div&gt;&#13;&#13;&#13;&#13;&#13;&#13;&lt;div style="margin-bottom: 3pt; text-align: left; margin-top: 3pt; line-height: 1"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif; color: #000000"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;&lt;/font&gt;&lt;br style="line-height: 1" /&gt;&#13; &amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;A tabular summary of the revenue categories and cumulative amounts of revenue recognition associated with the License Agreement follows:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="f2d1a33d3eb548a2afb87d449627c214" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Category&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Totals&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 86%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;License fees and milestone amounts paid / achieved&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,920,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 86%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Third party obligations recorded, including WU&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;(363,700&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 86%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Deferred revenue balance&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,556,300&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 86%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Revenue amortization to June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;(345,93&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;7&lt;/font&gt;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 86%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 86%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Net deferred revenue balance at June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,210,36&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;3&lt;/font&gt;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;table id="a36bc686410dc4269bd2d2dea3cf0710d" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Commencement of license fees revenue recognition&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Upon signing or receipt&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Commencement of milestone revenue recognition&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Upon milestone achievement over then remaining life&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Original amortization period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;197 months&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Note 8.&amp;#160;&amp;#160;Commitments and contingencies:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Commitments:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;As of June 30, 2016, the Company had employment agreements with two officers providing aggregate annual minimum commitments totaling&amp;#160;$655,000.&amp;#160;&amp;#160;The agreements automatically renew at the end of each year unless terminated by either party and contain customary confidentiality and benefit provisions.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Venaxis determined in the first quarter of 2016 to begin winding down and ceasing its &lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt;APPY&lt;/font&gt;1 commercial activities, due to continuing limited sales and losses from the European operations.&amp;#160; This decision also resulted in a reduction of the Company&amp;#8217;s workforce, which was implemented as of January 31, 2016. In February 2016, Venaxis sent notices to its four European distributors informing them of the wind-down and therefore the termination of their distribution agreements. Two of the distributors, linked by common management / ownership, subsequently communicated to Venaxis that they dispute that Venaxis had the right to terminate the agreements. Under the terms of the distribution agreements, such a dispute shall first be attempted to be resolved between management of the parties and then subject to binding arbitration.&amp;#160; The parties are currently attempting to resolve the dispute without arbitration.&amp;#160; Venaxis believes that the distributors&amp;#8217; claims are without merit and any potential settlement or resolution will not be material to the Company&amp;#8217;s financial position.&amp;#160;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Contingencies:&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;In the ordinary course of business and in the general industry in which the Company is engaged, it is not atypical to periodically receive a third party communication which may be in the form of a notice, threat, or &amp;#8220;cease and desist&amp;#8221; letter concerning certain activities.&amp;#160;&amp;#160;For example, this can occur in the context of the Company&amp;#8217;s pursuit of intellectual property rights.&amp;#160;&amp;#160;This can also occur in the context of operations such as the using, making, having made, selling, and offering to sell products and services, and in other contexts.&amp;#160;&amp;#160;The Company makes rational assessments of each situation on a case-by-case basis as such may arise.&amp;#160;&amp;#160;The Company periodically evaluates its options for trademark positions and considers a full spectrum of alternatives for trademark protection and product branding.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;We are currently not a party to any legal proceedings, the adverse outcome of which would, in our management&amp;#8217;s opinion, have a material adverse effect on our business, financial condition and results of operations.&lt;/div&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <appy:CashAndCashEquivalentsAndInvestmentsPolicyTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Cash, cash equivalents and investments:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company considers all highly liquid investments with an original maturity of three months or less at the date of acquisition to be cash equivalents. From time to time, the Company&amp;#8217;s cash account balances exceed the balances as covered by the Federal Deposit Insurance System. The Company has never suffered a loss due to such excess balances.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company invests excess cash from time to time in highly-liquid debt and equity investments of highly-rated entities, which are classified as trading securities. Historically, the purpose of the investments has been to fund research and development, product development, FDA clearance-related activities and general corporate purposes. Such amounts are recorded at market values using Level 1 inputs in determining fair value and are generally classified as current, as the Company does not intend to hold the investments beyond twelve months. Investment securities classified as trading are those securities that are bought and held principally for the purpose of selling them in the near term, with the objective of preserving principal and generating profits. These securities are reported at fair value with unrealized gains and losses reported as an element of other (expense) income in current period earnings. The Company&amp;#8217;s Board of Directors has approved an investment policy covering the investment parameters to be followed with the primary goals being the safety of principal amounts and maintaining liquidity. The policy provides for minimum investment rating requirements as well as limitations on investment duration and concentrations. Based upon market conditions, the investment guidelines have been tightened to increase the minimum acceptable investment ratings required for investments and shorten the maximum investment term. As of June 30, 2016, approximately 20% of the investment portfolio was in cash and cash equivalents, which is presented as such on the accompanying balance sheet, and the remaining funds were invested in marketable securities with none individually representing a material amount of the portfolio.&amp;#160; Investments with a scheduled maturity beyond one year are classified as long-term investments on the balance sheet.&amp;#160; To date, the Company&amp;#8217;s cumulative realized market loss from the investments has not been significant.&amp;#160;For the six months ended June 30, 2016 and 2015, there was approximately $11,000 and $16,000, respectively, in management fee expenses.&lt;/div&gt;&lt;/div&gt;</appy:CashAndCashEquivalentsAndInvestmentsPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Fair value of financial instruments:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company accounts for financial instruments under Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) Accounting Standards Codification Topic (&amp;#8220;ASC&amp;#8221;) 820,&lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt; Fair Value Measurements&lt;/font&gt;.&amp;#160; This statement defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements.&amp;#160; To increase consistency and comparability in fair value measurements, ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels as follows:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Level 1&amp;#8212; quoted prices (unadjusted) in active markets for identical assets or liabilities;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Level 2 &amp;#8212; observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Level 3 &amp;#8212; assets and liabilities whose significant value drivers are unobservable.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company&amp;#8217;s market assumptions.&amp;#160; Unobservable inputs require significant management judgment or estimation.&amp;#160; In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy.&amp;#160; In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement.&amp;#160; Such determination requires significant management judgment. There were no financial assets or liabilities measured at fair value, with the exception of cash, cash equivalents and short-term investments as of June 30, 2016 and December 31, 2015.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The carrying amounts of the Company&amp;#8217;s financial instruments (other than cash, cash equivalents and short-term investments as discussed above) approximate fair value because of their variable interest rates and/or short maturities combined with the recent historical interest rate levels.&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Revenue recognition and accounts receivable:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;We recognized sales of goods under the provisions of ASC 605 and the U.S. Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) Staff Accounting Bulletin (&amp;#8220;SAB&amp;#8221;) 104, &lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt;Revenue Recognition&lt;/font&gt;. Future revenue is expected to be generated primarily from the sale of products. Product revenue primarily consists of sales of instrumentation and consumables.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Revenue was recognized when the following four basic criteria were met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred and risk of loss has passed; (iii) the seller&amp;#8217;s price to the buyer is fixed or determinable; and (iv) collectability is reasonably assured.&amp;#160; In international markets, the Company sells its products to distributors or re-sellers, who subsequently resell the products to hospitals. The Company has an agreement with the distributor which provides that title and risk of loss pass to the distributor upon shipment of the products, FOB to the distributor. Revenue is recognized upon shipment of products to the distributor as the products are shipped based on FOB shipping point terms (See Note 8).&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Revenues were recorded less a reserve for estimated product returns and allowances which to date has not been significant. Determination of the reserve for estimated product returns and allowances is based on management&amp;#8217;s analyses and judgments regarding certain conditions. Should future changes in conditions prove management&amp;#8217;s conclusions and judgments on previous analyses to be incorrect, revenue recognized for any reporting period could be adversely affected.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company extended credit to customers generally without requiring collateral. As of June 30, 2016 and December 31, 2015, the Company did not have any accounts receivable. During the six months ended June 30, 2016, no sales were recorded.&amp;#160; During the six months ended June 30, 2015, three European-based customers accounted for the total net sales, representing 58%, 28% and 14%, respectively.&lt;/div&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Property and equipment consisted of the following:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="a41f4a22cf460475b9b6bb9aa1628d0c2" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;June 30,&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2016&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;(Unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;December 31,&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Land and improvements&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,107,508&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Building&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;2,589,231&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Building improvements&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;253,526&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Laboratory equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;848,014&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Office and computer equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;64,619&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;318,254&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;64,619&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;5,116,533&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Less accumulated depreciation&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;64,080&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;3,162,037&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;539&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,954,496&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;/div&gt;</us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock>
    <appy:ScheduleOfOtherLongTermAssetsTableTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Other long-term assets consisted of the following:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;table id="a64e8d8b9b95f4752b2179c5df90115d0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;June 30,&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2016&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;(Unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;December 31,&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-left: 18pt; text-indent: -18pt"&gt;Patents, trademarks and applications, net of&amp;#160;accumulated&amp;#160;amortization of $554,967&amp;#160;and $548,327, respectively&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;943,475&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,136,410&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Goodwill&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;387,239&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;387,239&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,330,714&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,523,649&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;/div&gt;</appy:ScheduleOfOtherLongTermAssetsTableTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Notes payable and other obligations consisted of the following:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="cab9cc4c9e284d67983e6dad9dcaf305" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;June 30,&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2016&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;(Unaudited)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;December 31,&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Mortgage notes&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,997,701&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Other short-term installment obligations&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;142,328&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;2,140,029&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Less current portion&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;301,250&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,838,779&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;The Company recognized total expenses for stock-based compensation during the three and six months ended June 30, 2016 and 2015 which are included in the accompanying statements of operations, in the following categories:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="a3f23189dc0764f08aaafe5057d207e44" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Three Months Ended&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="7" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Six Months Ended&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 44%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Selling, general and administrative expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;176,388&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;303,644&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;221,712&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;696,006&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 44%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Research and development expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;43,937&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;2,560&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;84,977&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 44%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 44%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total stock-based compensation&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;176,388&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;347,581&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;224,272&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;780,983&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company currently provides stock-based compensation to employees, directors and consultants under the Plan.&amp;#160;The Company utilized assumptions in the estimation of fair value of stock-based compensation for the six months ended June 30, 2016 and 2015 as follows:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="fa017df72c9c440bbd4a4dab605ea181" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Dividend yield&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;0&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;0&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Expected price volatility&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;99&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;93&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Risk free interest rate&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1.20&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1.39&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Expected term&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;5 years&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;5 years&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;A summary of activity under the Plan for the six months ended June 30, 2016 is presented below:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="a8c8d3e82c6d44c82b343752305cdc095" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="width: 12.8%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Shares&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Underlying&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Options&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="width: 12.79%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Weighted&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Average&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Exercise&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 13.81%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Weighted&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Average&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Remaining&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Contractual&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Term (Years)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 16.12%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Aggregate&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Intrinsic&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Value&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="width: 12.8%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="width: 12.79%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 13.81%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 16.12%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Outstanding at January 1, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.73%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;332,560&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;35.36&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Granted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.73%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;227,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;2.89&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Exercised&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.73%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Forfeited&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.73%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;(25,445&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;36.30&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.73%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Outstanding at June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.73%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;534,115&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;21.55&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;8.1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.24%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 13.82%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;140,740&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.73%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.24%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 13.82%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 38.31%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Exercisable at June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.73%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;331,427&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;32.44&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.02%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.72%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;7.1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.24%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 13.82%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right"&gt;23,870&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;A summary of the activity of nonvested options under the Plan to acquire common shares granted to employees, officers, directors and consultants during the six months ended June 30, 2016 is presented below:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; text-align: left; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="a803bc49bdf14c89b8c428d6c75c12ef" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Nonvested Shares&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Nonvested&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Shares&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Underlying&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Options&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Weighted&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Average&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Exercise&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Weighted&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Average&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Grant Date&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Fair Value&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 58%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Nonvested at January 1, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;33,336&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;15.54&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;11.41&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 58%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Granted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;227,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;2.89&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;2.13&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 58%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Vested&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;(54,028&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;6.67&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;5.02&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 58%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Forfeited&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;(3,620&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;15.13&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;10.75&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 58%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 58%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Nonvested at June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;202,688&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;3.75&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;2.73&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Following is a summary of outstanding options and warrants that were issued outside of the Plan for the six months ended June 30, 2016:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="c42e36b37b494fd99c6f9c9aaed437d8" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 48.94%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.41%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="width: 11.08%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Shares&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Underlying&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Options / Warrants&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.63%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="width: 12.17%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Weighted&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Average&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Exercise&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.57%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Weighted&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Average&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Remaining&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Contractual&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Term (Years)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.21%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.73%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Aggregate&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Intrinsic&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Value&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 48.94%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.41%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.97%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 10.11%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.63%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.21%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.57%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.21%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.73%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 48.94%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #cceeff"&gt;Outstanding at January 1, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.41%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.97%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 10.11%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #cceeff"&gt;432,003&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.63%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #cceeff"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11.21%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #cceeff"&gt;15.47&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.57%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.21%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.73%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 48.94%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Granted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.41%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.97%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 10.11%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.63%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.21%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.57%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.21%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.73%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 48.94%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #cceeff"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Exercised&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.41%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.97%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 10.11%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #cceeff"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.63%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.21%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #cceeff"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.57%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.21%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.73%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 48.94%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Forfeited&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.41%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.97%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 10.11%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.63%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.21%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.57%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.21%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.73%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 48.94%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.41%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.97%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 10.11%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.63%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11.21%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.57%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.21%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.73%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 48.94%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff"&gt;Outstanding and exercisable at June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.41%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.97%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 10.11%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff"&gt;432,003&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.63%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11.21%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff"&gt;15.47&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9.57%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center; background-color: #ffffff"&gt;1.8&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1.21%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.42%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9.73%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; text-align: left; margin-top: 3pt; line-height: 1"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock>
    <us-gaap:DeferredRevenueByArrangementDisclosureTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;A tabular summary of the revenue categories and cumulative amounts of revenue recognition associated with the License Agreement follows:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="f2d1a33d3eb548a2afb87d449627c214" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Category&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Totals&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 86%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;License fees and milestone amounts paid / achieved&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,920,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 86%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Third party obligations recorded, including WU&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;(363,700&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 86%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Deferred revenue balance&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,556,300&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 86%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Revenue amortization to June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;(345,93&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;7&lt;/font&gt;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 86%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 86%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Net deferred revenue balance at June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000"&gt;1,210,36&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;3&lt;/font&gt;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;table id="a36bc686410dc4269bd2d2dea3cf0710d" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Commencement of license fees revenue recognition&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Upon signing or receipt&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Commencement of milestone revenue recognition&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;Upon milestone achievement over then remaining life&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;Original amortization period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center"&gt;197 months&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;/div&gt;</us-gaap:DeferredRevenueByArrangementDisclosureTextBlock>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2015-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:AccountsReceivableNetCurrent contextRef="C790972" unitRef="USD" xsi:nil="true" />
    <invest:InvestmentOptionsExpirationDate contextRef="From2016-01-01to2016-06-30_custom_NonqualifiedMember_custom_NonCompensatoryRightsMember">2018-05-31</invest:InvestmentOptionsExpirationDate>
    <invest:InvestmentOptionsExpirationDate contextRef="From2016-01-01to2016-06-30_custom_NonqualifiedMember_custom_CompensatoryRightsMember">2018-12-31</invest:InvestmentOptionsExpirationDate>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; text-align: left; margin-top: 3pt; line-height: 1"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Note 1.&amp;#160;&amp;#160;Significant accounting policies:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Cash, cash equivalents and investments:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company considers all highly liquid investments with an original maturity of three months or less at the date of acquisition to be cash equivalents. From time to time, the Company&amp;#8217;s cash account balances exceed the balances as covered by the Federal Deposit Insurance System. The Company has never suffered a loss due to such excess balances.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company invests excess cash from time to time in highly-liquid debt and equity investments of highly-rated entities, which are classified as trading securities. Historically, the purpose of the investments has been to fund research and development, product development, FDA clearance-related activities and general corporate purposes. Such amounts are recorded at market values using Level 1 inputs in determining fair value and are generally classified as current, as the Company does not intend to hold the investments beyond twelve months. Investment securities classified as trading are those securities that are bought and held principally for the purpose of selling them in the near term, with the objective of preserving principal and generating profits. These securities are reported at fair value with unrealized gains and losses reported as an element of other (expense) income in current period earnings. The Company&amp;#8217;s Board of Directors has approved an investment policy covering the investment parameters to be followed with the primary goals being the safety of principal amounts and maintaining liquidity. The policy provides for minimum investment rating requirements as well as limitations on investment duration and concentrations. Based upon market conditions, the investment guidelines have been tightened to increase the minimum acceptable investment ratings required for investments and shorten the maximum investment term. As of June 30, 2016, approximately 20% of the investment portfolio was in cash and cash equivalents, which is presented as such on the accompanying balance sheet, and the remaining funds were invested in marketable securities with none individually representing a material amount of the portfolio.&amp;#160; Investments with a scheduled maturity beyond one year are classified as long-term investments on the balance sheet.&amp;#160; To date, the Company&amp;#8217;s cumulative realized market loss from the investments has not been significant.&amp;#160;For the six months ended June 30, 2016 and 2015, there was approximately $11,000 and $16,000, respectively, in management fee expenses.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Fair value of financial instruments:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company accounts for financial instruments under Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) Accounting Standards Codification Topic (&amp;#8220;ASC&amp;#8221;) 820,&lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt; Fair Value Measurements&lt;/font&gt;.&amp;#160; This statement defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements.&amp;#160; To increase consistency and comparability in fair value measurements, ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels as follows:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Level 1&amp;#8212; quoted prices (unadjusted) in active markets for identical assets or liabilities;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Level 2 &amp;#8212; observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Level 3 &amp;#8212; assets and liabilities whose significant value drivers are unobservable.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company&amp;#8217;s market assumptions.&amp;#160; Unobservable inputs require significant management judgment or estimation.&amp;#160; In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy.&amp;#160; In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement.&amp;#160; Such determination requires significant management judgment. There were no financial assets or liabilities measured at fair value, with the exception of cash, cash equivalents and short-term investments as of June 30, 2016 and December 31, 2015.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The carrying amounts of the Company&amp;#8217;s financial instruments (other than cash, cash equivalents and short-term investments as discussed above) approximate fair value because of their variable interest rates and/or short maturities combined with the recent historical interest rate levels.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;Revenue recognition and accounts receivable:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;We recognized sales of goods under the provisions of ASC 605 and the U.S. Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) Staff Accounting Bulletin (&amp;#8220;SAB&amp;#8221;) 104, &lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt;Revenue Recognition&lt;/font&gt;. Future revenue is expected to be generated primarily from the sale of products. Product revenue primarily consists of sales of instrumentation and consumables.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Revenue was recognized when the following four basic criteria were met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred and risk of loss has passed; (iii) the seller&amp;#8217;s price to the buyer is fixed or determinable; and (iv) collectability is reasonably assured.&amp;#160; In international markets, the Company sells its products to distributors or re-sellers, who subsequently resell the products to hospitals. The Company has an agreement with the distributor which provides that title and risk of loss pass to the distributor upon shipment of the products, FOB to the distributor. Revenue is recognized upon shipment of products to the distributor as the products are shipped based on FOB shipping point terms (See Note 8).&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Revenues were recorded less a reserve for estimated product returns and allowances which to date has not been significant. Determination of the reserve for estimated product returns and allowances is based on management&amp;#8217;s analyses and judgments regarding certain conditions. Should future changes in conditions prove management&amp;#8217;s conclusions and judgments on previous analyses to be incorrect, revenue recognized for any reporting period could be adversely affected.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company extended credit to customers generally without requiring collateral. As of June 30, 2016 and December 31, 2015, the Company did not have any accounts receivable. During the six months ended June 30, 2016, no sales were recorded.&amp;#160; During the six months ended June 30, 2015, three European-based customers accounted for the total net sales, representing 58%, 28% and 14%, respectively.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;font style="font-weight: bold"&gt;Recently issued and adopted accounting pronouncements:&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company's financial reporting, the Company undertakes a study to determine the consequences of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company's financial statements properly reflect the change.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;In May 2014, the FASB issued Accounting Standards Update ("ASU") No. 2014-09 "Revenue from Contracts from Customers," which supersedes the revenue recognition requirements in "Revenue Recognition (Topic 605)," and requires entities to recognize revenue in a way that depicts the transfer of potential goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to the exchange for those goods or services. In July 2015, the FASB extended the effective date of ASU 2014-09 by one year, to now be effective for fiscal years, and interim periods beginning after December 15, 2017, and is to be applied retrospectively, with early adoption now permitted for fiscal years and interim periods beginning after December 31, 2015. The Company does not believe the new standard will have a material impact on its operations and financial statements.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Income (loss) per share:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;ASC 260,&lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt; Earnings Per Share&lt;/font&gt;, requires dual presentation of basic and diluted earnings per share (&amp;#8220;EPS&amp;#8221;) with a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilution. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the entity.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Basic net earnings (loss) per share includes no dilution and is computed by dividing net earnings (loss) available to shareholders by the weighted average number of common shares outstanding for the period.&amp;#160;Diluted net earnings (loss) per share reflect the potential dilution of securities that could share in the Company&amp;#8217;s earnings (loss).&amp;#160; The effect of the inclusion of the dilutive shares would have resulted in a decrease in loss per share for the three and six months ended June 30, 2016&lt;font style="font: 10pt Times New Roman, Times, serif"&gt; and 2015 respectively&lt;/font&gt;.&amp;#160; Accordingly, the weighted average shares outstanding have not been adjusted for dilutive shares for any&amp;#160;period presented.&amp;#160; Outstanding stock options and warrants are not considered in the calculation, as the impact of the potential common shares (totaling approximately 966,000 shares and 776,000 shares for &lt;font style="font: 10pt Times New Roman, Times, serif"&gt;each of &lt;/font&gt;the &lt;font style="font: 10pt Times New Roman, Times, serif"&gt;three and &lt;/font&gt;six month periods ended June 30, 2016 and 2015, respectively) would be anti-dilutive.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Upon the completion of a special shareholders meeting on March 24, 2016, where such action was approved by shareholders, the Board of Directors authorized a reverse stock split of the Company&amp;#8217;s common stock at a ratio of one-for-eight, whereby each eight shares of common stock were combined into one share of common stock (the &amp;#8220;Reverse Stock Split&amp;#8221;).&amp;#160;&amp;#160;The Reverse Stock Split was implemented and effective on March 31, 2016. All historical references to shares and share amounts in this report have been retroactively revised to reflect the Reverse Stock Split.&amp;#160; A reconciliation of basic and diluted weighted average number of shares outstanding adjusted for the Reverse Stock Split for the period ended June 30, 2016 was 30,990,029 shares on a pre-split basis and 3,876,961 shares on a post-split basis.&lt;/div&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;&lt;font style="font-weight: bold"&gt;Recently issued and adopted accounting pronouncements:&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company's financial reporting, the Company undertakes a study to determine the consequences of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company's financial statements properly reflect the change.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;In May 2014, the FASB issued Accounting Standards Update ("ASU") No. 2014-09 "Revenue from Contracts from Customers," which supersedes the revenue recognition requirements in "Revenue Recognition (Topic 605)," and requires entities to recognize revenue in a way that depicts the transfer of potential goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to the exchange for those goods or services. In July 2015, the FASB extended the effective date of ASU 2014-09 by one year, to now be effective for fiscal years, and interim periods beginning after December 15, 2017, and is to be applied retrospectively, with early adoption now permitted for fiscal years and interim periods beginning after December 31, 2015. The Company does not believe the new standard will have a material impact on its operations and financial statements.&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Income (loss) per share:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;ASC 260,&lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt; Earnings Per Share&lt;/font&gt;, requires dual presentation of basic and diluted earnings per share (&amp;#8220;EPS&amp;#8221;) with a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilution. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the entity.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Basic net earnings (loss) per share includes no dilution and is computed by dividing net earnings (loss) available to shareholders by the weighted average number of common shares outstanding for the period.&amp;#160;Diluted net earnings (loss) per share reflect the potential dilution of securities that could share in the Company&amp;#8217;s earnings (loss).&amp;#160; The effect of the inclusion of the dilutive shares would have resulted in a decrease in loss per share for the three and six months ended June 30, 2016&lt;font style="font: 10pt Times New Roman, Times, serif"&gt; and 2015 respectively&lt;/font&gt;.&amp;#160; Accordingly, the weighted average shares outstanding have not been adjusted for dilutive shares for any&amp;#160;period presented.&amp;#160; Outstanding stock options and warrants are not considered in the calculation, as the impact of the potential common shares (totaling approximately 966,000 shares and 776,000 shares for &lt;font style="font: 10pt Times New Roman, Times, serif"&gt;each of &lt;/font&gt;the &lt;font style="font: 10pt Times New Roman, Times, serif"&gt;three and &lt;/font&gt;six month periods ended June 30, 2016 and 2015, respectively) would be anti-dilutive.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Upon the completion of a special shareholders meeting on March 24, 2016, where such action was approved by shareholders, the Board of Directors authorized a reverse stock split of the Company&amp;#8217;s common stock at a ratio of one-for-eight, whereby each eight shares of common stock were combined into one share of common stock (the &amp;#8220;Reverse Stock Split&amp;#8221;).&amp;#160;&amp;#160;The Reverse Stock Split was implemented and effective on March 31, 2016. All historical references to shares and share amounts in this report have been retroactively revised to reflect the Reverse Stock Split.&amp;#160; A reconciliation of basic and diluted weighted average number of shares outstanding adjusted for the Reverse Stock Split for the period ended June 30, 2016 was 30,990,029 shares on a pre-split basis and 3,876,961 shares on a post-split basis.&lt;/div&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2016-01-01to2016-06-30">&lt;div&gt;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt"&gt;INTERIM FINANCIAL STATEMENTS&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The accompanying financial statements of Venaxis, Inc. (the &amp;#8220;Company,&amp;#8221;&amp;#160; &amp;#8220;we,&amp;#8221;&amp;#160;or &amp;#8220;Venaxis&amp;#8221;) have been prepared in accordance with the instructions to quarterly reports on Form 10-Q. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and changes in financial position at June 30, 2016 and for all periods presented have been made. Certain information and footnote data necessary for fair presentation of financial position and results of operations in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted. It is therefore suggested that these financial statements be read in conjunction with the summary of significant accounting policies and notes to financial statements included in the Company&amp;#8217;s Annual Report on Form 10-K for the year ended December 31, 2015. The results of operations for the period ended June 30, 2016 are not necessarily an indication of operating results for the full year.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Management&amp;#8217;s plans and basis of presentation:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;The Company has experienced recurring losses and negative cash flows from operations.&amp;#160;&amp;#160;At June 30, 2016, the Company had approximate balances of cash and liquid investments of $16,147,000, working capital of $15,801,000, total stockholders&amp;#8217; equity of $16,019,000 and an accumulated deficit of $105,859,000. To date, the Company has in large part relied on equity financing to fund its operations.&amp;#160; The Company expects to continue to incur losses from operations for the near-term and these losses could be significant, as professional and other associated expenses in connection with possible strategic considerations, evaluations and transactions, appendicitis portfolio related expenses, public company and administrative related expenses are incurred. The Company believes that its current working capital position will be sufficient to meet its estimated cash needs into 2017.&amp;#160; The Company is closely monitoring its cash balances, cash needs and expense levels.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;As of January 26, 2016, Venaxis publicly disclosed that it had entered into a series of agreements, including a Master Agreement, for a combination transaction (the &amp;#8220;Strand transaction&amp;#8221;) with Strand Life Sciences Private Limited and its shareholders (&amp;#8220;Strand&amp;#8221;).&amp;#160; Strand is privately-held, and operates clinical reference labs in the U.S. and in India, providing testing and lab services in India and other world-wide markets.&amp;#160; Strand has commercialized a next generation sequencing (NGS) based, targeted, multi-gene, pan-cancer diagnostic panel in select international markets and has engaged in initial commercialization activities in the United States.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;On March 11, 2016, Venaxis and Strand entered into a Mutual Termination Agreement to terminate the series of agreements.&amp;#160; Pursuant to the Mutual Termination Agreement, each of the parties was relieved of any obligations or responsibilities under the Master Agreement and other transaction agreements.&amp;#160; Each party remains responsible for its respective transaction-related expenses.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Following the recent termination of the Strand transaction, the Company has begun evaluating potential strategic alternatives. The Company expects, in the near term, to utilize the primary criteria it has established as it evaluates its next steps and strategic path forward with the goal of maximizing value for its shareholders. As a result of the current market trends and uncertainties, and&amp;#160;the impact on many companies, management believes that there may currently be attractive opportunities available to the Company.&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;Management&amp;#8217;s strategic assessment includes the following potential options:&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; text-align: justify; margin-top: 3pt; line-height: 1"&gt;&#13;&lt;table id="c003a99e15fe41bcabea240953a7f4a0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 20.25pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top; color: #000000"&gt;&amp;#183;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: auto; vertical-align: top; color: #000000; text-align: justify"&gt;exploring other possible strategic options available to the Company following termination of the Strand transaction;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; text-align: justify; margin-top: 3pt; line-height: 1"&gt;&#13;&lt;table id="f9aa29e3274c4cb8847031f6cd0728ed" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 20.25pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top; color: #000000"&gt;&amp;#183;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: auto; vertical-align: top; color: #000000; text-align: justify"&gt;evaluating options to monetize, partner or license the Company's appendicitis product portfolio;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; text-align: justify; margin-top: 3pt; line-height: 1"&gt;&#13;&lt;table id="a06d2b190839645a1b482731c2b9c509e" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 20.25pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top; color: #000000"&gt;&amp;#183;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: auto; vertical-align: top; color: #000000; text-align: justify"&gt;continuing to explore prospective partnering or licensing opportunities with complementary opportunities and technologies; and&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; text-align: justify; margin-top: 3pt; line-height: 1"&gt;&#13;&lt;table id="a82f7bd38ab934e61acd2cb6dcdcab6e1" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 20.25pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top; color: #000000"&gt;&amp;#183;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: auto; vertical-align: top; color: #000000; text-align: justify"&gt;continuing to implement cost control initiatives to conserve cash.&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"&gt;&lt;br style="line-height: 1" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"&gt;As part of the Company&amp;#8217;s process to identify possible strategic partners, several targets were identified that the Company assessed as possibly having a business model that could be interested in discussions with Venaxis for potentially acquiring or licensing the appendicitis assets. Venaxis has made initial contact with several of these parties to gauge their interest level, which initially is more focused on the &lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt;APPY&lt;/font&gt;2 development assets. Management believes that the estimated potential market for an appendicitis test continues to be significant. If Venaxis is unable to locate a new strategic target, a partner or other third-party interested in advancing development and commercial activities of the Venaxis appendicitis portfolio, the capitalized costs on the Company&amp;#8217;s balance sheet, totaling approximately $371,000, as of June 30, 2016 for the acute appendicitis patents may be deemed impaired.&lt;/div&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>appy-20160630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: appy%2D20160630 Final.xfr; Date: 2016%2D08%2D10T18:55:44Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80060000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +a45o7xRiXhun8uHZnVMWa6K+bPtx5R6Cekxs2R8HUkKTy0kGFxvqS1ashYGgcMC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:appy="http://venaxis.com/20160630" elementFormDefault="qualified" targetNamespace="http://venaxis.com/20160630">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://venaxis.com/role/appy-daei" id="appy-daei">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-bs" id="appy-bs">
	  <link:definition>00000002 - Statement - Balance Sheets (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-bsp" id="appy-bsp">
	  <link:definition>00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-soo" id="appy-soo">
	  <link:definition>00000004 - Statement - Statements of Operations (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-socf" id="appy-socf">
	  <link:definition>00000005 - Statement - Statements of Cash Flows (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-ifs" id="appy-ifs">
	  <link:definition>00000006 - Disclosure - INTERIM FINANCIAL STATEMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-sap" id="appy-sap">
	  <link:definition>00000007 - Disclosure - Significant accounting policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-pae" id="appy-pae">
	  <link:definition>00000008 - Disclosure - Property and equipment</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-ola" id="appy-ola">
	  <link:definition>00000009 - Disclosure - Other long-term assets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-naoo" id="appy-naoo">
	  <link:definition>00000010 - Disclosure - Notes and Other Obligations</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-se" id="appy-se">
	  <link:definition>00000011 - Disclosure - Stockholders' equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-soaw" id="appy-soaw">
	  <link:definition>00000012 - Disclosure - Stock options and warrants</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-ahla" id="appy-ahla">
	  <link:definition>00000013 - Disclosure - Animal Health License Agreements</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-cac" id="appy-cac">
	  <link:definition>00000014 - Disclosure - Commitments and contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-rpt" id="appy-rpt">
	  <link:definition>00000015 - Disclosure - Related Party Transactions</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/SubsequentEvent" id="SubsequentEvent">
	  <link:definition>00000016 - Disclosure - Subsequent event</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-sapp" id="appy-sapp">
	  <link:definition>00000017 - Disclosure - Significant accounting policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-paet" id="appy-paet">
	  <link:definition>00000018 - Disclosure - Property and equipment (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-olat" id="appy-olat">
	  <link:definition>00000019 - Disclosure - Other long-term assets (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-naoot" id="appy-naoot">
	  <link:definition>00000020 - Disclosure - Notes and Other Obligations (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-soawt" id="appy-soawt">
	  <link:definition>00000021 - Disclosure - Stock options and warrants (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-ahlat" id="appy-ahlat">
	  <link:definition>00000022 - Disclosure - Animal Health License Agreements (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-ifsd" id="appy-ifsd">
	  <link:definition>00000023 - Disclosure - INTERIM FINANCIAL STATEMENTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/SignificantAccountingPoliciesNarrativeDetails" id="SignificantAccountingPoliciesNarrativeDetails">
	  <link:definition>00000024 - Disclosure - Significant accounting policies (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/SignificantAccountingPoliciesRevenueRecognitionAndAccountsReceivableDetails" id="SignificantAccountingPoliciesRevenueRecognitionAndAccountsReceivableDetails">
	  <link:definition>00000025 - Disclosure - Significant accounting policies (Revenue recognition and accounts receivable) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/PropertyAndEquipmentNarrativeDetails" id="PropertyAndEquipmentNarrativeDetails">
	  <link:definition>00000026 - Disclosure - Property and equipment (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/PropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" id="PropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails">
	  <link:definition>00000027 - Disclosure - Property and equipment (Schedule of Property and Equipment) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-olad" id="appy-olad">
	  <link:definition>00000028 - Disclosure - Other long-term assets (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-naoond" id="appy-naoond">
	  <link:definition>00000029 - Disclosure - Notes and Other Obligations (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-naoosoldd" id="appy-naoosoldd">
	  <link:definition>00000030 - Disclosure - Notes and Other Obligations (Schedule of Long-Term Debt) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/StockOptionsAndWarrantsStockIncentivePlanOptionsNarrativeDetails" id="StockOptionsAndWarrantsStockIncentivePlanOptionsNarrativeDetails">
	  <link:definition>00000031 - Disclosure - Stock options and warrants (Stock incentive plan options) (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfStock-basedCompensationDetails" id="StockOptionsAndWarrantsScheduleOfStock-basedCompensationDetails">
	  <link:definition>00000032 - Disclosure - Stock options and warrants (Schedule of Stock-based Compensation) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfFairValueAssumptionsDetails" id="StockOptionsAndWarrantsScheduleOfFairValueAssumptionsDetails">
	  <link:definition>00000033 - Disclosure - Stock options and warrants (Schedule of fair value assumptions) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfAwardActivityDetails" id="StockOptionsAndWarrantsScheduleOfAwardActivityDetails">
	  <link:definition>00000034 - Disclosure - Stock options and warrants (Schedule of Award Activity) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfNonvestedAwardsDetails" id="StockOptionsAndWarrantsScheduleOfNonvestedAwardsDetails">
	  <link:definition>00000035 - Disclosure - Stock options and warrants (Schedule of Nonvested Awards) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-ahland" id="appy-ahland">
	  <link:definition>00000036 - Disclosure - Animal Health License Agreements (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/appy-ahlasorrawlad" id="appy-ahlasorrawlad">
	  <link:definition>00000037 - Disclosure - Animal Health License Agreements (Schedule of Revenue Recognition Associated with the License Agreement) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://venaxis.com/role/CommitmentsAndContingenciesDetails" id="CommitmentsAndContingenciesDetails">
	  <link:definition>00000038 - Disclosure - Commitments and contingencies (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="appy-20160630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="appy-20160630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="appy-20160630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="appy-20160630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
    <element id="appy_WorkingCapital" name="WorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="appy_LicenseAndMilestonePaymentsRevenue" name="LicenseAndMilestonePaymentsRevenue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="appy_DeferredRevenueAccumulatedRecognition" name="DeferredRevenueAccumulatedRecognition" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="appy_NumberOfOfficersUnderEmployementAgreements" name="NumberOfOfficersUnderEmployementAgreements" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="appy_TotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners" name="TotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="appy_SalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty" name="SalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="appy_PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee" name="PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="appy_LicenseAgreementMaximumMilestonePayments" name="LicenseAgreementMaximumMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="appy_AdditionalMilestoneMaximumPayments" name="AdditionalMilestoneMaximumPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="appy_DeferredRevenueGross" name="DeferredRevenueGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="appy_PercentageOfInvestmentPortfolioCashAndCashEquivalent" name="PercentageOfInvestmentPortfolioCashAndCashEquivalent" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="appy_WeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit" name="WeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="appy_DebtInstrumentAmortizationPeriod" name="DebtInstrumentAmortizationPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="appy_DebtInstrumentMaturityPeriod" name="DebtInstrumentMaturityPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="appy_ConcentrationRiskNumberOfCustomers" name="ConcentrationRiskNumberOfCustomers" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="appy_BasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis" name="BasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="appy_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="appy_VestingPeriodSixMonthAnniversaryPercentOfSharesVesting" name="VestingPeriodSixMonthAnniversaryPercentOfSharesVesting" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="appy_LicenseFeesAndMilestoneRevenue" name="LicenseFeesAndMilestoneRevenue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="appy_LiabilityPayoffsUponPropertySale" name="LiabilityPayoffsUponPropertySale" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="appy_CashAndCashEquivalentsAndInvestmentsPolicyTextBlock" name="CashAndCashEquivalentsAndInvestmentsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="appy_ScheduleOfOtherLongTermAssetsTableTextBlock" name="ScheduleOfOtherLongTermAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="appy_NotesPayableToBankMember" name="NotesPayableToBankMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="appy_UnitedStatesSmallBusinessAdministrationMember" name="UnitedStatesSmallBusinessAdministrationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="appy_StockIncentivePlanMember" name="StockIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="appy_NonqualifiedMember" name="NonqualifiedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="appy_CustomerOneMember" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="appy_CustomerTwoMember" name="CustomerTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="appy_CustomerThreeMember" name="CustomerThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="appy_IndependentDirectorsMember" name="IndependentDirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="appy_OfficersAndEmployeesMember" name="OfficersAndEmployeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="appy_DirectorsEmployeesAndConsultantsMember" name="DirectorsEmployeesAndConsultantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="appy_NonCompensatoryRightsMember" name="NonCompensatoryRightsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="appy_ShareBasedCompensationAwardTrancheFourMember" name="ShareBasedCompensationAwardTrancheFourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="appy_CompensatoryRightsMember" name="CompensatoryRightsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="appy_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="appy_AnimalHealthLicenseAgreementsAbstract" name="AnimalHealthLicenseAgreementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="appy_IssuanceTypeAxis" name="IssuanceTypeAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="appy_IssuanceTypeDomain" name="IssuanceTypeDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesVestingInArrears" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesVestingInArrears" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAnnuallyInArrearsOverSpecificPeriod" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAnnuallyInArrearsOverSpecificPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodToVestAnnuallyInArrears" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodToVestAnnuallyInArrears" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="appy_RightsExercisable" name="RightsExercisable" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="appy_RightsExercisablePricePerCommonShare" name="RightsExercisablePricePerCommonShare" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="appy_RightsExpirationDate" name="RightsExpirationDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="appy_WeightedAverageRemainingContractualTermAbstract" name="WeightedAverageRemainingContractualTermAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="appy_AggregateIntrinsicValueAbstract" name="AggregateIntrinsicValueAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>appy-20160630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: appy%2D20160630 Final.xfr; Date: 2016%2D08%2D10T18:55:44Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80060000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://venaxis.com/role/appy-daei" xlink:href="appy-20160630.xsd#appy-daei" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-bs" xlink:href="appy-20160630.xsd#appy-bs" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-bsp" xlink:href="appy-20160630.xsd#appy-bsp" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-soo" xlink:href="appy-20160630.xsd#appy-soo" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-socf" xlink:href="appy-20160630.xsd#appy-socf" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ifs" xlink:href="appy-20160630.xsd#appy-ifs" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-sap" xlink:href="appy-20160630.xsd#appy-sap" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-pae" xlink:href="appy-20160630.xsd#appy-pae" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ola" xlink:href="appy-20160630.xsd#appy-ola" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-naoo" xlink:href="appy-20160630.xsd#appy-naoo" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-se" xlink:href="appy-20160630.xsd#appy-se" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-soaw" xlink:href="appy-20160630.xsd#appy-soaw" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ahla" xlink:href="appy-20160630.xsd#appy-ahla" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-cac" xlink:href="appy-20160630.xsd#appy-cac" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-rpt" xlink:href="appy-20160630.xsd#appy-rpt" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/SubsequentEvent" xlink:href="appy-20160630.xsd#SubsequentEvent" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-sapp" xlink:href="appy-20160630.xsd#appy-sapp" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-paet" xlink:href="appy-20160630.xsd#appy-paet" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-olat" xlink:href="appy-20160630.xsd#appy-olat" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-naoot" xlink:href="appy-20160630.xsd#appy-naoot" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-soawt" xlink:href="appy-20160630.xsd#appy-soawt" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ahlat" xlink:href="appy-20160630.xsd#appy-ahlat" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ifsd" xlink:href="appy-20160630.xsd#appy-ifsd" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:href="appy-20160630.xsd#SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/SignificantAccountingPoliciesRevenueRecognitionAndAccountsReceivableDetails" xlink:href="appy-20160630.xsd#SignificantAccountingPoliciesRevenueRecognitionAndAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/PropertyAndEquipmentNarrativeDetails" xlink:href="appy-20160630.xsd#PropertyAndEquipmentNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/PropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:href="appy-20160630.xsd#PropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-olad" xlink:href="appy-20160630.xsd#appy-olad" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-naoond" xlink:href="appy-20160630.xsd#appy-naoond" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-naoosoldd" xlink:href="appy-20160630.xsd#appy-naoosoldd" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/StockOptionsAndWarrantsStockIncentivePlanOptionsNarrativeDetails" xlink:href="appy-20160630.xsd#StockOptionsAndWarrantsStockIncentivePlanOptionsNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfStock-basedCompensationDetails" xlink:href="appy-20160630.xsd#StockOptionsAndWarrantsScheduleOfStock-basedCompensationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfFairValueAssumptionsDetails" xlink:href="appy-20160630.xsd#StockOptionsAndWarrantsScheduleOfFairValueAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfAwardActivityDetails" xlink:href="appy-20160630.xsd#StockOptionsAndWarrantsScheduleOfAwardActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfNonvestedAwardsDetails" xlink:href="appy-20160630.xsd#StockOptionsAndWarrantsScheduleOfNonvestedAwardsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ahland" xlink:href="appy-20160630.xsd#appy-ahland" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ahlasorrawlad" xlink:href="appy-20160630.xsd#appy-ahlasorrawlad" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/CommitmentsAndContingenciesDetails" xlink:href="appy-20160630.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-daei" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-bs" xlink:title="00000002 - Statement - Balance Sheets (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermInvestments" xlink:label="loc_us-gaapLongTermInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapLongTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:label="loc_us-gaapCommonStocksIncludingAdditionalPaidInCapital" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStocksIncludingAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-bsp" xlink:title="00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-soo" xlink:title="00000004 - Statement - Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaapSalesRevenueGoodsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapSalesRevenueGoodsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaapCostOfGoodsSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LicensesRevenue" xlink:label="loc_us-gaapLicensesRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapLicensesRevenue" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-socf" xlink:title="00000005 - Statement - Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaapOtherNoncashExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapOtherNoncashExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RecognitionOfDeferredRevenue" xlink:label="loc_us-gaapRecognitionOfDeferredRevenue" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapRecognitionOfDeferredRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedSalaries" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedSalaries" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="loc_us-gaapPaymentsToAcquireShortTermInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapPaymentsToAcquireShortTermInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromSaleOfShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ifs" xlink:title="00000006 - Disclosure - INTERIM FINANCIAL STATEMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-sap" xlink:title="00000007 - Disclosure - Significant accounting policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-pae" xlink:title="00000008 - Disclosure - Property and equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ola" xlink:title="00000009 - Disclosure - Other long-term assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-naoo" xlink:title="00000010 - Disclosure - Notes and Other Obligations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-se" xlink:title="00000011 - Disclosure - Stockholders' equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-soaw" xlink:title="00000012 - Disclosure - Stock options and warrants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ahla" xlink:title="00000013 - Disclosure - Animal Health License Agreements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-cac" xlink:title="00000014 - Disclosure - Commitments and contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-rpt" xlink:title="00000015 - Disclosure - Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/SubsequentEvent" xlink:title="00000016 - Disclosure - Subsequent event" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-sapp" xlink:title="00000017 - Disclosure - Significant accounting policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-paet" xlink:title="00000018 - Disclosure - Property and equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-olat" xlink:title="00000019 - Disclosure - Other long-term assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-naoot" xlink:title="00000020 - Disclosure - Notes and Other Obligations (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-soawt" xlink:title="00000021 - Disclosure - Stock options and warrants (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ahlat" xlink:title="00000022 - Disclosure - Animal Health License Agreements (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ifsd" xlink:title="00000023 - Disclosure - INTERIM FINANCIAL STATEMENTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:title="00000024 - Disclosure - Significant accounting policies (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/SignificantAccountingPoliciesRevenueRecognitionAndAccountsReceivableDetails" xlink:title="00000025 - Disclosure - Significant accounting policies (Revenue recognition and accounts receivable) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/PropertyAndEquipmentNarrativeDetails" xlink:title="00000026 - Disclosure - Property and equipment (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/PropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:title="00000027 - Disclosure - Property and equipment (Schedule of Property and Equipment) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-olad" xlink:title="00000028 - Disclosure - Other long-term assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsNoncurrent" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:label="loc_us-gaapOtherAssetsMiscellaneousNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsNoncurrent" xlink:to="loc_us-gaapOtherAssetsMiscellaneousNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsNoncurrent" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-naoond" xlink:title="00000029 - Disclosure - Notes and Other Obligations (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-naoosoldd" xlink:title="00000030 - Disclosure - Notes and Other Obligations (Schedule of Long-Term Debt) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebt" xlink:label="loc_us-gaapSecuredDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNotesPayable" xlink:to="loc_us-gaapSecuredDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherShortTermBorrowings" xlink:label="loc_us-gaapOtherShortTermBorrowings" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNotesPayable" xlink:to="loc_us-gaapOtherShortTermBorrowings" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/StockOptionsAndWarrantsStockIncentivePlanOptionsNarrativeDetails" xlink:title="00000031 - Disclosure - Stock options and warrants (Stock incentive plan options) (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfStock-basedCompensationDetails" xlink:title="00000032 - Disclosure - Stock options and warrants (Schedule of Stock-based Compensation) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfFairValueAssumptionsDetails" xlink:title="00000033 - Disclosure - Stock options and warrants (Schedule of fair value assumptions) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfAwardActivityDetails" xlink:title="00000034 - Disclosure - Stock options and warrants (Schedule of Award Activity) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfNonvestedAwardsDetails" xlink:title="00000035 - Disclosure - Stock options and warrants (Schedule of Nonvested Awards) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ahland" xlink:title="00000036 - Disclosure - Animal Health License Agreements (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ahlasorrawlad" xlink:title="00000037 - Disclosure - Animal Health License Agreements (Schedule of Revenue Recognition Associated with the License Agreement) (Details)">
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_DeferredRevenueGross" xlink:label="loc_appyDeferredRevenueGross" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_LicenseAndMilestonePaymentsRevenue" xlink:label="loc_appyLicenseAndMilestonePaymentsRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_appyDeferredRevenueGross" xlink:to="loc_appyLicenseAndMilestonePaymentsRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredCostsCurrentAndNoncurrent" xlink:label="loc_us-gaapDeferredCostsCurrentAndNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_appyDeferredRevenueGross" xlink:to="loc_us-gaapDeferredCostsCurrentAndNoncurrent" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredRevenue" xlink:to="loc_appyDeferredRevenueGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_DeferredRevenueAccumulatedRecognition" xlink:label="loc_appyDeferredRevenueAccumulatedRecognition" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredRevenue" xlink:to="loc_appyDeferredRevenueAccumulatedRecognition" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://venaxis.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000038 - Disclosure - Commitments and contingencies (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>appy-20160630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: appy%2D20160630 Final.xfr; Date: 2016%2D08%2D10T18:55:44Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80060000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://venaxis.com/role/appy-daei" xlink:href="appy-20160630.xsd#appy-daei" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-bs" xlink:href="appy-20160630.xsd#appy-bs" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-bsp" xlink:href="appy-20160630.xsd#appy-bsp" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-soo" xlink:href="appy-20160630.xsd#appy-soo" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-socf" xlink:href="appy-20160630.xsd#appy-socf" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ifs" xlink:href="appy-20160630.xsd#appy-ifs" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-sap" xlink:href="appy-20160630.xsd#appy-sap" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-pae" xlink:href="appy-20160630.xsd#appy-pae" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ola" xlink:href="appy-20160630.xsd#appy-ola" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-naoo" xlink:href="appy-20160630.xsd#appy-naoo" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-se" xlink:href="appy-20160630.xsd#appy-se" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-soaw" xlink:href="appy-20160630.xsd#appy-soaw" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ahla" xlink:href="appy-20160630.xsd#appy-ahla" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-cac" xlink:href="appy-20160630.xsd#appy-cac" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-rpt" xlink:href="appy-20160630.xsd#appy-rpt" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/SubsequentEvent" xlink:href="appy-20160630.xsd#SubsequentEvent" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-sapp" xlink:href="appy-20160630.xsd#appy-sapp" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-paet" xlink:href="appy-20160630.xsd#appy-paet" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-olat" xlink:href="appy-20160630.xsd#appy-olat" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-naoot" xlink:href="appy-20160630.xsd#appy-naoot" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-soawt" xlink:href="appy-20160630.xsd#appy-soawt" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ahlat" xlink:href="appy-20160630.xsd#appy-ahlat" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ifsd" xlink:href="appy-20160630.xsd#appy-ifsd" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:href="appy-20160630.xsd#SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/SignificantAccountingPoliciesRevenueRecognitionAndAccountsReceivableDetails" xlink:href="appy-20160630.xsd#SignificantAccountingPoliciesRevenueRecognitionAndAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/PropertyAndEquipmentNarrativeDetails" xlink:href="appy-20160630.xsd#PropertyAndEquipmentNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/PropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:href="appy-20160630.xsd#PropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-olad" xlink:href="appy-20160630.xsd#appy-olad" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-naoond" xlink:href="appy-20160630.xsd#appy-naoond" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-naoosoldd" xlink:href="appy-20160630.xsd#appy-naoosoldd" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/StockOptionsAndWarrantsStockIncentivePlanOptionsNarrativeDetails" xlink:href="appy-20160630.xsd#StockOptionsAndWarrantsStockIncentivePlanOptionsNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfStock-basedCompensationDetails" xlink:href="appy-20160630.xsd#StockOptionsAndWarrantsScheduleOfStock-basedCompensationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfFairValueAssumptionsDetails" xlink:href="appy-20160630.xsd#StockOptionsAndWarrantsScheduleOfFairValueAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfAwardActivityDetails" xlink:href="appy-20160630.xsd#StockOptionsAndWarrantsScheduleOfAwardActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfNonvestedAwardsDetails" xlink:href="appy-20160630.xsd#StockOptionsAndWarrantsScheduleOfNonvestedAwardsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ahland" xlink:href="appy-20160630.xsd#appy-ahland" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ahlasorrawlad" xlink:href="appy-20160630.xsd#appy-ahlasorrawlad" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/CommitmentsAndContingenciesDetails" xlink:href="appy-20160630.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-daei" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-bs" xlink:title="00000002 - Statement - Balance Sheets (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-bsp" xlink:title="00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-soo" xlink:title="00000004 - Statement - Statements of Operations (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-socf" xlink:title="00000005 - Statement - Statements of Cash Flows (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ifs" xlink:title="00000006 - Disclosure - INTERIM FINANCIAL STATEMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-sap" xlink:title="00000007 - Disclosure - Significant accounting policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-pae" xlink:title="00000008 - Disclosure - Property and equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ola" xlink:title="00000009 - Disclosure - Other long-term assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-naoo" xlink:title="00000010 - Disclosure - Notes and Other Obligations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-se" xlink:title="00000011 - Disclosure - Stockholders' equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-soaw" xlink:title="00000012 - Disclosure - Stock options and warrants" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ahla" xlink:title="00000013 - Disclosure - Animal Health License Agreements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-cac" xlink:title="00000014 - Disclosure - Commitments and contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-rpt" xlink:title="00000015 - Disclosure - Related Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/SubsequentEvent" xlink:title="00000016 - Disclosure - Subsequent event" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-sapp" xlink:title="00000017 - Disclosure - Significant accounting policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-paet" xlink:title="00000018 - Disclosure - Property and equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-olat" xlink:title="00000019 - Disclosure - Other long-term assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-naoot" xlink:title="00000020 - Disclosure - Notes and Other Obligations (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-soawt" xlink:title="00000021 - Disclosure - Stock options and warrants (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ahlat" xlink:title="00000022 - Disclosure - Animal Health License Agreements (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ifsd" xlink:title="00000023 - Disclosure - INTERIM FINANCIAL STATEMENTS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:title="00000024 - Disclosure - Significant accounting policies (Narrative) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/SignificantAccountingPoliciesRevenueRecognitionAndAccountsReceivableDetails" xlink:title="00000025 - Disclosure - Significant accounting policies (Revenue recognition and accounts receivable) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:label="loc_us-gaapGeographicConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapGeographicConcentrationRiskMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="loc_us-gaapMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaapNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMajorCustomersAxis" xlink:to="loc_us-gaapNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaapNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMajorCustomersAxis" xlink:to="loc_us-gaapNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_CustomerOneMember" xlink:label="loc_appyCustomerOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_appyCustomerOneMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_CustomerTwoMember" xlink:label="loc_appyCustomerTwoMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_appyCustomerTwoMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_CustomerThreeMember" xlink:label="loc_appyCustomerThreeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_appyCustomerThreeMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ConcentrationRiskNumberOfCustomers" xlink:label="loc_appyConcentrationRiskNumberOfCustomers_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_appyConcentrationRiskNumberOfCustomers_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/PropertyAndEquipmentNarrativeDetails" xlink:title="00000026 - Disclosure - Property and equipment (Narrative) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/PropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:title="00000027 - Disclosure - Property and equipment (Schedule of Property and Equipment) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LandAndLandImprovementsMember" xlink:label="loc_us-gaapLandAndLandImprovementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandAndLandImprovementsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaapBuildingAndBuildingImprovementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingAndBuildingImprovementsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:label="loc_us-gaapOtherMachineryAndEquipmentMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOtherMachineryAndEquipmentMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOfficeEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_130" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-olad" xlink:title="00000028 - Disclosure - Other long-term assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-naoond" xlink:title="00000029 - Disclosure - Notes and Other Obligations (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_NotesPayableToBankMember" xlink:label="loc_appyNotesPayableToBankMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_appyNotesPayableToBankMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_UnitedStatesSmallBusinessAdministrationMember" xlink:label="loc_appyUnitedStatesSmallBusinessAdministrationMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_appyUnitedStatesSmallBusinessAdministrationMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MortgagesMember" xlink:label="loc_us-gaapMortgagesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapMortgagesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_DebtInstrumentAmortizationPeriod" xlink:label="loc_appyDebtInstrumentAmortizationPeriod_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_appyDebtInstrumentAmortizationPeriod_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_DebtInstrumentMaturityPeriod" xlink:label="loc_appyDebtInstrumentMaturityPeriod_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_appyDebtInstrumentMaturityPeriod_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentInterest_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapShortTermBorrowings_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaapLongTermDebtByMaturityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtByMaturityAbstract_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongTermDebtByMaturityAbstract_70" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_70" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-naoosoldd" xlink:title="00000030 - Disclosure - Notes and Other Obligations (Schedule of Long-Term Debt) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/StockOptionsAndWarrantsStockIncentivePlanOptionsNarrativeDetails" xlink:title="00000031 - Disclosure - Stock options and warrants (Stock incentive plan options) (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_StockIncentivePlanMember" xlink:label="loc_appyStockIncentivePlanMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_appyStockIncentivePlanMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_NonqualifiedMember" xlink:label="loc_appyNonqualifiedMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_appyNonqualifiedMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_IssuanceTypeAxis" xlink:label="loc_appyIssuanceTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_appyIssuanceTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_IssuanceTypeDomain" xlink:label="loc_appyIssuanceTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_appyIssuanceTypeAxis" xlink:to="loc_appyIssuanceTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_IssuanceTypeDomain" xlink:label="loc_appyIssuanceTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_appyIssuanceTypeAxis" xlink:to="loc_appyIssuanceTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_IndependentDirectorsMember" xlink:label="loc_appyIndependentDirectorsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_appyIssuanceTypeDomain" xlink:to="loc_appyIndependentDirectorsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_OfficersAndEmployeesMember" xlink:label="loc_appyOfficersAndEmployeesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_appyIssuanceTypeDomain" xlink:to="loc_appyOfficersAndEmployeesMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_NonCompensatoryRightsMember" xlink:label="loc_appyNonCompensatoryRightsMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_appyIssuanceTypeDomain" xlink:to="loc_appyNonCompensatoryRightsMember_230" xlink:type="arc" order="232" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_CompensatoryRightsMember" xlink:label="loc_appyCompensatoryRightsMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_appyIssuanceTypeDomain" xlink:to="loc_appyCompensatoryRightsMember_250" xlink:type="arc" order="252" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapVestingAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheOneMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheOneMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheThreeMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheThreeMember_70" xlink:type="arc" order="73" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ShareBasedCompensationAwardTrancheFourMember" xlink:label="loc_appyShareBasedCompensationAwardTrancheFourMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_appyShareBasedCompensationAwardTrancheFourMember_150" xlink:type="arc" order="153" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapStockOptionMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_280" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_280" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_280" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised_280" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_280" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_280" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_280" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_280" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_VestingPeriodSixMonthAnniversaryPercentOfSharesVesting" xlink:label="loc_appyVestingPeriodSixMonthAnniversaryPercentOfSharesVesting_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appyVestingPeriodSixMonthAnniversaryPercentOfSharesVesting_280" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesVestingInArrears" xlink:label="loc_appyShareBasedCompensationArrangementByShareBasedPaymentAwardSharesVestingInArrears_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appyShareBasedCompensationArrangementByShareBasedPaymentAwardSharesVestingInArrears_280" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_280" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_280" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_280" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAnnuallyInArrearsOverSpecificPeriod" xlink:label="loc_appySharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAnnuallyInArrearsOverSpecificPeriod_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appySharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAnnuallyInArrearsOverSpecificPeriod_280" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodToVestAnnuallyInArrears" xlink:label="loc_appyShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodToVestAnnuallyInArrears_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appyShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodToVestAnnuallyInArrears_280" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_280" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_280" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_280" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_280" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_280" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_280" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_280" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_280" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_280" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_280" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_280" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentOptionsExpirationDate" xlink:label="loc_investInvestmentOptionsExpirationDate_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_investInvestmentOptionsExpirationDate_280" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_RightsExercisable" xlink:label="loc_appyRightsExercisable_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appyRightsExercisable_280" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_RightsExercisablePricePerCommonShare" xlink:label="loc_appyRightsExercisablePricePerCommonShare_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appyRightsExercisablePricePerCommonShare_280" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_RightsExpirationDate" xlink:label="loc_appyRightsExpirationDate_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appyRightsExpirationDate_280" xlink:type="arc" order="29" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfStock-basedCompensationDetails" xlink:title="00000032 - Disclosure - Stock options and warrants (Schedule of Stock-based Compensation) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfFairValueAssumptionsDetails" xlink:title="00000033 - Disclosure - Stock options and warrants (Schedule of fair value assumptions) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfAwardActivityDetails" xlink:title="00000034 - Disclosure - Stock options and warrants (Schedule of Award Activity) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_StockIncentivePlanMember" xlink:label="loc_appyStockIncentivePlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_appyStockIncentivePlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_NonqualifiedMember" xlink:label="loc_appyNonqualifiedMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_appyNonqualifiedMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_WeightedAverageRemainingContractualTermAbstract" xlink:label="loc_appyWeightedAverageRemainingContractualTermAbstract_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appyWeightedAverageRemainingContractualTermAbstract_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_appyWeightedAverageRemainingContractualTermAbstract_30" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_30" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_appyWeightedAverageRemainingContractualTermAbstract_30" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_AggregateIntrinsicValueAbstract" xlink:label="loc_appyAggregateIntrinsicValueAbstract_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appyAggregateIntrinsicValueAbstract_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_appyAggregateIntrinsicValueAbstract_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_30" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_appyAggregateIntrinsicValueAbstract_30" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_30" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfNonvestedAwardsDetails" xlink:title="00000035 - Disclosure - Stock options and warrants (Schedule of Nonvested Awards) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_StockIncentivePlanMember" xlink:label="loc_appyStockIncentivePlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_appyStockIncentivePlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_20" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_20" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice" xlink:label="loc_appySharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_20" xlink:to="loc_appySharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice_20" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:label="loc_appyShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_20" xlink:to="loc_appyShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_20" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_20" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_20" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_20" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_20" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ahland" xlink:title="00000036 - Disclosure - Animal Health License Agreements (Narrative) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ahlasorrawlad" xlink:title="00000037 - Disclosure - Animal Health License Agreements (Schedule of Revenue Recognition Associated with the License Agreement) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://venaxis.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000038 - Disclosure - Commitments and contingencies (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:label="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:label="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:label="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentTable" xlink:to="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:label="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:to="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:label="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:to="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmploymentContractsMember" xlink:label="loc_us-gaapEmploymentContractsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:to="loc_us-gaapEmploymentContractsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_NumberOfOfficersUnderEmployementAgreements" xlink:label="loc_appyNumberOfOfficersUnderEmployementAgreements_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="loc_appyNumberOfOfficersUnderEmployementAgreements_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:label="loc_us-gaapPurchaseCommitmentRemainingMinimumAmountCommitted_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="loc_us-gaapPurchaseCommitmentRemainingMinimumAmountCommitted_30" xlink:type="arc" order="1" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>appy-20160630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: appy%2D20160630 Final.xfr; Date: 2016%2D08%2D10T18:55:44Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80060000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LandAndLandImprovementsMember" xlink:label="us-gaap_LandAndLandImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandAndLandImprovementsMember" xlink:to="us-gaap_LandAndLandImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandAndLandImprovementsMember_lbl" xml:lang="en-US">Land and improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US">Building [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="us-gaap_BuildingAndBuildingImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember_lbl" xml:lang="en-US">Building improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:label="us-gaap_OtherMachineryAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherMachineryAndEquipmentMember" xlink:to="us-gaap_OtherMachineryAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherMachineryAndEquipmentMember_lbl" xml:lang="en-US">Laboratory equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfficeEquipmentMember_lbl" xml:lang="en-US">Office and computer equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MortgagesMember" xlink:label="us-gaap_MortgagesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MortgagesMember" xlink:to="us-gaap_MortgagesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MortgagesMember_lbl" xml:lang="en-US">Mortgage Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_NotesPayableToBankMember" xlink:label="appy_NotesPayableToBankMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_NotesPayableToBankMember" xlink:to="appy_NotesPayableToBankMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_NotesPayableToBankMember_lbl" xml:lang="en-US">Commercial Banks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_UnitedStatesSmallBusinessAdministrationMember" xlink:label="appy_UnitedStatesSmallBusinessAdministrationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_UnitedStatesSmallBusinessAdministrationMember" xlink:to="appy_UnitedStatesSmallBusinessAdministrationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_UnitedStatesSmallBusinessAdministrationMember_lbl" xml:lang="en-US">U.S. Small Business Administration [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_StockIncentivePlanMember" xlink:label="appy_StockIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_StockIncentivePlanMember" xlink:to="appy_StockIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_StockIncentivePlanMember_lbl" xml:lang="en-US">Stock Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_NonqualifiedMember" xlink:label="appy_NonqualifiedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_NonqualifiedMember" xlink:to="appy_NonqualifiedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_NonqualifiedMember_lbl" xml:lang="en-US">Nonqualified [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:label="us-gaap_GeographicConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeographicConcentrationRiskMember" xlink:to="us-gaap_GeographicConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeographicConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Net Sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_CustomerOneMember" xlink:label="appy_CustomerOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_CustomerOneMember" xlink:to="appy_CustomerOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_CustomerOneMember_lbl" xml:lang="en-US">Customer One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="us-gaap_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="us-gaap_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_CustomerTwoMember" xlink:label="appy_CustomerTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_CustomerTwoMember" xlink:to="appy_CustomerTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_CustomerTwoMember_lbl" xml:lang="en-US">Customer Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_CustomerThreeMember" xlink:label="appy_CustomerThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_CustomerThreeMember" xlink:to="appy_CustomerThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_CustomerThreeMember_lbl" xml:lang="en-US">Customer Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_IndependentDirectorsMember" xlink:label="appy_IndependentDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_IndependentDirectorsMember" xlink:to="appy_IndependentDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_IndependentDirectorsMember_lbl" xml:lang="en-US">Independent Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_IssuanceTypeAxis" xlink:label="appy_IssuanceTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_IssuanceTypeAxis" xlink:to="appy_IssuanceTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_IssuanceTypeAxis_lbl" xml:lang="en-US">Issuance Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_OfficersAndEmployeesMember" xlink:label="appy_OfficersAndEmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_OfficersAndEmployeesMember" xlink:to="appy_OfficersAndEmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_OfficersAndEmployeesMember_lbl" xml:lang="en-US">Officers and Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xml:lang="en-US">Selling, general and administrative expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and development expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmploymentContractsMember" xlink:label="us-gaap_EmploymentContractsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmploymentContractsMember" xlink:to="us-gaap_EmploymentContractsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmploymentContractsMember_lbl" xml:lang="en-US">Employment Contracts [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:to="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis_lbl" xml:lang="en-US">Purchase Commitment, Excluding Long-term Commitment [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_NonCompensatoryRightsMember" xlink:label="appy_NonCompensatoryRightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_NonCompensatoryRightsMember" xlink:to="appy_NonCompensatoryRightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_NonCompensatoryRightsMember_lbl" xml:lang="en-US">Non-compensatory Rights [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xml:lang="en-US">Vesting in Period One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingAxis_lbl" xml:lang="en-US">Vesting [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xml:lang="en-US">Vesting In Period Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xml:lang="en-US">Vesting In Period Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ShareBasedCompensationAwardTrancheFourMember" xlink:label="appy_ShareBasedCompensationAwardTrancheFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_ShareBasedCompensationAwardTrancheFourMember" xlink:to="appy_ShareBasedCompensationAwardTrancheFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_ShareBasedCompensationAwardTrancheFourMember_lbl" xml:lang="en-US">Vesting In Period Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_CompensatoryRightsMember" xlink:label="appy_CompensatoryRightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_CompensatoryRightsMember" xlink:to="appy_CompensatoryRightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_CompensatoryRightsMember_lbl" xml:lang="en-US">Compensatory Rights [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_DocumentAndEntityInformationAbstract" xlink:label="appy_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_DocumentAndEntityInformationAbstract" xlink:to="appy_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short-term investments (Note 1)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets (Note 1)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net (Note 2)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermInvestments" xlink:label="us-gaap_LongTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermInvestments" xlink:to="us-gaap_LongTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermInvestments_lbl" xml:lang="en-US">Long-term investments (Note 1)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other long term assets, net (Notes 1 and 3)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Notes and other obligations, current portion (Note 4)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Deferred revenue, current portion (Note 7)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermNotesPayable_lbl" xml:lang="en-US">Notes and other obligations, less current portion (Note 4)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xml:lang="en-US">Deferred revenue, less current portion (Note 7)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Notes 7 and 9)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' equity (Notes 5 and 6):</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:label="us-gaap_CommonStocksIncludingAdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:to="us-gaap_CommonStocksIncludingAdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStocksIncludingAdditionalPaidInCapital_lbl" xml:lang="en-US">Common stock, no par value, 60,000,000 shares authorized; 3,876,961 shares issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="us-gaap_CommonStockNoParValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNoParValue" xlink:to="us-gaap_CommonStockNoParValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockNoParValue_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="us-gaap_SalesRevenueGoodsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueGoodsNet" xlink:to="us-gaap_SalesRevenueGoodsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueGoodsNet_lbl" xml:lang="en-US">Sales (Note 1)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="us-gaap_CostOfGoodsSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsSold" xlink:to="us-gaap_CostOfGoodsSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsSold_lbl" xml:lang="en-US">Cost of sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LicensesRevenue" xlink:label="us-gaap_LicensesRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicensesRevenue" xlink:to="us-gaap_LicensesRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LicensesRevenue_lbl" xml:lang="en-US">Other revenue - fee (Note 7)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense):</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US">Gain on sale of property and equipment (Note 2)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Investment (loss) income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted net loss per share (Note 1)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted weighted average number of shares outstanding (Note 1)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation for services</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RecognitionOfDeferredRevenue" xlink:label="us-gaap_RecognitionOfDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RecognitionOfDeferredRevenue" xlink:to="us-gaap_RecognitionOfDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RecognitionOfDeferredRevenue_lbl" xml:lang="en-US">Amortization of license fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncashExpense" xlink:label="us-gaap_OtherNoncashExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashExpense" xlink:to="us-gaap_OtherNoncashExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncashExpense_lbl" xml:lang="en-US">Other non-cash charges</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_2_lbl" xml:lang="en-US">Gain on sale of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Change in:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:label="us-gaap_IncreaseDecreaseInAccruedSalaries" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:to="us-gaap_IncreaseDecreaseInAccruedSalaries_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedSalaries_lbl" xml:lang="en-US">Accrued compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash (used in) operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xml:lang="en-US">Purchases of short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl" xml:lang="en-US">Sales of short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Proceeds from sale of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Purchases of patent and trademark application costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash provided by investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of notes payable and other obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash (used in) financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Cash paid during the period for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Supplemental disclosure of investing information:</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_LiabilityPayoffsUponPropertySale" xlink:label="appy_LiabilityPayoffsUponPropertySale" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_LiabilityPayoffsUponPropertySale" xlink:to="appy_LiabilityPayoffsUponPropertySale_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_LiabilityPayoffsUponPropertySale_lbl" xml:lang="en-US">Liability payoffs upon property sale</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">INTERIM FINANCIAL STATEMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant accounting policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Other long-term assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Notes and Other Obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Stock options and warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_AnimalHealthLicenseAgreementsAbstract" xlink:label="appy_AnimalHealthLicenseAgreementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_AnimalHealthLicenseAgreementsAbstract" xlink:to="appy_AnimalHealthLicenseAgreementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_AnimalHealthLicenseAgreementsAbstract_lbl" xml:lang="en-US">Animal Health License Agreements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xml:lang="en-US">Animal Health License Agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent event</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_CashAndCashEquivalentsAndInvestmentsPolicyTextBlock" xlink:label="appy_CashAndCashEquivalentsAndInvestmentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_CashAndCashEquivalentsAndInvestmentsPolicyTextBlock" xlink:to="appy_CashAndCashEquivalentsAndInvestmentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_CashAndCashEquivalentsAndInvestmentsPolicyTextBlock_lbl" xml:lang="en-US">Cash, cash equivalents and investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair value of financial instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue recognition and accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently issued and adopted accounting pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Income (loss) per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">Nature of operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Management's plans and basis of presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of long-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ScheduleOfOtherLongTermAssetsTableTextBlock" xlink:label="appy_ScheduleOfOtherLongTermAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_ScheduleOfOtherLongTermAssetsTableTextBlock" xlink:to="appy_ScheduleOfOtherLongTermAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_ScheduleOfOtherLongTermAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Long-Term Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US">Schedule of Long-Term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US">Schedule of the Income Statement Allocation of Stock-based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value Assumptions Used to Estimate Stock-based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Summary of Stock Incentive Plan Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Nonvested Share Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Nonqualified Award Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueByArrangementDisclosureTextBlock" xlink:label="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock" xlink:to="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock_lbl" xml:lang="en-US">Schedule of Current and Long-Term Deferred Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsAndCash" xlink:label="us-gaap_InvestmentsAndCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAndCash" xlink:to="us-gaap_InvestmentsAndCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsAndCash_lbl" xml:lang="en-US">Cash and liquid investments</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_WorkingCapital" xlink:label="appy_WorkingCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_WorkingCapital" xlink:to="appy_WorkingCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_WorkingCapital_lbl" xml:lang="en-US">Working capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_TotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners" xlink:label="appy_TotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_TotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners" xlink:to="appy_TotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_TotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners_lbl" xml:lang="en-US">Total value of capitalized patent costs that could be impaired due to inability to locate a new strategic target, a partner or other third-party interested in advancing development and commercial activities of the Venaxis appendicitis portfolio</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrentAbstract" xlink:label="us-gaap_AccountsReceivableNetCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrentAbstract_lbl" xml:lang="en-US">Accounts Receivable, Net, Current [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_lbl" xml:lang="en-US">Cash, cash equivalents and short-term investments:</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_PercentageOfInvestmentPortfolioCashAndCashEquivalent" xlink:label="appy_PercentageOfInvestmentPortfolioCashAndCashEquivalent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_PercentageOfInvestmentPortfolioCashAndCashEquivalent" xlink:to="appy_PercentageOfInvestmentPortfolioCashAndCashEquivalent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_PercentageOfInvestmentPortfolioCashAndCashEquivalent_lbl" xml:lang="en-US">Cash and cash equivalent investment portfolio, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense" xlink:label="us-gaap_InvestmentIncomeInvestmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInvestmentExpense" xlink:to="us-gaap_InvestmentIncomeInvestmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInvestmentExpense_lbl" xml:lang="en-US">Management fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueGoodsNet" xlink:to="us-gaap_SalesRevenueGoodsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SalesRevenueGoodsNet_2_lbl" xml:lang="en-US">Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Income (loss) per share:</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_WeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit" xlink:label="appy_WeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_WeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit" xlink:to="appy_WeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_WeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit_lbl" xml:lang="en-US">Basic and diluted weighted average number of shares outstanding pre-stock split basis</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_BasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis" xlink:label="appy_BasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_BasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis" xlink:to="appy_BasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_BasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis_lbl" xml:lang="en-US">Basic and diluted weighted average number of shares outstanding post-split basis</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Shares not included in the computation of EPS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US">Concentration Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ConcentrationRiskNumberOfCustomers" xlink:label="appy_ConcentrationRiskNumberOfCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_ConcentrationRiskNumberOfCustomers" xlink:to="appy_ConcentrationRiskNumberOfCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_ConcentrationRiskNumberOfCustomers_lbl" xml:lang="en-US">Number of customers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Risk percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_SalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty" xlink:label="appy_SalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_SalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty" xlink:to="appy_SalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_SalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty_lbl" xml:lang="en-US">Sales price of corporate headquarters, land and building to a third party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Total property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Patents, trademarks and applications, net of accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:label="us-gaap_OtherAssetsMiscellaneousNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="us-gaap_OtherAssetsMiscellaneousNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsMiscellaneousNoncurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_2_lbl" xml:lang="en-US">Total other long-term assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Finite-lived assets, accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_lbl" xml:lang="en-US">Future amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2016</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2018</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_lbl" xml:lang="en-US">Impairment charges</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Fixed interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_DebtInstrumentAmortizationPeriod" xlink:label="appy_DebtInstrumentAmortizationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_DebtInstrumentAmortizationPeriod" xlink:to="appy_DebtInstrumentAmortizationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_DebtInstrumentAmortizationPeriod_lbl" xml:lang="en-US">Amortization period</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_DebtInstrumentMaturityPeriod" xlink:label="appy_DebtInstrumentMaturityPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_DebtInstrumentMaturityPeriod" xlink:to="appy_DebtInstrumentMaturityPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_DebtInstrumentMaturityPeriod_lbl" xml:lang="en-US">Balloon maturity period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Periodic payments, principal and interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentInterest_lbl" xml:lang="en-US">Periodic payments, interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="us-gaap_ShortTermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">Other short-term installment obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="us-gaap_LongTermDebtByMaturityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtByMaturityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtByMaturityAbstract_lbl" xml:lang="en-US">Future Maturities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" xml:lang="en-US">Remainder of 2016</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebt" xlink:label="us-gaap_SecuredDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredDebt" xlink:to="us-gaap_SecuredDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuredDebt_lbl" xml:lang="en-US">Mortgage notes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherShortTermBorrowings" xlink:label="us-gaap_OtherShortTermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherShortTermBorrowings" xlink:to="us-gaap_OtherShortTermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherShortTermBorrowings_lbl" xml:lang="en-US">Other short-term installment obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Notes and other obligations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayableCurrent_2_lbl" xml:lang="en-US">Less current portion</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermNotesPayable_2_lbl" xml:lang="en-US">Notes and other obligations, noncurrent</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Stock Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Number of shares reserved under the Plan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Vesting period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Incentive stock options exercised to purchase common shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Total proceeds from stock options exercised to purchase common shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Options exercised, intrinsic value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options granted, exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Expiration period</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_VestingPeriodSixMonthAnniversaryPercentOfSharesVesting" xlink:label="appy_VestingPeriodSixMonthAnniversaryPercentOfSharesVesting" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_VestingPeriodSixMonthAnniversaryPercentOfSharesVesting" xlink:to="appy_VestingPeriodSixMonthAnniversaryPercentOfSharesVesting_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_VestingPeriodSixMonthAnniversaryPercentOfSharesVesting_lbl" xml:lang="en-US">Percent of shares vesting on the six month anniversary from grant date</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesVestingInArrears" xlink:label="appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesVestingInArrears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesVestingInArrears" xlink:to="appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesVestingInArrears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesVestingInArrears_lbl" xml:lang="en-US">Number of shares vesting in arrears</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US">Vesting rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Option forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Unvested options exercisable, exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAnnuallyInArrearsOverSpecificPeriod" xlink:label="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAnnuallyInArrearsOverSpecificPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAnnuallyInArrearsOverSpecificPeriod" xlink:to="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAnnuallyInArrearsOverSpecificPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAnnuallyInArrearsOverSpecificPeriod_lbl" xml:lang="en-US">Options vested annually in arrears from grant date</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodToVestAnnuallyInArrears" xlink:label="appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodToVestAnnuallyInArrears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodToVestAnnuallyInArrears" xlink:to="appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodToVestAnnuallyInArrears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodToVestAnnuallyInArrears_lbl" xml:lang="en-US">Vesting period to vest annually in arrears from grant date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Options forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Options expired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">Options forfeited, unvested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options forfeited, exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options expired, exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options forfeited, unvested, exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Fair value of options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Expected to vest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized compensation cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Unrecognized compensation cost, period for recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Awards outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentOptionsExpirationDate" xlink:label="invest_InvestmentOptionsExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="invest_InvestmentOptionsExpirationDate" xlink:to="invest_InvestmentOptionsExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="invest_InvestmentOptionsExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_RightsExercisable" xlink:label="appy_RightsExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_RightsExercisable" xlink:to="appy_RightsExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_RightsExercisable_lbl" xml:lang="en-US">Rights exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_RightsExercisablePricePerCommonShare" xlink:label="appy_RightsExercisablePricePerCommonShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_RightsExercisablePricePerCommonShare" xlink:to="appy_RightsExercisablePricePerCommonShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_RightsExercisablePricePerCommonShare_lbl" xml:lang="en-US">Rights exercisable price per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_RightsExpirationDate" xlink:label="appy_RightsExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_RightsExpirationDate" xlink:to="appy_RightsExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_RightsExpirationDate_lbl" xml:lang="en-US">Rights expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected price volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US">Shares Underlying Options</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Outstanding, beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Outstanding, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US">Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Outstanding, beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Outstanding, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_WeightedAverageRemainingContractualTermAbstract" xlink:label="appy_WeightedAverageRemainingContractualTermAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_WeightedAverageRemainingContractualTermAbstract" xlink:to="appy_WeightedAverageRemainingContractualTermAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_WeightedAverageRemainingContractualTermAbstract_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_AggregateIntrinsicValueAbstract" xlink:label="appy_AggregateIntrinsicValueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_AggregateIntrinsicValueAbstract" xlink:to="appy_AggregateIntrinsicValueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_AggregateIntrinsicValueAbstract_lbl" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_lbl" xml:lang="en-US">Nonvested Shares Underlying Options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice" xlink:label="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice" xlink:to="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:label="appy_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:to="appy_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice" xlink:to="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:label="us-gaap_OtherCommitmentDueInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:to="us-gaap_OtherCommitmentDueInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentDueInNextTwelveMonths_lbl" xml:lang="en-US">Annual royalty commitment</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee" xlink:label="appy_PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee" xlink:to="appy_PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee_lbl" xml:lang="en-US">Prior written notice period for termination of license agreement by the licensee</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_LicenseAgreementMaximumMilestonePayments" xlink:label="appy_LicenseAgreementMaximumMilestonePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_LicenseAgreementMaximumMilestonePayments" xlink:to="appy_LicenseAgreementMaximumMilestonePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_LicenseAgreementMaximumMilestonePayments_lbl" xml:lang="en-US">Aggregate milestone payments, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_AdditionalMilestoneMaximumPayments" xlink:label="appy_AdditionalMilestoneMaximumPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_AdditionalMilestoneMaximumPayments" xlink:to="appy_AdditionalMilestoneMaximumPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_AdditionalMilestoneMaximumPayments_lbl" xml:lang="en-US">Additional milestone payments, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_DeferredRevenueGross" xlink:label="appy_DeferredRevenueGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_DeferredRevenueGross" xlink:to="appy_DeferredRevenueGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_DeferredRevenueGross_lbl" xml:lang="en-US">Original amount of deferred revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenueCurrent_2_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenueNoncurrent_2_lbl" xml:lang="en-US">Deferred revenue, noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RecognitionOfDeferredRevenue" xlink:to="us-gaap_RecognitionOfDeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RecognitionOfDeferredRevenue_2_lbl" xml:lang="en-US">Recognition of license fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xml:lang="en-US">Obligation for license fees</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_LicenseFeesAndMilestoneRevenue" xlink:label="appy_LicenseFeesAndMilestoneRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_LicenseFeesAndMilestoneRevenue" xlink:to="appy_LicenseFeesAndMilestoneRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_LicenseFeesAndMilestoneRevenue_lbl" xml:lang="en-US">License fees and milestone revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_LicenseAndMilestonePaymentsRevenue" xlink:label="appy_LicenseAndMilestonePaymentsRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_LicenseAndMilestonePaymentsRevenue" xlink:to="appy_LicenseAndMilestonePaymentsRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_LicenseAndMilestonePaymentsRevenue_lbl" xml:lang="en-US">License fees and milestone amounts paid / achieved</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredCostsCurrentAndNoncurrent" xlink:label="us-gaap_DeferredCostsCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCurrentAndNoncurrent" xlink:to="us-gaap_DeferredCostsCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredCostsCurrentAndNoncurrent_lbl" xml:lang="en-US">Third party obligations recorded, including WU</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_DeferredRevenueGross" xlink:to="appy_DeferredRevenueGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="appy_DeferredRevenueGross_2_lbl" xml:lang="en-US">Deferred revenue balance</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_DeferredRevenueAccumulatedRecognition" xlink:label="appy_DeferredRevenueAccumulatedRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_DeferredRevenueAccumulatedRecognition" xlink:to="appy_DeferredRevenueAccumulatedRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="appy_DeferredRevenueAccumulatedRecognition_lbl" xml:lang="en-US">Revenue amortization to June 30, 2016</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredRevenue_lbl" xml:lang="en-US">Net deferred revenue balance at June 30, 2016</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Original amortization period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:to="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable_lbl" xml:lang="en-US">Purchase Commitment, Excluding Long-term Commitment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems_lbl" xml:lang="en-US">Purchase Commitment, Excluding Long-term Commitment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_NumberOfOfficersUnderEmployementAgreements" xlink:label="appy_NumberOfOfficersUnderEmployementAgreements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_NumberOfOfficersUnderEmployementAgreements" xlink:to="appy_NumberOfOfficersUnderEmployementAgreements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_NumberOfOfficersUnderEmployementAgreements_lbl" xml:lang="en-US">Number of officers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:label="us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:to="us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_lbl" xml:lang="en-US">Annual commitment amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_AdditionalMilestoneMaximumPayments" xlink:to="appy_AdditionalMilestoneMaximumPayments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_AdditionalMilestoneMaximumPayments_doc" xml:lang="en-US">Additional milestone payments up to a certain amount as part of a license agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_CashAndCashEquivalentsAndInvestmentsPolicyTextBlock" xlink:to="appy_CashAndCashEquivalentsAndInvestmentsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_CashAndCashEquivalentsAndInvestmentsPolicyTextBlock_doc" xml:lang="en-US">The accounting policy for cash, cash equivalents and short-term investments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_ConcentrationRiskNumberOfCustomers" xlink:to="appy_ConcentrationRiskNumberOfCustomers_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_ConcentrationRiskNumberOfCustomers_doc" xml:lang="en-US">Number of customers contributing to concentration risk during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_CustomerOneMember" xlink:to="appy_CustomerOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_CustomerOneMember_doc" xml:lang="en-US">Customer One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_CustomerThreeMember" xlink:to="appy_CustomerThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_CustomerThreeMember_doc" xml:lang="en-US">Customer Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_CustomerTwoMember" xlink:to="appy_CustomerTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_CustomerTwoMember_doc" xml:lang="en-US">Customer Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_DebtInstrumentAmortizationPeriod" xlink:to="appy_DebtInstrumentAmortizationPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_DebtInstrumentAmortizationPeriod_doc" xml:lang="en-US">Period for amortization.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_DebtInstrumentMaturityPeriod" xlink:to="appy_DebtInstrumentMaturityPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_DebtInstrumentMaturityPeriod_doc" xml:lang="en-US">Balloon maturity period for a debt instrument.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_DeferredRevenueAccumulatedRecognition" xlink:to="appy_DeferredRevenueAccumulatedRecognition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_DeferredRevenueAccumulatedRecognition_doc" xml:lang="en-US">Amount of revenue recognized from deferred revenue arrangements as of the balance sheet date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_DeferredRevenueGross" xlink:to="appy_DeferredRevenueGross_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_DeferredRevenueGross_doc" xml:lang="en-US">Amount of deferred revenue, net of deferred costs.</link:label>
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_DirectorsEmployeesAndConsultantsMember" xlink:label="appy_DirectorsEmployeesAndConsultantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_DirectorsEmployeesAndConsultantsMember" xlink:to="appy_DirectorsEmployeesAndConsultantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_DirectorsEmployeesAndConsultantsMember_doc" xml:lang="en-US">Directors, Employees and Consultants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_DocumentAndEntityInformationAbstract" xlink:to="appy_DocumentAndEntityInformationAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_DocumentAndEntityInformationAbstract_doc" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_IndependentDirectorsMember" xlink:to="appy_IndependentDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_IndependentDirectorsMember_doc" xml:lang="en-US">Independent Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_IssuanceTypeAxis" xlink:to="appy_IssuanceTypeAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_IssuanceTypeAxis_doc" xml:lang="en-US">Type of Issuance [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_LiabilityPayoffsUponPropertySale" xlink:to="appy_LiabilityPayoffsUponPropertySale_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_LiabilityPayoffsUponPropertySale_doc" xml:lang="en-US">Liability payoffs upon property sale.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_LicenseAgreementMaximumMilestonePayments" xlink:to="appy_LicenseAgreementMaximumMilestonePayments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_LicenseAgreementMaximumMilestonePayments_doc" xml:lang="en-US">Maximum aggregate milestone payments receivable as party of a license agreement with a third party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_LicenseAndMilestonePaymentsRevenue" xlink:to="appy_LicenseAndMilestonePaymentsRevenue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_LicenseAndMilestonePaymentsRevenue_doc" xml:lang="en-US">Net amount of license and milestone payments made and received.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_NonqualifiedMember" xlink:to="appy_NonqualifiedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_NonqualifiedMember_doc" xml:lang="en-US">Arrangements options, stock or warrants that are issued outside of any plan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_NumberOfOfficersUnderEmployementAgreements" xlink:to="appy_NumberOfOfficersUnderEmployementAgreements_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_NumberOfOfficersUnderEmployementAgreements_doc" xml:lang="en-US">Number of officers of the entity under employment agreements. Renew of the agreements is automatic in nature and termination can be executed by either party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_OfficersAndEmployeesMember" xlink:to="appy_OfficersAndEmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_OfficersAndEmployeesMember_doc" xml:lang="en-US">Officers and Employees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_PercentageOfInvestmentPortfolioCashAndCashEquivalent" xlink:to="appy_PercentageOfInvestmentPortfolioCashAndCashEquivalent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_PercentageOfInvestmentPortfolioCashAndCashEquivalent_doc" xml:lang="en-US">The percentage of cash and cash equivalents investments held within the entity's investment portfolio.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee" xlink:to="appy_PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee_doc" xml:lang="en-US">The prior written notice period for termination of license agreement by the licensee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_SalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty" xlink:to="appy_SalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_SalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty_doc" xml:lang="en-US">Sales price of corporate headquarters, land and building to a third party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_ScheduleOfOtherLongTermAssetsTableTextBlock" xlink:to="appy_ScheduleOfOtherLongTermAssetsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_ScheduleOfOtherLongTermAssetsTableTextBlock_doc" xml:lang="en-US">The tabular disclosure for other long term assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodToVestAnnuallyInArrears" xlink:to="appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodToVestAnnuallyInArrears_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodToVestAnnuallyInArrears_doc" xml:lang="en-US">Represents information pertaining to vesting period to vest annually in arrears from grant date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice" xlink:to="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average exercise price of nonvested options outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAnnuallyInArrearsOverSpecificPeriod" xlink:to="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAnnuallyInArrearsOverSpecificPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAnnuallyInArrearsOverSpecificPeriod_doc" xml:lang="en-US">Number of options vested annually in arrears from grant date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesVestingInArrears" xlink:to="appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesVestingInArrears_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesVestingInArrears_doc" xml:lang="en-US">Represents the number of shares vesting in arrears during the reporting period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:to="appy_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average exercise price of share-based payment awards that vested during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_StockIncentivePlanMember" xlink:to="appy_StockIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_StockIncentivePlanMember_doc" xml:lang="en-US">Stock Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_TotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners" xlink:to="appy_TotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_TotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners_doc" xml:lang="en-US">Total value of capitalized patent costs that could be impaired due to inability to locate a new strategic target, a partner or other third-party interested in advancing development and commercial activities of the Venaxis appendicitis portfolio.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_UnitedStatesSmallBusinessAdministrationMember" xlink:to="appy_UnitedStatesSmallBusinessAdministrationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_UnitedStatesSmallBusinessAdministrationMember_doc" xml:lang="en-US">United States Small Business Administration [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_VestingPeriodSixMonthAnniversaryPercentOfSharesVesting" xlink:to="appy_VestingPeriodSixMonthAnniversaryPercentOfSharesVesting_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_VestingPeriodSixMonthAnniversaryPercentOfSharesVesting_doc" xml:lang="en-US">Represents the percent of shares vesting on the six month anniversary from grant date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_WeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit" xlink:to="appy_WeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_WeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit_doc" xml:lang="en-US">Basic and diluted weighted average number of shares outstanding pre-stock split basis.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_WorkingCapital" xlink:to="appy_WorkingCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_WorkingCapital_doc" xml:lang="en-US">Working capital as measured by current assets less current liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_BasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis" xlink:to="appy_BasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_BasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis_doc" xml:lang="en-US">Basic and diluted weighted average number of shares outstanding post-split basis.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_RightsExercisable" xlink:to="appy_RightsExercisable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_RightsExercisable_doc" xml:lang="en-US">Non-compensatory rights number exercisable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_RightsExercisablePricePerCommonShare" xlink:to="appy_RightsExercisablePricePerCommonShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_RightsExercisablePricePerCommonShare_doc" xml:lang="en-US">Non-compensatory rights exercisable price per common share.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_LicenseFeesAndMilestoneRevenue" xlink:to="appy_LicenseFeesAndMilestoneRevenue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_LicenseFeesAndMilestoneRevenue_doc" xml:lang="en-US">License fees and milestone revenue.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_RightsExpirationDate" xlink:to="appy_RightsExpirationDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_RightsExpirationDate_doc" xml:lang="en-US">Non-compensatory rights expiration date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_NonCompensatoryRightsMember" xlink:to="appy_NonCompensatoryRightsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_NonCompensatoryRightsMember_doc" xml:lang="en-US">Noncompensatory rights [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_NotesPayableToBankMember" xlink:to="appy_NotesPayableToBankMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_NotesPayableToBankMember_doc" xml:lang="en-US">Notes Payable to Bank [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_ShareBasedCompensationAwardTrancheFourMember" xlink:to="appy_ShareBasedCompensationAwardTrancheFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_ShareBasedCompensationAwardTrancheFourMember_doc" xml:lang="en-US">Share-based Compensation Award Tranche Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_CompensatoryRightsMember" xlink:to="appy_CompensatoryRightsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="appy_CompensatoryRightsMember_doc" xml:lang="en-US">Compensatory Rights [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_2_lbl" xml:lang="en-US">Assets [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:to="us-gaap_IncreaseDecreaseInAccruedSalaries_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedSalaries_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Salaries</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_2_lbl" xml:lang="en-US">Payments to Acquire Short-term Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_2_lbl" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_2_lbl" xml:lang="en-US">Goodwill [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherShortTermBorrowings" xlink:to="us-gaap_OtherShortTermBorrowings_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherShortTermBorrowings_2_lbl" xml:lang="en-US">Other Short-term Borrowings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_2_lbl" xml:lang="en-US">Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xml:lang="en-US">Allocated Share-based Compensation Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice" xlink:to="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice_4_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCurrentAndNoncurrent" xlink:to="us-gaap_DeferredCostsCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Deferred Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_DeferredRevenueAccumulatedRecognition" xlink:to="appy_DeferredRevenueAccumulatedRecognition_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_DeferredRevenueAccumulatedRecognition_3_lbl" xml:lang="en-US">DeferredRevenueAccumulatedRecognition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenue_2_lbl" xml:lang="en-US">Deferred Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="appy_DirectorsEmployeesAndConsultantsMember" xlink:to="appy_DirectorsEmployeesAndConsultantsMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="appy_DirectorsEmployeesAndConsultantsMember_2_lbl" xml:lang="en-US">DirectorsEmployeesAndConsultantsMember</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>appy-20160630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: appy%2D20160630 Final.xfr; Date: 2016%2D08%2D10T18:55:44Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80060000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://venaxis.com/role/appy-daei" xlink:href="appy-20160630.xsd#appy-daei" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-bs" xlink:href="appy-20160630.xsd#appy-bs" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-bsp" xlink:href="appy-20160630.xsd#appy-bsp" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-soo" xlink:href="appy-20160630.xsd#appy-soo" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-socf" xlink:href="appy-20160630.xsd#appy-socf" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ifs" xlink:href="appy-20160630.xsd#appy-ifs" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-sap" xlink:href="appy-20160630.xsd#appy-sap" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-pae" xlink:href="appy-20160630.xsd#appy-pae" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ola" xlink:href="appy-20160630.xsd#appy-ola" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-naoo" xlink:href="appy-20160630.xsd#appy-naoo" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-se" xlink:href="appy-20160630.xsd#appy-se" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-soaw" xlink:href="appy-20160630.xsd#appy-soaw" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ahla" xlink:href="appy-20160630.xsd#appy-ahla" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-cac" xlink:href="appy-20160630.xsd#appy-cac" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-rpt" xlink:href="appy-20160630.xsd#appy-rpt" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/SubsequentEvent" xlink:href="appy-20160630.xsd#SubsequentEvent" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-sapp" xlink:href="appy-20160630.xsd#appy-sapp" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-paet" xlink:href="appy-20160630.xsd#appy-paet" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-olat" xlink:href="appy-20160630.xsd#appy-olat" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-naoot" xlink:href="appy-20160630.xsd#appy-naoot" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-soawt" xlink:href="appy-20160630.xsd#appy-soawt" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ahlat" xlink:href="appy-20160630.xsd#appy-ahlat" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ifsd" xlink:href="appy-20160630.xsd#appy-ifsd" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:href="appy-20160630.xsd#SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/SignificantAccountingPoliciesRevenueRecognitionAndAccountsReceivableDetails" xlink:href="appy-20160630.xsd#SignificantAccountingPoliciesRevenueRecognitionAndAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/PropertyAndEquipmentNarrativeDetails" xlink:href="appy-20160630.xsd#PropertyAndEquipmentNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/PropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:href="appy-20160630.xsd#PropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-olad" xlink:href="appy-20160630.xsd#appy-olad" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-naoond" xlink:href="appy-20160630.xsd#appy-naoond" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-naoosoldd" xlink:href="appy-20160630.xsd#appy-naoosoldd" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/StockOptionsAndWarrantsStockIncentivePlanOptionsNarrativeDetails" xlink:href="appy-20160630.xsd#StockOptionsAndWarrantsStockIncentivePlanOptionsNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfStock-basedCompensationDetails" xlink:href="appy-20160630.xsd#StockOptionsAndWarrantsScheduleOfStock-basedCompensationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfFairValueAssumptionsDetails" xlink:href="appy-20160630.xsd#StockOptionsAndWarrantsScheduleOfFairValueAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfAwardActivityDetails" xlink:href="appy-20160630.xsd#StockOptionsAndWarrantsScheduleOfAwardActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfNonvestedAwardsDetails" xlink:href="appy-20160630.xsd#StockOptionsAndWarrantsScheduleOfNonvestedAwardsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ahland" xlink:href="appy-20160630.xsd#appy-ahland" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/appy-ahlasorrawlad" xlink:href="appy-20160630.xsd#appy-ahlasorrawlad" xlink:type="simple" />
    <link:roleRef roleURI="http://venaxis.com/role/CommitmentsAndContingenciesDetails" xlink:href="appy-20160630.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-daei" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_DocumentAndEntityInformationAbstract" xlink:label="loc_appyDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-bs" xlink:title="00000002 - Statement - Balance Sheets (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermInvestments" xlink:label="loc_us-gaapLongTermInvestments" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapLongTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:label="loc_us-gaapCommonStocksIncludingAdditionalPaidInCapital" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStocksIncludingAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-bsp" xlink:title="00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaapCommonStockNoParValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockNoParValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-soo" xlink:title="00000004 - Statement - Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaapSalesRevenueGoodsNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSalesRevenueGoodsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaapCostOfGoodsSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LicensesRevenue" xlink:label="loc_us-gaapLicensesRevenue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapLicensesRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-socf" xlink:title="00000005 - Statement - Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RecognitionOfDeferredRevenue" xlink:label="loc_us-gaapRecognitionOfDeferredRevenue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapRecognitionOfDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaapOtherNoncashExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherNoncashExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedSalaries" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedSalaries" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="loc_us-gaapPaymentsToAcquireShortTermInvestments" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireShortTermInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfShortTermInvestments" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_LiabilityPayoffsUponPropertySale" xlink:label="loc_appyLiabilityPayoffsUponPropertySale" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_appyLiabilityPayoffsUponPropertySale" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ifs" xlink:title="00000006 - Disclosure - INTERIM FINANCIAL STATEMENTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-sap" xlink:title="00000007 - Disclosure - Significant accounting policies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-pae" xlink:title="00000008 - Disclosure - Property and equipment">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ola" xlink:title="00000009 - Disclosure - Other long-term assets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-naoo" xlink:title="00000010 - Disclosure - Notes and Other Obligations">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-se" xlink:title="00000011 - Disclosure - Stockholders' equity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-soaw" xlink:title="00000012 - Disclosure - Stock options and warrants">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ahla" xlink:title="00000013 - Disclosure - Animal Health License Agreements">
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_AnimalHealthLicenseAgreementsAbstract" xlink:label="loc_appyAnimalHealthLicenseAgreementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="loc_us-gaapCollaborativeArrangementDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_us-gaapCollaborativeArrangementDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-cac" xlink:title="00000014 - Disclosure - Commitments and contingencies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-rpt" xlink:title="00000015 - Disclosure - Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/SubsequentEvent" xlink:title="00000016 - Disclosure - Subsequent event">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-sapp" xlink:title="00000017 - Disclosure - Significant accounting policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_CashAndCashEquivalentsAndInvestmentsPolicyTextBlock" xlink:label="loc_appyCashAndCashEquivalentsAndInvestmentsPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_appyCashAndCashEquivalentsAndInvestmentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-paet" xlink:title="00000018 - Disclosure - Property and equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-olat" xlink:title="00000019 - Disclosure - Other long-term assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ScheduleOfOtherLongTermAssetsTableTextBlock" xlink:label="loc_appyScheduleOfOtherLongTermAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_appyScheduleOfOtherLongTermAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-naoot" xlink:title="00000020 - Disclosure - Notes and Other Obligations (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="loc_us-gaapScheduleOfDebtInstrumentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-soawt" xlink:title="00000021 - Disclosure - Stock options and warrants (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfOtherShareBasedCompensationActivityTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ahlat" xlink:title="00000022 - Disclosure - Animal Health License Agreements (Tables)">
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_AnimalHealthLicenseAgreementsAbstract" xlink:label="loc_appyAnimalHealthLicenseAgreementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueByArrangementDisclosureTextBlock" xlink:label="loc_us-gaapDeferredRevenueByArrangementDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_us-gaapDeferredRevenueByArrangementDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ifsd" xlink:title="00000023 - Disclosure - INTERIM FINANCIAL STATEMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsAndCash" xlink:label="loc_us-gaapInvestmentsAndCash" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapInvestmentsAndCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_WorkingCapital" xlink:label="loc_appyWorkingCapital" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_appyWorkingCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_TotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners" xlink:label="loc_appyTotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_appyTotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:title="00000024 - Disclosure - Significant accounting policies (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrentAbstract" xlink:label="loc_us-gaapAccountsReceivableNetCurrentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:label="loc_us-gaapCashCashEquivalentsAndShortTermInvestmentsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsReceivableNetCurrentAbstract" xlink:to="loc_us-gaapCashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_PercentageOfInvestmentPortfolioCashAndCashEquivalent" xlink:label="loc_appyPercentageOfInvestmentPortfolioCashAndCashEquivalent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:to="loc_appyPercentageOfInvestmentPortfolioCashAndCashEquivalent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense" xlink:label="loc_us-gaapInvestmentIncomeInvestmentExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsReceivableNetCurrentAbstract" xlink:to="loc_us-gaapInvestmentIncomeInvestmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsReceivableNetCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaapSalesRevenueGoodsNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsReceivableNetCurrentAbstract" xlink:to="loc_us-gaapSalesRevenueGoodsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsReceivableNetCurrentAbstract" xlink:to="loc_us-gaapEarningsPerShareAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_WeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit" xlink:label="loc_appyWeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_appyWeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_BasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis" xlink:label="loc_appyBasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_appyBasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/SignificantAccountingPoliciesRevenueRecognitionAndAccountsReceivableDetails" xlink:title="00000025 - Disclosure - Significant accounting policies (Revenue recognition and accounts receivable) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:label="loc_us-gaapGeographicConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapGeographicConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="loc_us-gaapMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaapNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMajorCustomersAxis" xlink:to="loc_us-gaapNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_CustomerOneMember" xlink:label="loc_appyCustomerOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_appyCustomerOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_CustomerTwoMember" xlink:label="loc_appyCustomerTwoMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_appyCustomerTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_CustomerThreeMember" xlink:label="loc_appyCustomerThreeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_appyCustomerThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ConcentrationRiskNumberOfCustomers" xlink:label="loc_appyConcentrationRiskNumberOfCustomers" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_appyConcentrationRiskNumberOfCustomers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/PropertyAndEquipmentNarrativeDetails" xlink:title="00000026 - Disclosure - Property and equipment (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_SalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty" xlink:label="loc_appySalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_appySalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/PropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:title="00000027 - Disclosure - Property and equipment (Schedule of Property and Equipment) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LandAndLandImprovementsMember" xlink:label="loc_us-gaapLandAndLandImprovementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandAndLandImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaapBuildingAndBuildingImprovementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingAndBuildingImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:label="loc_us-gaapOtherMachineryAndEquipmentMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOtherMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOfficeEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-olad" xlink:title="00000028 - Disclosure - Other long-term assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:label="loc_us-gaapOtherAssetsMiscellaneousNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherAssetsMiscellaneousNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-naoond" xlink:title="00000029 - Disclosure - Notes and Other Obligations (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_NotesPayableToBankMember" xlink:label="loc_appyNotesPayableToBankMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_appyNotesPayableToBankMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_UnitedStatesSmallBusinessAdministrationMember" xlink:label="loc_appyUnitedStatesSmallBusinessAdministrationMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_appyUnitedStatesSmallBusinessAdministrationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MortgagesMember" xlink:label="loc_us-gaapMortgagesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapMortgagesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_DebtInstrumentAmortizationPeriod" xlink:label="loc_appyDebtInstrumentAmortizationPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_appyDebtInstrumentAmortizationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_DebtInstrumentMaturityPeriod" xlink:label="loc_appyDebtInstrumentMaturityPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_appyDebtInstrumentMaturityPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentInterest" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaapLongTermDebtByMaturityAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtByMaturityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermDebtByMaturityAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-naoosoldd" xlink:title="00000030 - Disclosure - Notes and Other Obligations (Schedule of Long-Term Debt) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SecuredDebt" xlink:label="loc_us-gaapSecuredDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapSecuredDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherShortTermBorrowings" xlink:label="loc_us-gaapOtherShortTermBorrowings" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapOtherShortTermBorrowings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/StockOptionsAndWarrantsStockIncentivePlanOptionsNarrativeDetails" xlink:title="00000031 - Disclosure - Stock options and warrants (Stock incentive plan options) (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_StockIncentivePlanMember" xlink:label="loc_appyStockIncentivePlanMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_appyStockIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_NonqualifiedMember" xlink:label="loc_appyNonqualifiedMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_appyNonqualifiedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_IssuanceTypeAxis" xlink:label="loc_appyIssuanceTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_appyIssuanceTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_IssuanceTypeDomain" xlink:label="loc_appyIssuanceTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyIssuanceTypeAxis" xlink:to="loc_appyIssuanceTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_IndependentDirectorsMember" xlink:label="loc_appyIndependentDirectorsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyIssuanceTypeDomain" xlink:to="loc_appyIndependentDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_OfficersAndEmployeesMember" xlink:label="loc_appyOfficersAndEmployeesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyIssuanceTypeDomain" xlink:to="loc_appyOfficersAndEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_NonCompensatoryRightsMember" xlink:label="loc_appyNonCompensatoryRightsMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyIssuanceTypeDomain" xlink:to="loc_appyNonCompensatoryRightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_CompensatoryRightsMember" xlink:label="loc_appyCompensatoryRightsMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyIssuanceTypeDomain" xlink:to="loc_appyCompensatoryRightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapVestingAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheOneMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheThreeMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ShareBasedCompensationAwardTrancheFourMember" xlink:label="loc_appyShareBasedCompensationAwardTrancheFourMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_appyShareBasedCompensationAwardTrancheFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_VestingPeriodSixMonthAnniversaryPercentOfSharesVesting" xlink:label="loc_appyVestingPeriodSixMonthAnniversaryPercentOfSharesVesting" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appyVestingPeriodSixMonthAnniversaryPercentOfSharesVesting" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesVestingInArrears" xlink:label="loc_appyShareBasedCompensationArrangementByShareBasedPaymentAwardSharesVestingInArrears" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appyShareBasedCompensationArrangementByShareBasedPaymentAwardSharesVestingInArrears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAnnuallyInArrearsOverSpecificPeriod" xlink:label="loc_appySharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAnnuallyInArrearsOverSpecificPeriod" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appySharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAnnuallyInArrearsOverSpecificPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodToVestAnnuallyInArrears" xlink:label="loc_appyShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodToVestAnnuallyInArrears" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appyShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodToVestAnnuallyInArrears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentOptionsExpirationDate" xlink:label="loc_investInvestmentOptionsExpirationDate" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_investInvestmentOptionsExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_RightsExercisable" xlink:label="loc_appyRightsExercisable" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appyRightsExercisable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_RightsExercisablePricePerCommonShare" xlink:label="loc_appyRightsExercisablePricePerCommonShare" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appyRightsExercisablePricePerCommonShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_RightsExpirationDate" xlink:label="loc_appyRightsExpirationDate" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appyRightsExpirationDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfStock-basedCompensationDetails" xlink:title="00000032 - Disclosure - Stock options and warrants (Schedule of Stock-based Compensation) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfFairValueAssumptionsDetails" xlink:title="00000033 - Disclosure - Stock options and warrants (Schedule of fair value assumptions) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfAwardActivityDetails" xlink:title="00000034 - Disclosure - Stock options and warrants (Schedule of Award Activity) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_StockIncentivePlanMember" xlink:label="loc_appyStockIncentivePlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_appyStockIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_NonqualifiedMember" xlink:label="loc_appyNonqualifiedMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_appyNonqualifiedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_WeightedAverageRemainingContractualTermAbstract" xlink:label="loc_appyWeightedAverageRemainingContractualTermAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appyWeightedAverageRemainingContractualTermAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyWeightedAverageRemainingContractualTermAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyWeightedAverageRemainingContractualTermAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_AggregateIntrinsicValueAbstract" xlink:label="loc_appyAggregateIntrinsicValueAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_appyAggregateIntrinsicValueAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfNonvestedAwardsDetails" xlink:title="00000035 - Disclosure - Stock options and warrants (Schedule of Nonvested Awards) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_StockIncentivePlanMember" xlink:label="loc_appyStockIncentivePlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_appyStockIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice" xlink:label="loc_appySharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_appySharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:label="loc_appyShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_appyShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice" xlink:label="loc_appySharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_appySharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ahland" xlink:title="00000036 - Disclosure - Animal Health License Agreements (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_AnimalHealthLicenseAgreementsAbstract" xlink:label="loc_appyAnimalHealthLicenseAgreementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:label="loc_us-gaapOtherCommitmentDueInNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_us-gaapOtherCommitmentDueInNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee" xlink:label="loc_appyPriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_appyPriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_LicenseAgreementMaximumMilestonePayments" xlink:label="loc_appyLicenseAgreementMaximumMilestonePayments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_appyLicenseAgreementMaximumMilestonePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_AdditionalMilestoneMaximumPayments" xlink:label="loc_appyAdditionalMilestoneMaximumPayments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_appyAdditionalMilestoneMaximumPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_DeferredRevenueGross" xlink:label="loc_appyDeferredRevenueGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_appyDeferredRevenueGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RecognitionOfDeferredRevenue" xlink:label="loc_us-gaapRecognitionOfDeferredRevenue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_us-gaapRecognitionOfDeferredRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaapLossContingencyAccrualAtCarryingValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_us-gaapLossContingencyAccrualAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_LicenseFeesAndMilestoneRevenue" xlink:label="loc_appyLicenseFeesAndMilestoneRevenue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_appyLicenseFeesAndMilestoneRevenue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/appy-ahlasorrawlad" xlink:title="00000037 - Disclosure - Animal Health License Agreements (Schedule of Revenue Recognition Associated with the License Agreement) (Details)">
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_AnimalHealthLicenseAgreementsAbstract" xlink:label="loc_appyAnimalHealthLicenseAgreementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_LicenseAndMilestonePaymentsRevenue" xlink:label="loc_appyLicenseAndMilestonePaymentsRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_appyLicenseAndMilestonePaymentsRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredCostsCurrentAndNoncurrent" xlink:label="loc_us-gaapDeferredCostsCurrentAndNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_us-gaapDeferredCostsCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_DeferredRevenueGross" xlink:label="loc_appyDeferredRevenueGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_appyDeferredRevenueGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_DeferredRevenueAccumulatedRecognition" xlink:label="loc_appyDeferredRevenueAccumulatedRecognition" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_appyDeferredRevenueAccumulatedRecognition" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_us-gaapDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_appyAnimalHealthLicenseAgreementsAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://venaxis.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000038 - Disclosure - Commitments and contingencies (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:label="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:label="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentTable" xlink:to="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:label="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentTable" xlink:to="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:label="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:to="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmploymentContractsMember" xlink:label="loc_us-gaapEmploymentContractsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:to="loc_us-gaapEmploymentContractsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="appy-20160630.xsd#appy_NumberOfOfficersUnderEmployementAgreements" xlink:label="loc_appyNumberOfOfficersUnderEmployementAgreements" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="loc_appyNumberOfOfficersUnderEmployementAgreements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:label="loc_us-gaapPurchaseCommitmentRemainingMinimumAmountCommitted" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="loc_us-gaapPurchaseCommitmentRemainingMinimumAmountCommitted" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image24.jpg
<TEXT>
begin 644 image24.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0Y!WX# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
,@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6818320576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Aug. 10, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Venaxis, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001167419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,876,961<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document and Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6815541760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,489,809<span></span>
</td>
<td class="nump">$ 2,012,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments (Note 1)</a></td>
<td class="nump">11,657,412<span></span>
</td>
<td class="nump">14,147,991<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets (Note 1)</a></td>
<td class="nump">111,042<span></span>
</td>
<td class="nump">251,778<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">16,258,263<span></span>
</td>
<td class="nump">16,412,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net (Note 2)</a></td>
<td class="nump">539<span></span>
</td>
<td class="nump">1,954,496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments (Note 1)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">972,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long term assets, net (Notes 1 and 3)</a></td>
<td class="nump">1,330,714<span></span>
</td>
<td class="nump">1,523,649<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">17,589,516<span></span>
</td>
<td class="nump">20,862,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">194,599<span></span>
</td>
<td class="nump">701,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">13,408<span></span>
</td>
<td class="nump">449,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">152,602<span></span>
</td>
<td class="nump">241,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes and other obligations, current portion (Note 4)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">301,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue, current portion (Note 7)</a></td>
<td class="nump">96,698<span></span>
</td>
<td class="nump">96,698<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">457,307<span></span>
</td>
<td class="nump">1,790,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes and other obligations, less current portion (Note 4)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,838,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue, less current portion (Note 7)</a></td>
<td class="nump">1,113,665<span></span>
</td>
<td class="nump">1,162,015<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,570,972<span></span>
</td>
<td class="nump">4,791,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Notes 7 and 9)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (Notes 5 and 6):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital', window );">Common stock, no par value, 60,000,000 shares authorized; 3,876,961 shares issued and outstanding</a></td>
<td class="nump">121,877,347<span></span>
</td>
<td class="nump">121,653,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(105,858,803)<span></span>
</td>
<td class="num">(105,582,439)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">16,018,544<span></span>
</td>
<td class="nump">16,070,636<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 17,589,516<span></span>
</td>
<td class="nump">$ 20,862,197<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of par value plus amounts in excess of par value or issuance value for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStocksIncludingAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(c).Q3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(c).Q3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6815245408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Common stock, par value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">60,000,000<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">3,876,961<span></span>
</td>
<td class="nump">3,876,961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">3,876,961<span></span>
</td>
<td class="nump">3,876,961<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6815261760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Operations (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Sales (Note 1)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 24,517<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 35,805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsSold', window );">Cost of sales</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,096<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">12,103<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">16,421<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">23,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LicensesRevenue', window );">Other revenue - fee (Note 7)</a></td>
<td class="nump">24,174<span></span>
</td>
<td class="nump">24,174<span></span>
</td>
<td class="nump">48,349<span></span>
</td>
<td class="nump">48,349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">822,835<span></span>
</td>
<td class="nump">1,482,608<span></span>
</td>
<td class="nump">1,852,961<span></span>
</td>
<td class="nump">3,018,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">73,085<span></span>
</td>
<td class="nump">552,408<span></span>
</td>
<td class="nump">445,671<span></span>
</td>
<td class="nump">1,260,150<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">895,920<span></span>
</td>
<td class="nump">2,035,016<span></span>
</td>
<td class="nump">2,298,632<span></span>
</td>
<td class="nump">4,278,609<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(871,746)<span></span>
</td>
<td class="num">(1,994,421)<span></span>
</td>
<td class="num">(2,250,283)<span></span>
</td>
<td class="num">(4,206,558)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on sale of property and equipment (Note 2)</a></td>
<td class="nump">912<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,920,273<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(148)<span></span>
</td>
<td class="num">(24,195)<span></span>
</td>
<td class="num">(25,746)<span></span>
</td>
<td class="num">(49,259)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment (loss) income</a></td>
<td class="nump">35,107<span></span>
</td>
<td class="num">(14,619)<span></span>
</td>
<td class="nump">79,392<span></span>
</td>
<td class="nump">36,209<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="nump">35,871<span></span>
</td>
<td class="num">(38,814)<span></span>
</td>
<td class="nump">1,973,919<span></span>
</td>
<td class="num">(13,050)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (835,875)<span></span>
</td>
<td class="num">$ (2,033,235)<span></span>
</td>
<td class="num">$ (276,364)<span></span>
</td>
<td class="num">$ (4,219,608)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per share (Note 1)</a></td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="num">$ (0.52)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.09)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average number of shares outstanding (Note 1)</a></td>
<td class="nump">3,876,961<span></span>
</td>
<td class="nump">3,876,961<span></span>
</td>
<td class="nump">3,876,961<span></span>
</td>
<td class="nump">3,876,961<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs related to goods produced and sold during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LicensesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LicensesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueGoodsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueGoodsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6815503104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (276,364)<span></span>
</td>
<td class="num">$ (4,219,608)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation for services</a></td>
<td class="nump">224,272<span></span>
</td>
<td class="nump">780,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">46,031<span></span>
</td>
<td class="nump">129,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecognitionOfDeferredRevenue', window );">Amortization of license fees</a></td>
<td class="num">(48,350)<span></span>
</td>
<td class="num">(48,349)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashExpense', window );">Other non-cash charges</a></td>
<td class="nump">168,077<span></span>
</td>
<td class="nump">4,647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on sale of property and equipment</a></td>
<td class="num">(1,920,273)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(30,260)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">193,930<span></span>
</td>
<td class="nump">232,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(506,465)<span></span>
</td>
<td class="num">(143,793)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedSalaries', window );">Accrued compensation</a></td>
<td class="num">(436,465)<span></span>
</td>
<td class="num">(547,607)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">9,531<span></span>
</td>
<td class="nump">17,161<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash (used in) operating activities</a></td>
<td class="num">(2,546,076)<span></span>
</td>
<td class="num">(3,825,014)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchases of short-term investments</a></td>
<td class="num">(10,149,937)<span></span>
</td>
<td class="num">(16,216,718)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Sales of short-term investments</a></td>
<td class="nump">13,612,516<span></span>
</td>
<td class="nump">21,652,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property and equipment</a></td>
<td class="nump">1,749,484<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchases of patent and trademark application costs</a></td>
<td class="num">(14,378)<span></span>
</td>
<td class="num">(47,022)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash provided by investing activities</a></td>
<td class="nump">5,197,685<span></span>
</td>
<td class="nump">5,388,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of notes payable and other obligations</a></td>
<td class="num">(174,083)<span></span>
</td>
<td class="num">(235,935)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net cash (used in) financing activities</a></td>
<td class="num">(174,083)<span></span>
</td>
<td class="num">(235,935)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net change in cash and cash equivalents</a></td>
<td class="nump">2,477,526<span></span>
</td>
<td class="nump">1,327,921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">2,012,283<span></span>
</td>
<td class="nump">3,539,911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">4,489,809<span></span>
</td>
<td class="nump">4,867,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid during the period for interest</a></td>
<td class="nump">31,362<span></span>
</td>
<td class="nump">$ 49,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of investing information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_LiabilityPayoffsUponPropertySale', window );">Liability payoffs upon property sale</a></td>
<td class="nump">$ 2,064,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_LiabilityPayoffsUponPropertySale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability payoffs upon property sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_LiabilityPayoffsUponPropertySale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in accrued salaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense or loss included in net income that result in no cash flow, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3179-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecognitionOfDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of previously reported deferred or unearned revenue that was recognized as revenue during the period. For cash flows, this element primarily pertains to amortization of deferred credits on long-term arrangements. As a noncash item, it is deducted from net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecognitionOfDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6811047760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTERIM FINANCIAL STATEMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">INTERIM FINANCIAL STATEMENTS</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"></div>

<div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">INTERIM FINANCIAL STATEMENTS</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The accompanying financial statements of Venaxis, Inc. (the &#8220;Company,&#8221;&#160; &#8220;we,&#8221;&#160;or &#8220;Venaxis&#8221;) have been prepared in accordance with the instructions to quarterly reports on Form 10-Q. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and changes in financial position at June 30, 2016 and for all periods presented have been made. Certain information and footnote data necessary for fair presentation of financial position and results of operations in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted. It is therefore suggested that these financial statements be read in conjunction with the summary of significant accounting policies and notes to financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2015. The results of operations for the period ended June 30, 2016 are not necessarily an indication of operating results for the full year.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Management&#8217;s plans and basis of presentation:</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">&#160;</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company has experienced recurring losses and negative cash flows from operations.&#160;&#160;At June 30, 2016, the Company had approximate balances of cash and liquid investments of $16,147,000, working capital of $15,801,000, total stockholders&#8217; equity of $16,019,000 and an accumulated deficit of $105,859,000. To date, the Company has in large part relied on equity financing to fund its operations.&#160; The Company expects to continue to incur losses from operations for the near-term and these losses could be significant, as professional and other associated expenses in connection with possible strategic considerations, evaluations and transactions, appendicitis portfolio related expenses, public company and administrative related expenses are incurred. The Company believes that its current working capital position will be sufficient to meet its estimated cash needs into 2017.&#160; The Company is closely monitoring its cash balances, cash needs and expense levels.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">As of January 26, 2016, Venaxis publicly disclosed that it had entered into a series of agreements, including a Master Agreement, for a combination transaction (the &#8220;Strand transaction&#8221;) with Strand Life Sciences Private Limited and its shareholders (&#8220;Strand&#8221;).&#160; Strand is privately-held, and operates clinical reference labs in the U.S. and in India, providing testing and lab services in India and other world-wide markets.&#160; Strand has commercialized a next generation sequencing (NGS) based, targeted, multi-gene, pan-cancer diagnostic panel in select international markets and has engaged in initial commercialization activities in the United States.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">On March 11, 2016, Venaxis and Strand entered into a Mutual Termination Agreement to terminate the series of agreements.&#160; Pursuant to the Mutual Termination Agreement, each of the parties was relieved of any obligations or responsibilities under the Master Agreement and other transaction agreements.&#160; Each party remains responsible for its respective transaction-related expenses.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Following the recent termination of the Strand transaction, the Company has begun evaluating potential strategic alternatives. The Company expects, in the near term, to utilize the primary criteria it has established as it evaluates its next steps and strategic path forward with the goal of maximizing value for its shareholders. As a result of the current market trends and uncertainties, and&#160;the impact on many companies, management believes that there may currently be attractive opportunities available to the Company.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Management&#8217;s strategic assessment includes the following potential options:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; text-align: justify; margin-top: 3pt; line-height: 1">
<table id="c003a99e15fe41bcabea240953a7f4a0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="width: 20.25pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top; color: #000000">&#183;</td>
<td style="font: 10pt Times New Roman, Times, serif; width: auto; vertical-align: top; color: #000000; text-align: justify">exploring other possible strategic options available to the Company following termination of the Strand transaction;</td>
</tr>
</table>
</div>

<div style="margin-bottom: 3pt; text-align: justify; margin-top: 3pt; line-height: 1">
<table id="f9aa29e3274c4cb8847031f6cd0728ed" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="width: 20.25pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top; color: #000000">&#183;</td>
<td style="font: 10pt Times New Roman, Times, serif; width: auto; vertical-align: top; color: #000000; text-align: justify">evaluating options to monetize, partner or license the Company's appendicitis product portfolio;</td>
</tr>
</table>
</div>

<div style="margin-bottom: 3pt; text-align: justify; margin-top: 3pt; line-height: 1">
<table id="a06d2b190839645a1b482731c2b9c509e" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="width: 20.25pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top; color: #000000">&#183;</td>
<td style="font: 10pt Times New Roman, Times, serif; width: auto; vertical-align: top; color: #000000; text-align: justify">continuing to explore prospective partnering or licensing opportunities with complementary opportunities and technologies; and</td>
</tr>
</table>
</div>

<div style="margin-bottom: 3pt; text-align: justify; margin-top: 3pt; line-height: 1">
<table id="a82f7bd38ab934e61acd2cb6dcdcab6e1" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="width: 20.25pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top; color: #000000">&#183;</td>
<td style="font: 10pt Times New Roman, Times, serif; width: auto; vertical-align: top; color: #000000; text-align: justify">continuing to implement cost control initiatives to conserve cash.</td>
</tr>
</table>
</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">As part of the Company&#8217;s process to identify possible strategic partners, several targets were identified that the Company assessed as possibly having a business model that could be interested in discussions with Venaxis for potentially acquiring or licensing the appendicitis assets. Venaxis has made initial contact with several of these parties to gauge their interest level, which initially is more focused on the <font style="font: italic 10pt Times New Roman, Times, serif">APPY</font>2 development assets. Management believes that the estimated potential market for an appendicitis test continues to be significant. If Venaxis is unable to locate a new strategic target, a partner or other third-party interested in advancing development and commercial activities of the Venaxis appendicitis portfolio, the capitalized costs on the Company&#8217;s balance sheet, totaling approximately $371,000, as of June 30, 2016 for the acute appendicitis patents may be deemed impaired.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=35735333&amp;loc=d3e288-107754<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=d3e5614-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6744058320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant accounting policies</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; text-align: left; margin-top: 3pt; line-height: 1"></div>

<div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Note 1.&#160;&#160;Significant accounting policies:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Cash, cash equivalents and investments:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company considers all highly liquid investments with an original maturity of three months or less at the date of acquisition to be cash equivalents. From time to time, the Company&#8217;s cash account balances exceed the balances as covered by the Federal Deposit Insurance System. The Company has never suffered a loss due to such excess balances.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company invests excess cash from time to time in highly-liquid debt and equity investments of highly-rated entities, which are classified as trading securities. Historically, the purpose of the investments has been to fund research and development, product development, FDA clearance-related activities and general corporate purposes. Such amounts are recorded at market values using Level 1 inputs in determining fair value and are generally classified as current, as the Company does not intend to hold the investments beyond twelve months. Investment securities classified as trading are those securities that are bought and held principally for the purpose of selling them in the near term, with the objective of preserving principal and generating profits. These securities are reported at fair value with unrealized gains and losses reported as an element of other (expense) income in current period earnings. The Company&#8217;s Board of Directors has approved an investment policy covering the investment parameters to be followed with the primary goals being the safety of principal amounts and maintaining liquidity. The policy provides for minimum investment rating requirements as well as limitations on investment duration and concentrations. Based upon market conditions, the investment guidelines have been tightened to increase the minimum acceptable investment ratings required for investments and shorten the maximum investment term. As of June 30, 2016, approximately 20% of the investment portfolio was in cash and cash equivalents, which is presented as such on the accompanying balance sheet, and the remaining funds were invested in marketable securities with none individually representing a material amount of the portfolio.&#160; Investments with a scheduled maturity beyond one year are classified as long-term investments on the balance sheet.&#160; To date, the Company&#8217;s cumulative realized market loss from the investments has not been significant.&#160;For the six months ended June 30, 2016 and 2015, there was approximately $11,000 and $16,000, respectively, in management fee expenses.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Fair value of financial instruments:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company accounts for financial instruments under Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification Topic (&#8220;ASC&#8221;) 820,<font style="font: italic 10pt Times New Roman, Times, serif"> Fair Value Measurements</font>.&#160; This statement defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements.&#160; To increase consistency and comparability in fair value measurements, ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels as follows:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Level 1&#8212; quoted prices (unadjusted) in active markets for identical assets or liabilities;</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Level 2 &#8212; observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Level 3 &#8212; assets and liabilities whose significant value drivers are unobservable.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company&#8217;s market assumptions.&#160; Unobservable inputs require significant management judgment or estimation.&#160; In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy.&#160; In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement.&#160; Such determination requires significant management judgment. There were no financial assets or liabilities measured at fair value, with the exception of cash, cash equivalents and short-term investments as of June 30, 2016 and December 31, 2015.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The carrying amounts of the Company&#8217;s financial instruments (other than cash, cash equivalents and short-term investments as discussed above) approximate fair value because of their variable interest rates and/or short maturities combined with the recent historical interest rate levels.</div>



<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Revenue recognition and accounts receivable:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">We recognized sales of goods under the provisions of ASC 605 and the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) Staff Accounting Bulletin (&#8220;SAB&#8221;) 104, <font style="font: italic 10pt Times New Roman, Times, serif">Revenue Recognition</font>. Future revenue is expected to be generated primarily from the sale of products. Product revenue primarily consists of sales of instrumentation and consumables.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Revenue was recognized when the following four basic criteria were met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred and risk of loss has passed; (iii) the seller&#8217;s price to the buyer is fixed or determinable; and (iv) collectability is reasonably assured.&#160; In international markets, the Company sells its products to distributors or re-sellers, who subsequently resell the products to hospitals. The Company has an agreement with the distributor which provides that title and risk of loss pass to the distributor upon shipment of the products, FOB to the distributor. Revenue is recognized upon shipment of products to the distributor as the products are shipped based on FOB shipping point terms (See Note 8).</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Revenues were recorded less a reserve for estimated product returns and allowances which to date has not been significant. Determination of the reserve for estimated product returns and allowances is based on management&#8217;s analyses and judgments regarding certain conditions. Should future changes in conditions prove management&#8217;s conclusions and judgments on previous analyses to be incorrect, revenue recognized for any reporting period could be adversely affected.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company extended credit to customers generally without requiring collateral. As of June 30, 2016 and December 31, 2015, the Company did not have any accounts receivable. During the six months ended June 30, 2016, no sales were recorded.&#160; During the six months ended June 30, 2015, three European-based customers accounted for the total net sales, representing 58%, 28% and 14%, respectively.</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"><br style="line-height: 1" />
<font style="font-weight: bold">Recently issued and adopted accounting pronouncements:</font></div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company's financial reporting, the Company undertakes a study to determine the consequences of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company's financial statements properly reflect the change.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">In May 2014, the FASB issued Accounting Standards Update ("ASU") No. 2014-09 "Revenue from Contracts from Customers," which supersedes the revenue recognition requirements in "Revenue Recognition (Topic 605)," and requires entities to recognize revenue in a way that depicts the transfer of potential goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to the exchange for those goods or services. In July 2015, the FASB extended the effective date of ASU 2014-09 by one year, to now be effective for fiscal years, and interim periods beginning after December 15, 2017, and is to be applied retrospectively, with early adoption now permitted for fiscal years and interim periods beginning after December 31, 2015. The Company does not believe the new standard will have a material impact on its operations and financial statements.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Income (loss) per share:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">ASC 260,<font style="font: italic 10pt Times New Roman, Times, serif"> Earnings Per Share</font>, requires dual presentation of basic and diluted earnings per share (&#8220;EPS&#8221;) with a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilution. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the entity.</div>



<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Basic net earnings (loss) per share includes no dilution and is computed by dividing net earnings (loss) available to shareholders by the weighted average number of common shares outstanding for the period.&#160;Diluted net earnings (loss) per share reflect the potential dilution of securities that could share in the Company&#8217;s earnings (loss).&#160; The effect of the inclusion of the dilutive shares would have resulted in a decrease in loss per share for the three and six months ended June 30, 2016<font style="font: 10pt Times New Roman, Times, serif"> and 2015 respectively</font>.&#160; Accordingly, the weighted average shares outstanding have not been adjusted for dilutive shares for any&#160;period presented.&#160; Outstanding stock options and warrants are not considered in the calculation, as the impact of the potential common shares (totaling approximately 966,000 shares and 776,000 shares for <font style="font: 10pt Times New Roman, Times, serif">each of </font>the <font style="font: 10pt Times New Roman, Times, serif">three and </font>six month periods ended June 30, 2016 and 2015, respectively) would be anti-dilutive.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Upon the completion of a special shareholders meeting on March 24, 2016, where such action was approved by shareholders, the Board of Directors authorized a reverse stock split of the Company&#8217;s common stock at a ratio of one-for-eight, whereby each eight shares of common stock were combined into one share of common stock (the &#8220;Reverse Stock Split&#8221;).&#160;&#160;The Reverse Stock Split was implemented and effective on March 31, 2016. All historical references to shares and share amounts in this report have been retroactively revised to reflect the Reverse Stock Split.&#160; A reconciliation of basic and diluted weighted average number of shares outstanding adjusted for the Reverse Stock Split for the period ended June 30, 2016 was 30,990,029 shares on a pre-split basis and 3,876,961 shares on a post-split basis.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18861-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18743-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18854-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6811049824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and equipment</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Note 2. Property and equipment:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Property and equipment consisted of the following:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="a41f4a22cf460475b9b6bb9aa1628d0c2" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">June 30,</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2016</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">(Unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">December 31,</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Land and improvements</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,107,508</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Building</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">2,589,231</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Building improvements</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">253,526</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Laboratory equipment</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">848,014</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Office and computer equipment</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">64,619</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">318,254</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">64,619</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">5,116,533</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Less accumulated depreciation</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">64,080</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">3,162,037</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">539</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,954,496</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Depreciation expense totaled approximately $400 and $38,000, and $800 and $51,000, for the three and six month periods ended June 30, 2016 and 2015, respectively.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">On February 25, 2016, the Company completed the sale of its corporate headquarters, land, building and certain fixtures and equipment to a third party for a purchase price of approximately $4,000,000.&#160;The sale resulted in a gain of approximately $1,900,000 and generated approximately $1,700,000 in net cash after expenses and mortgage payoffs. The Company is leasing back space in the building under short-term lease agreements that provide office and storage space required for its current level of operations.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13-14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64862545&amp;loc=d3e2921-110230<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6744191184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other long-term assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Other long-term assets</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Note 3.&#160;&#160;Other long-term assets:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Other long-term assets consisted of the following:</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">&#160;</div>

<table id="a64e8d8b9b95f4752b2179c5df90115d0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">June 30,</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2016</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">(Unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">December 31,</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-left: 18pt; text-indent: -18pt">Patents, trademarks and applications, net of&#160;accumulated&#160;amortization of $554,967&#160;and $548,327, respectively</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">943,475</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,136,410</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Goodwill</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">387,239</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">387,239</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,330,714</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,523,649</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company capitalizes legal costs and filing fees associated with obtaining patents on its new discoveries. Once the patents have been issued, the Company amortizes these costs over the shorter of the legal life of the patent or its estimated economic life using the straight-line method. Based upon the current status of the above intangible assets, the aggregate amortization expense is estimated to be approximately $81,000 for each of the next five fiscal years. The Company tests intangible assets with finite lives for impairment upon significant changes in the Company&#8217;s business environment. The testing resulted in net patent impairment charges of $34,000 and $5,000, and $168,000 and $5,000, for the three and six month periods ended June 30, 2016 and 2015, respectively.&#160; The impairment charges are related to the Company&#8217;s ongoing analysis of which specific country patents in its portfolio are determined as potentially worth pursuing.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final.  May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6715905888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes and Other Obligations<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes and Other Obligations</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Note 4. Notes and Other Obligations:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Notes payable and other obligations consisted of the following:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="cab9cc4c9e284d67983e6dad9dcaf305" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">June 30,</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2016</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">(Unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">December 31,</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Mortgage notes</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,997,701</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Other short-term installment obligations</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">142,328</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">2,140,029</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Less current portion</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">301,250</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,838,779</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Mortgage notes:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Prior to the February 2016 sale of the corporate headquarters, the Company had a permanent mortgage on its land and building that was refinanced in May 2013. The mortgage was held by a commercial bank and included a portion guaranteed by the U. S. Small Business Administration (&#8220;SBA&#8221;).&#160; The loan was collateralized by the real property and the SBA portion was also personally guaranteed by a former officer of the Company.&#160;The commercial bank loan terms included a payment schedule based on a fifteen year amortization, with a balloon&#160;maturity at five years. The commercial bank portion had an interest rate fixed at 3.95%, and the SBA portion bore interest at the rate of 5.86%. The commercial bank portion of the loan required total monthly payments of approximately $11,700, which included approximately $4,500 per month in interest. The SBA portion of the loan required total monthly payments of approximately $9,000 through July 2023, which included approximately $3,500 per month in interest and fees in 2016.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">On February 25, 2016, the Company completed the sale of its corporate headquarters, land and building, and also paid off its mortgage obligations.&#160; See Note 2.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Future maturities:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company did not have any debt obligations at June 30, 2016.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20,22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6810931680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' equity</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Note 5. Stockholders&#8217; equity:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Upon the completion of a special shareholders meeting on March 24, 2016, where such action was approved by shareholders, the Board of Directors authorized the Reverse Stock Split at a ratio of one-for-eight, whereby each eight shares of common stock were combined into one share of common stock.&#160;&#160;The Reverse Stock Split was implemented and effective on March 31, 2016. All historical references to shares and share amounts in this report have been retroactively revised to reflect the Reverse Stock Split.&#160; Following the Reverse Stock Split, the Company regained its compliance with the Nasdaq minimum bid price requirement, allowing its common stock to continue to be listed on the Nasdaq Capital Market.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74567-122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Preferred Stock<br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6811074464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock options and warrants<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock options and warrants</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Note 6. Stock options and warrants:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Stock options:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company currently provides stock-based compensation to employees, directors and consultants, both under the Company's 2002 Stock Incentive Plan, as amended (the "Plan"), and non-qualified options and warrants issued outside of the Plan. During September 2015, the Company's shareholders approved amendments to the Plan to increase the number of shares reserved under the Plan from 459,141 to 709,141. The Company estimates the fair value of the share-based awards on the date of grant using the Black-Scholes option-pricing model (the "Black-Scholes model").&#160;&#160;Using the Black-Scholes model, the value of the award that is ultimately expected to vest is recognized over the requisite service period in the statement of operations.&#160;&#160;Option forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.&#160;&#160;The Company attributes compensation to expense using the straight-line single option method for all options granted.&#160;</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company&#8217;s determination of the estimated fair value of share-based payment awards on the date of grant is affected by the following variables and assumptions:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="aab49304acf41eeac694c2470606a6e" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="width: 2.98%; vertical-align: top">
<div style="font: 10pt/1 Symbol, serif; color: #000000; text-align: center">&#183;</div>
</td>
<td style="width: 97.02%; vertical-align: top">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Grant date exercise price &#8211; the closing market price of the Company&#8217;s common stock on the date of the grant;</div>
</td>
</tr>

<tr>
<td style="width: 2.98%; vertical-align: top">
<div style="font: 10pt/1 Symbol, serif; color: #000000; text-align: center">&#183;</div>
</td>
<td style="width: 97.02%; vertical-align: top">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Estimated option term &#8211; based on historical experience with existing option holders;</div>
</td>
</tr>

<tr>
<td style="width: 2.98%; vertical-align: top">
<div style="font: 10pt/1 Symbol, serif; color: #000000; text-align: center">&#183;</div>
</td>
<td style="width: 97.02%; vertical-align: top">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Estimated dividend rates &#8211; based on historical and anticipated dividends&#160;over the life of the option;</div>
</td>
</tr>

<tr>
<td style="width: 2.98%; vertical-align: top">
<div style="font: 10pt/1 Symbol, serif; color: #000000; text-align: center">&#183;</div>
</td>
<td style="width: 97.02%; vertical-align: top">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Term of the option &#8211; based on historical experience, grants have lives of approximately 3-5 years;</div>
</td>
</tr>

<tr>
<td style="width: 2.98%; vertical-align: top">
<div style="font: 10pt/1 Symbol, serif; color: #000000; text-align: center">&#183;</div>
</td>
<td style="width: 97.02%; vertical-align: top">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Risk-free interest rates &#8211; with maturities that approximate the expected life of the options granted;</div>
</td>
</tr>

<tr>
<td style="width: 2.98%; vertical-align: top">
<div style="font: 10pt/1 Symbol, serif; color: #000000; text-align: center">&#183;</div>
</td>
<td style="width: 97.02%; vertical-align: top">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Calculated stock price volatility &#8211; calculated over the expected life of the options granted, which is calculated based on the daily closing price of the Company&#8217;s common stock over a period equal to the expected term of the option; and</div>
</td>
</tr>

<tr>
<td style="width: 2.98%; vertical-align: top">
<div style="font: 10pt/1 Symbol, serif; color: #000000; text-align: center">&#183;</div>
</td>
<td style="width: 97.02%; vertical-align: top">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Option exercise behaviors &#8211; based on actual and projected employee stock option exercises and forfeitures.</div>
</td>
</tr>
</table>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">The Company recognized total expenses for stock-based compensation during the three and six months ended June 30, 2016 and 2015 which are included in the accompanying statements of operations, in the following categories:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="f23189dc0764f08aaafe5057d207e44" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Three Months Ended</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="7" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Six Months Ended</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;</div>
</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 44%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Selling, general and administrative expenses</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">176,388</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">303,644</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">221,712</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">696,006</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 44%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Research and development expenses</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">43,937</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">2,560</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">84,977</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 44%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 44%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;&#160;&#160;&#160;Total stock-based compensation</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">176,388</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">347,581</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">224,272</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">780,983</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">During the six months ended June 30, 2016 and 2015, respectively, no options were exercised.&#160;&#160;</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Stock incentive plan options:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company currently provides stock-based compensation to employees, directors and consultants under the Plan.&#160;The Company utilized assumptions in the estimation of fair value of stock-based compensation for the six months ended June 30, 2016 and 2015 as follows:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="fa017df72c9c440bbd4a4dab605ea181" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;</div>
</td>
<td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;</div>
</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Dividend yield</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">0</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">%</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">0</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">%</div>
</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Expected price volatility</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">99</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">%</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">93</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">%</div>
</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Risk free interest rate</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1.20</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">%</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1.39</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">%</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Expected term</div>
</td>
<td colspan="3" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">5 years</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">5 years</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>



<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">A summary of activity under the Plan for the six months ended June 30, 2016 is presented below:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="c8d3e82c6d44c82b343752305cdc095" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="width: 38.31%; vertical-align: bottom">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom">&#160;</td>
<td colspan="2" style="width: 12.8%; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Shares</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Underlying</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Options</div>
</td>
<td style="width: 1.03%; vertical-align: bottom">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom">&#160;</td>
<td colspan="2" style="width: 12.79%; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Weighted</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Average</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Exercise</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Price</div>
</td>
<td style="width: 1.02%; vertical-align: bottom">&#160;</td>
<td colspan="3" style="width: 13.81%; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Weighted</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Average</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Remaining</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Contractual</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Term (Years)</div>
</td>
<td style="width: 1.04%; vertical-align: bottom">&#160;</td>
<td colspan="3" style="width: 16.12%; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Aggregate</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Intrinsic</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Value</div>
</td>
<td style="width: 1.04%; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom">&#160;</td>
<td colspan="2" style="width: 12.8%; vertical-align: bottom">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom">&#160;</td>
<td colspan="2" style="width: 12.79%; vertical-align: bottom">&#160;</td>
<td style="width: 1.02%; vertical-align: bottom">&#160;</td>
<td colspan="3" style="width: 13.81%; vertical-align: bottom">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom">&#160;</td>
<td colspan="3" style="width: 16.12%; vertical-align: bottom">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Outstanding at January 1, 2016</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.73%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">332,560</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">$</div>
</td>
<td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">35.36</div>
</td>
<td style="width: 1.02%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;&#160;&#160;&#160;&#160;Granted</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 11.73%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">227,000</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 11.72%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">2.89</div>
</td>
<td style="width: 1.02%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;&#160;&#160;&#160;&#160;Exercised</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.73%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">-</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">-</div>
</td>
<td style="width: 1.02%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;&#160;&#160;&#160;&#160;Forfeited</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff">&#160;</td>
<td style="width: 11.73%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">(25,445</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">)</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff">&#160;</td>
<td style="width: 11.72%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">36.30</div>
</td>
<td style="width: 1.02%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.73%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.02%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Outstanding at June 30, 2016</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">&#160;</td>
<td style="width: 11.73%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">534,115</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">$</div>
</td>
<td style="width: 11.72%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">21.55</div>
</td>
<td style="width: 1.02%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 11.72%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">8.1</div>
</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.24%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">$</div>
</td>
<td style="width: 13.82%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">140,740</div>
</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.73%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.02%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.24%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 13.82%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Exercisable at June 30, 2016</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">&#160;</td>
<td style="width: 11.73%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">331,427</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">$</div>
</td>
<td style="width: 11.72%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">32.44</div>
</td>
<td style="width: 1.02%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 11.72%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">7.1</div>
</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.24%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">$</div>
</td>
<td style="width: 13.82%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">23,870</div>
</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
</tr>
</table>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company&#8217;s closing stock price on June 30, 2016 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders, had all option holders been able to, and in fact had, exercised their options on June 30, 2016.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">During the six months ended June 30, 2016, 77,000 options were issued to non-employee directors under the Plan, exercisable at an average of $2.89 per share. The options expire ten years from the date of grant and vest 50% upon on the date of grant, and 25% on each of July 1, 2016 and October 1, 2016.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">During the six months ended June 30, 2016,&#160;150,000 options were issued to officers and employees under the Plan, exercisable at an average of $2.89 per share. The options expire ten years from the date of grant and vest 50% upon each of the six month and the one year anniversary of the grant date.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">During the six months ended June 30, 2015, 43,000 options were issued to non-employee directors under the Plan, exercisable at an average of $15.12 per share. The options expire ten years from the date of grant and vested over one year, based upon 25% on the date of grant, and 25% on each of April 1, 2015, July 1, 2015, and October 1, 2015.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">During the six months ended June 30, 2015,&#160;93,813 options were issued to officers and employees under the Plan, exercisable at an average of $15.12 per share. The options expire ten years from the date of grant and vest over two years with 50% vesting upon six month anniversary of grant date and the remaining balance vesting over the following six quarters in arrears.</div>

<div style="background-color: #ffffff; line-height: 1"><br style="line-height: 1" />
 &#160;</div>

<div style="line-height: 1; background-color: #ffffff">
<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">During the six months ended June 30, 2016, a total of 25,445 options that were granted under the Plan were forfeited, of which 21,825 were vested and 3,620 were unvested. The vested options were exercisable at an average of $39.81 per share and the unvested options were exercisable at an average of $15.13 per share. During the six months ended June 30, 2015, a total of 24,742 options that were granted under the Plan were forfeited, of which 4,128 were vested and 20,614 were unvested. The vested options were exercisable at an average of $98.56 per share and the unvested options were exercisable at an average of $16.48 per share.</div>

<div style="line-height: 1"><br style="line-height: 1" />
 &#160;</div>
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The total fair value of stock options granted to employees, directors and consultants that vested and became exercisable during the six months ended June 30, 2016 and 2015, was approximately&#160;$271,000 and $449,000, respectively.&#160;&#160;&#160;Based upon the Company&#8217;s experience, approximately 80% of the outstanding nonvested stock options, or approximately 162,000 options, are expected to vest in the future, under their terms.</div>



<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">A summary of the activity of nonvested options under the Plan to acquire common shares granted to employees, officers, directors and consultants during the six months ended June 30, 2016 is presented below:</div>

<div style="margin-bottom: 3pt; text-align: left; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="a803bc49bdf14c89b8c428d6c75c12ef" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Nonvested Shares</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Nonvested</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Shares</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Underlying</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Options</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Weighted</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Average</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Exercise</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Price</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Weighted</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Average</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Grant Date</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Fair Value</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 58%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Nonvested at January 1, 2016</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">33,336</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">15.54</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">11.41</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 58%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;&#160;&#160;&#160;&#160;Granted</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">227,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">2.89</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">2.13</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 58%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;&#160;&#160;&#160;&#160;Vested</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">(54,028</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">)</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">6.67</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">5.02</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 58%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;&#160;&#160;&#160;&#160;Forfeited</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">(3,620</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">)</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">15.13</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">10.75</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 58%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 58%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Nonvested at June 30, 2016</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">202,688</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">3.75</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">2.73</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">At June 30, 2016, based upon employee, officer, director and consultant options granted under the Plan to that point, there was approximately $339,000 of additional unrecognized compensation cost related to stock options that will be recorded over a weighted average future period of one year.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Other common stock purchase options and warrants:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">As of June 30, 2016, in addition to the stock incentive plan options discussed above, the Company had outstanding 432,003 non-qualified options and warrants in connection with offering warrants and an officer&#8217;s employment that were not issued under the Plan.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">During the six month periods ended June 30, 2016 and 2015, respectively, no stock options were granted outside of the Plan.&#160; Operating expenses for the six months ended June 30, 2016 and 2015, did not include any value related to stock-based compensation of non-qualified options and warrants.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Following is a summary of outstanding options and warrants that were issued outside of the Plan for the six months ended June 30, 2016:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="c42e36b37b494fd99c6f9c9aaed437d8" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="width: 48.94%; vertical-align: bottom">&#160;</td>
<td style="width: 1.41%; vertical-align: bottom">&#160;</td>
<td colspan="2" style="width: 11.08%; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Shares</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Underlying</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Options / Warrants</div>
</td>
<td style="width: 1.63%; vertical-align: bottom">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom">&#160;</td>
<td colspan="2" style="width: 12.17%; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Weighted</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Average</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Exercise</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Price</div>
</td>
<td style="width: 1.42%; vertical-align: bottom">&#160;</td>
<td style="width: 9.57%; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Weighted</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Average</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Remaining</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Contractual</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Term (Years)</div>
</td>
<td style="width: 1.21%; vertical-align: bottom">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; border-bottom: #000000 2px solid">&#160;</td>
<td style="width: 9.73%; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Aggregate</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Intrinsic</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Value</div>
</td>
</tr>

<tr>
<td style="width: 48.94%; vertical-align: bottom">&#160;</td>
<td style="width: 1.41%; vertical-align: bottom">&#160;</td>
<td style="width: 0.97%; vertical-align: bottom">&#160;</td>
<td style="width: 10.11%; vertical-align: bottom">&#160;</td>
<td style="width: 1.63%; vertical-align: bottom">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom">&#160;</td>
<td style="width: 0.95%; vertical-align: bottom">&#160;</td>
<td style="width: 11.21%; vertical-align: bottom">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom">&#160;</td>
<td style="width: 9.57%; vertical-align: bottom">&#160;</td>
<td style="width: 1.21%; vertical-align: bottom">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom">&#160;</td>
<td style="width: 9.73%; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 48.94%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #cceeff">Outstanding at January 1, 2016</div>
</td>
<td style="width: 1.41%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 0.97%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 10.11%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #cceeff">432,003</div>
</td>
<td style="width: 1.63%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #cceeff">$</div>
</td>
<td style="width: 11.21%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #cceeff">15.47</div>
</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 9.57%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.21%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 9.73%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="width: 48.94%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff">&#160;&#160;&#160;&#160;&#160;Granted</div>
</td>
<td style="width: 1.41%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 0.97%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 10.11%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff">-</div>
</td>
<td style="width: 1.63%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 0.95%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 11.21%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff">-</div>
</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 9.57%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.21%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 9.73%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="width: 48.94%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #cceeff">&#160;&#160;&#160;&#160;&#160;Exercised</div>
</td>
<td style="width: 1.41%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 0.97%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 10.11%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #cceeff">-</div>
</td>
<td style="width: 1.63%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.21%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #cceeff">-</div>
</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 9.57%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.21%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 9.73%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="width: 48.94%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff">&#160;&#160;&#160;&#160;&#160;Forfeited</div>
</td>
<td style="width: 1.41%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 0.97%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff">&#160;</td>
<td style="width: 10.11%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff">-</div>
</td>
<td style="width: 1.63%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 0.95%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff">&#160;</td>
<td style="width: 11.21%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff">-</div>
</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 9.57%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.21%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 9.73%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="width: 48.94%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.41%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 0.97%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 10.11%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.63%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.21%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 9.57%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.21%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 9.73%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="width: 48.94%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff">Outstanding and exercisable at June 30, 2016</div>
</td>
<td style="width: 1.41%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 0.97%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">&#160;</td>
<td style="width: 10.11%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff">432,003</div>
</td>
<td style="width: 1.63%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 0.95%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff">$</div>
</td>
<td style="width: 11.21%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff">15.47</div>
</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 9.57%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center; background-color: #ffffff">1.8</div>
</td>
<td style="width: 1.21%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff">$</div>
</td>
<td style="width: 9.73%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff">-</div>
</td>
</tr>
</table>

<div style="margin-bottom: 3pt; text-align: left; margin-top: 3pt; line-height: 1">&#160;</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">During the six months ended June 30, 2016 and 2015, no warrants were exercised.&#160; Included at June 30, 2016 in the 432,003 total outstanding options are 429,503 non-compensatory rights, exercisable at an average of $15.40 per common share, expiring through May 2018, granted in connection with public offerings, and 2,500 rights exercisable at $27.36 per common share, expiring December 2018, issued under compensatory arrangements.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company&#8217;s closing stock price on June 30, 2016 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders, had all option holders been able to, and in fact had, exercised their options on June 30, 2016.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65895303&amp;loc=d3e17540-113929<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68057994&amp;loc=d3e25284-112666<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6811050512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Animal Health License Agreements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_AnimalHealthLicenseAgreementsAbstract', window );"><strong>Animal Health License Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Animal Health License Agreements</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Note 7.&#160;&#160;Animal Health License Agreements:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Effective May 1, 2004, Washington University in St. Louis (&#8220;WU&#8221;) and Venaxis entered into an Exclusive License Agreement (&#8220;WU License Agreement&#8221;), which grants Venaxis exclusive license and right to sublicense WU&#8217;s technology (as defined under the WU License Agreement) for veterinary products worldwide, except where such products are prohibited under U.S. laws for export. The term of the WU License Agreement continues until the expiration of the last of WU&#8217;s patents (as defined in the WU License Agreement) expire.&#160;&#160;Venaxis has agreed to pay minimum annual royalties of $20,000 during the term of the WU License Agreement and such amounts are creditable against future royalties.&#160;&#160;Royalties payable to WU under the WU License Agreement for covered product sales by Venaxis carry a mid-single digit royalty rate and for sublicense fees received by Venaxis&#160;carry a low double-digit royalty rate.&#160;&#160;The WU License Agreement contains customary terms for confidentiality, prosecution and infringement provisions for licensed patents, publication rights, indemnification and insurance coverage.&#160;&#160;The WU License Agreement is cancelable by Venaxis with ninety days advance notice at any time and by WU with sixty days advance notice if Venaxis materially breaches the WU License Agreement and fails to cure such breach.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">In July 2012, the Company entered into an Exclusive License Agreement (the &#8220;License Agreement&#8221;) with Ceva Sant&#233; Animale S.A. (&#8220;Licensee&#8221;), pursuant to which the Company granted the Licensee an exclusive royalty-bearing license, until December 31, 2028, to the Company&#8217;s intellectual property and other assets, including patent rights and know-how, relating to recombinant single chain reproductive hormone technology for use in non-human mammals (the &#8220;Company&#8217;s Animal Health Assets&#8221;). The License Agreement is subject to termination by the Licensee (a) for convenience on 180 days prior written notice, (b) in the Licensee&#8217;s discretion in the event of a sale or other disposal of the Company&#8217;s animal health assets, (c) in the Licensee&#8217;s discretion upon a change in control of the Company, (d) for a material breach of the License Agreement by the Company, or (e) in the Licensee&#8217;s discretion, if the Company becomes insolvent.&#160;&#160;The License Agreement is also terminable by the Company if there is a material breach of the License Agreement by the Licensee, or if the Licensee challenges the Company&#8217;s ownership of designated intellectual property.&#160;&#160;The License Agreement includes a sublicense of the technology licensed to the Company by WU. Under the terms of the WU License Agreement, a portion of license fees and royalties Venaxis receives from&#160;sublicensing agreements will be paid to WU. The obligation for such license fees due to WU is included in accrued expenses at June 30, 2016.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Under the License Agreement, the Licensee obtained a worldwide exclusive license to develop, seek regulatory approval for and offer to sell, market, distribute, import and export luteinizing hormone (&#8220;LH&#8221;) and/or follicle-stimulating hormone (&#8220;FSH&#8221;) products for bovine (cattle), equine and swine in the field of the assistance and facilitation of reproduction in bovine, equine and swine animals.&#160;&#160;</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Under the License Agreement, as of June 30, 2016, the following future milestone payments are provided, assuming future milestones are successfully achieved:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; text-align: justify; margin-top: 3pt; line-height: 1">
<table id="a46f60b17899a4fa9bf58cf56060ee6de" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top; color: #000000">&#8226;</td>
<td style="font: 10pt Times New Roman, Times, serif; width: auto; vertical-align: top; color: #000000; text-align: justify">Milestone payments, totaling up to a potential of $1.1 million in the aggregate, based on the satisfactory conclusion of&#160;milestones as defined in the License Agreement;</td>
</tr>
</table>
</div>

<div style="margin-bottom: 3pt; text-align: justify; margin-top: 3pt; line-height: 1">
<table id="a8e1ce6d41b4048fda8425a4e09cd603d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top; color: #000000">&#8226;</td>
<td style="font: 10pt Times New Roman, Times, serif; width: auto; vertical-align: top; color: #000000; text-align: justify">Potential for milestone payments of up to an additional $2 million for development and receipt of regulatory approval for additional licensed products; and</td>
</tr>
</table>
</div>

<div style="margin-bottom: 3pt; text-align: justify; margin-top: 3pt; line-height: 1">
<table id="a718e0784fab44347885ff20fd8c339c0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top; color: #000000">&#8226;</td>
<td style="font: 10pt Times New Roman, Times, serif; width: auto; vertical-align: top; color: #000000; text-align: justify">Royalties, at low double digit rates, based on sales of licensed products.</td>
</tr>
</table>
</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Revenue recognition related to the License Agreement and WU License Agreement is based primarily on the Company&#8217;s consideration of ASC 808-10-45, &#8220;<font style="font: italic 10pt Times New Roman, Times, serif">Accounting for Collaborative Arrangements.</font>&#8221;&#160;&#160;For financial reporting purposes, the license fees and milestone payments received from the License Agreement, net of the amounts due to third parties, including WU, have been recorded as deferred revenue and are amortized over the term of the License Agreement.&#160;&#160;License fees and milestone revenue totaling a net of approximately $1,500,000 commenced being amortized into income upon the July 2012 date of milestone achievement. As of June 30, 2016, deferred revenue of $96,698 has been classified as a current liability and $1,113,665 has been classified as a long-term liability. The current liability represents the next twelve months&#8217; portion of the amortizable milestone revenue.&#160;During the six months ended June 30, 2016 and 2015, $48,349 was recorded in each period as the amortized license fee revenue arising from the License Agreement.</div>





<div style="margin-bottom: 3pt; text-align: left; margin-top: 3pt; line-height: 1"><font style="font: 10pt Times New Roman, Times, serif; color: #000000"><br style="line-height: 1" />
<font style="font: 10pt Times New Roman, Times, serif"><br />
</font></font><br style="line-height: 1" />
 &#160;</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">A tabular summary of the revenue categories and cumulative amounts of revenue recognition associated with the License Agreement follows:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="f2d1a33d3eb548a2afb87d449627c214" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Category</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Totals</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 86%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">License fees and milestone amounts paid / achieved</div>
</td>
<td style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,920,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 86%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Third party obligations recorded, including WU</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">(363,700</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">)</div>
</td>
</tr>

<tr>
<td style="width: 86%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Deferred revenue balance</div>
</td>
<td style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,556,300</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 86%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Revenue amortization to June 30, 2016</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">(345,93<font style="font: 10pt Times New Roman, Times, serif">7</font></div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">)</div>
</td>
</tr>

<tr>
<td style="width: 86%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 86%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Net deferred revenue balance at June 30, 2016</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,210,36<font style="font: 10pt Times New Roman, Times, serif">3</font></div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>

<div>&#160;</div>

<table id="a36bc686410dc4269bd2d2dea3cf0710d" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="vertical-align: top; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Commencement of license fees revenue recognition</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Upon signing or receipt</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Commencement of milestone revenue recognition</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Upon milestone achievement over then remaining life</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Original amortization period</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">197 months</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>

</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_AnimalHealthLicenseAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_AnimalHealthLicenseAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6811072976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and contingencies</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Note 8.&#160;&#160;Commitments and contingencies:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Commitments:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">As of June 30, 2016, the Company had employment agreements with two officers providing aggregate annual minimum commitments totaling&#160;$655,000.&#160;&#160;The agreements automatically renew at the end of each year unless terminated by either party and contain customary confidentiality and benefit provisions.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Venaxis determined in the first quarter of 2016 to begin winding down and ceasing its <font style="font: italic 10pt Times New Roman, Times, serif">APPY</font>1 commercial activities, due to continuing limited sales and losses from the European operations.&#160; This decision also resulted in a reduction of the Company&#8217;s workforce, which was implemented as of January 31, 2016. In February 2016, Venaxis sent notices to its four European distributors informing them of the wind-down and therefore the termination of their distribution agreements. Two of the distributors, linked by common management / ownership, subsequently communicated to Venaxis that they dispute that Venaxis had the right to terminate the agreements. Under the terms of the distribution agreements, such a dispute shall first be attempted to be resolved between management of the parties and then subject to binding arbitration.&#160; The parties are currently attempting to resolve the dispute without arbitration.&#160; Venaxis believes that the distributors&#8217; claims are without merit and any potential settlement or resolution will not be material to the Company&#8217;s financial position.&#160;&#160;</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Contingencies:&#160;</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">In the ordinary course of business and in the general industry in which the Company is engaged, it is not atypical to periodically receive a third party communication which may be in the form of a notice, threat, or &#8220;cease and desist&#8221; letter concerning certain activities.&#160;&#160;For example, this can occur in the context of the Company&#8217;s pursuit of intellectual property rights.&#160;&#160;This can also occur in the context of operations such as the using, making, having made, selling, and offering to sell products and services, and in other contexts.&#160;&#160;The Company makes rational assessments of each situation on a case-by-case basis as such may arise.&#160;&#160;The Company periodically evaluates its options for trademark positions and considers a full spectrum of alternatives for trademark protection and product branding.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">We are currently not a party to any legal proceedings, the adverse outcome of which would, in our management&#8217;s opinion, have a material adverse effect on our business, financial condition and results of operations.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25287-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6743352048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_CashAndCashEquivalentsAndInvestmentsPolicyTextBlock', window );">Cash, cash equivalents and investments</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Cash, cash equivalents and investments:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company considers all highly liquid investments with an original maturity of three months or less at the date of acquisition to be cash equivalents. From time to time, the Company&#8217;s cash account balances exceed the balances as covered by the Federal Deposit Insurance System. The Company has never suffered a loss due to such excess balances.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company invests excess cash from time to time in highly-liquid debt and equity investments of highly-rated entities, which are classified as trading securities. Historically, the purpose of the investments has been to fund research and development, product development, FDA clearance-related activities and general corporate purposes. Such amounts are recorded at market values using Level 1 inputs in determining fair value and are generally classified as current, as the Company does not intend to hold the investments beyond twelve months. Investment securities classified as trading are those securities that are bought and held principally for the purpose of selling them in the near term, with the objective of preserving principal and generating profits. These securities are reported at fair value with unrealized gains and losses reported as an element of other (expense) income in current period earnings. The Company&#8217;s Board of Directors has approved an investment policy covering the investment parameters to be followed with the primary goals being the safety of principal amounts and maintaining liquidity. The policy provides for minimum investment rating requirements as well as limitations on investment duration and concentrations. Based upon market conditions, the investment guidelines have been tightened to increase the minimum acceptable investment ratings required for investments and shorten the maximum investment term. As of June 30, 2016, approximately 20% of the investment portfolio was in cash and cash equivalents, which is presented as such on the accompanying balance sheet, and the remaining funds were invested in marketable securities with none individually representing a material amount of the portfolio.&#160; Investments with a scheduled maturity beyond one year are classified as long-term investments on the balance sheet.&#160; To date, the Company&#8217;s cumulative realized market loss from the investments has not been significant.&#160;For the six months ended June 30, 2016 and 2015, there was approximately $11,000 and $16,000, respectively, in management fee expenses.</div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value of financial instruments</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Fair value of financial instruments:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company accounts for financial instruments under Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification Topic (&#8220;ASC&#8221;) 820,<font style="font: italic 10pt Times New Roman, Times, serif"> Fair Value Measurements</font>.&#160; This statement defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements.&#160; To increase consistency and comparability in fair value measurements, ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels as follows:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Level 1&#8212; quoted prices (unadjusted) in active markets for identical assets or liabilities;</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Level 2 &#8212; observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Level 3 &#8212; assets and liabilities whose significant value drivers are unobservable.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company&#8217;s market assumptions.&#160; Unobservable inputs require significant management judgment or estimation.&#160; In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy.&#160; In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement.&#160; Such determination requires significant management judgment. There were no financial assets or liabilities measured at fair value, with the exception of cash, cash equivalents and short-term investments as of June 30, 2016 and December 31, 2015.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The carrying amounts of the Company&#8217;s financial instruments (other than cash, cash equivalents and short-term investments as discussed above) approximate fair value because of their variable interest rates and/or short maturities combined with the recent historical interest rate levels.</div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue recognition and accounts receivable</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Revenue recognition and accounts receivable:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">We recognized sales of goods under the provisions of ASC 605 and the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) Staff Accounting Bulletin (&#8220;SAB&#8221;) 104, <font style="font: italic 10pt Times New Roman, Times, serif">Revenue Recognition</font>. Future revenue is expected to be generated primarily from the sale of products. Product revenue primarily consists of sales of instrumentation and consumables.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Revenue was recognized when the following four basic criteria were met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred and risk of loss has passed; (iii) the seller&#8217;s price to the buyer is fixed or determinable; and (iv) collectability is reasonably assured.&#160; In international markets, the Company sells its products to distributors or re-sellers, who subsequently resell the products to hospitals. The Company has an agreement with the distributor which provides that title and risk of loss pass to the distributor upon shipment of the products, FOB to the distributor. Revenue is recognized upon shipment of products to the distributor as the products are shipped based on FOB shipping point terms (See Note 8).</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Revenues were recorded less a reserve for estimated product returns and allowances which to date has not been significant. Determination of the reserve for estimated product returns and allowances is based on management&#8217;s analyses and judgments regarding certain conditions. Should future changes in conditions prove management&#8217;s conclusions and judgments on previous analyses to be incorrect, revenue recognized for any reporting period could be adversely affected.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company extended credit to customers generally without requiring collateral. As of June 30, 2016 and December 31, 2015, the Company did not have any accounts receivable. During the six months ended June 30, 2016, no sales were recorded.&#160; During the six months ended June 30, 2015, three European-based customers accounted for the total net sales, representing 58%, 28% and 14%, respectively.</div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently issued and adopted accounting pronouncements</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt"><font style="font-weight: bold">Recently issued and adopted accounting pronouncements:</font></div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company's financial reporting, the Company undertakes a study to determine the consequences of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company's financial statements properly reflect the change.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">In May 2014, the FASB issued Accounting Standards Update ("ASU") No. 2014-09 "Revenue from Contracts from Customers," which supersedes the revenue recognition requirements in "Revenue Recognition (Topic 605)," and requires entities to recognize revenue in a way that depicts the transfer of potential goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to the exchange for those goods or services. In July 2015, the FASB extended the effective date of ASU 2014-09 by one year, to now be effective for fiscal years, and interim periods beginning after December 15, 2017, and is to be applied retrospectively, with early adoption now permitted for fiscal years and interim periods beginning after December 31, 2015. The Company does not believe the new standard will have a material impact on its operations and financial statements.</div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Income (loss) per share</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Income (loss) per share:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">ASC 260,<font style="font: italic 10pt Times New Roman, Times, serif"> Earnings Per Share</font>, requires dual presentation of basic and diluted earnings per share (&#8220;EPS&#8221;) with a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilution. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the entity.</div>



<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Basic net earnings (loss) per share includes no dilution and is computed by dividing net earnings (loss) available to shareholders by the weighted average number of common shares outstanding for the period.&#160;Diluted net earnings (loss) per share reflect the potential dilution of securities that could share in the Company&#8217;s earnings (loss).&#160; The effect of the inclusion of the dilutive shares would have resulted in a decrease in loss per share for the three and six months ended June 30, 2016<font style="font: 10pt Times New Roman, Times, serif"> and 2015 respectively</font>.&#160; Accordingly, the weighted average shares outstanding have not been adjusted for dilutive shares for any&#160;period presented.&#160; Outstanding stock options and warrants are not considered in the calculation, as the impact of the potential common shares (totaling approximately 966,000 shares and 776,000 shares for <font style="font: 10pt Times New Roman, Times, serif">each of </font>the <font style="font: 10pt Times New Roman, Times, serif">three and </font>six month periods ended June 30, 2016 and 2015, respectively) would be anti-dilutive.</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Upon the completion of a special shareholders meeting on March 24, 2016, where such action was approved by shareholders, the Board of Directors authorized a reverse stock split of the Company&#8217;s common stock at a ratio of one-for-eight, whereby each eight shares of common stock were combined into one share of common stock (the &#8220;Reverse Stock Split&#8221;).&#160;&#160;The Reverse Stock Split was implemented and effective on March 31, 2016. All historical references to shares and share amounts in this report have been retroactively revised to reflect the Reverse Stock Split.&#160; A reconciliation of basic and diluted weighted average number of shares outstanding adjusted for the Reverse Stock Split for the period ended June 30, 2016 was 30,990,029 shares on a pre-split basis and 3,876,961 shares on a post-split basis.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_CashAndCashEquivalentsAndInvestmentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The accounting policy for cash, cash equivalents and short-term investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_CashAndCashEquivalentsAndInvestmentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13279-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6811046384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Property and equipment consisted of the following:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="a41f4a22cf460475b9b6bb9aa1628d0c2" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">June 30,</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2016</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">(Unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">December 31,</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Land and improvements</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,107,508</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Building</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">2,589,231</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Building improvements</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">253,526</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Laboratory equipment</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">848,014</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Office and computer equipment</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">64,619</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">318,254</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">64,619</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">5,116,533</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Less accumulated depreciation</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">64,080</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">3,162,037</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">539</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,954,496</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>

</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of public utility physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, deprecation expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 980<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6499596&amp;loc=d3e42232-110370<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6722010976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other long-term assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_ScheduleOfOtherLongTermAssetsTableTextBlock', window );">Schedule of Other Long-Term Assets</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Other long-term assets consisted of the following:</div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">&#160;</div>

<table id="a64e8d8b9b95f4752b2179c5df90115d0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">June 30,</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2016</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">(Unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">December 31,</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-left: 18pt; text-indent: -18pt">Patents, trademarks and applications, net of&#160;accumulated&#160;amortization of $554,967&#160;and $548,327, respectively</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">943,475</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,136,410</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Goodwill</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">387,239</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">387,239</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,330,714</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,523,649</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>

</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_ScheduleOfOtherLongTermAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure for other long term assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_ScheduleOfOtherLongTermAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6810986800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes and Other Obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-Term Debt</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">Notes payable and other obligations consisted of the following:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="cab9cc4c9e284d67983e6dad9dcaf305" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">June 30,</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2016</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">(Unaudited)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">December 31,</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Mortgage notes</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,997,701</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Other short-term installment obligations</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">142,328</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">2,140,029</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Less current portion</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">301,250</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,838,779</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>

</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6479336&amp;loc=d3e64711-112823<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21538-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28541-108399<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21521-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6617466304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock options and warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of the Income Statement Allocation of Stock-based Compensation</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"></div>

<div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; margin-top: 3pt">The Company recognized total expenses for stock-based compensation during the three and six months ended June 30, 2016 and 2015 which are included in the accompanying statements of operations, in the following categories:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="a3f23189dc0764f08aaafe5057d207e44" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Three Months Ended</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="7" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Six Months Ended</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;</div>
</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 44%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Selling, general and administrative expenses</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">176,388</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">303,644</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">221,712</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">696,006</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 44%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Research and development expenses</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">43,937</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">2,560</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">84,977</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 44%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 44%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;&#160;&#160;&#160;Total stock-based compensation</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">176,388</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">347,581</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">224,272</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">780,983</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>

</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Fair Value Assumptions Used to Estimate Stock-based Compensation</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">The Company currently provides stock-based compensation to employees, directors and consultants under the Plan.&#160;The Company utilized assumptions in the estimation of fair value of stock-based compensation for the six months ended June 30, 2016 and 2015 as follows:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="fa017df72c9c440bbd4a4dab605ea181" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;</div>
</td>
<td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;</div>
</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Dividend yield</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">0</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">%</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">0</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">%</div>
</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Expected price volatility</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">99</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">%</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">93</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">%</div>
</td>
</tr>

<tr>
<td style="width: 72%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Risk free interest rate</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1.20</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">%</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1.39</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">%</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Expected term</div>
</td>
<td colspan="3" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">5 years</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td colspan="3" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">5 years</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>



</div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Incentive Plan Activity</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">A summary of activity under the Plan for the six months ended June 30, 2016 is presented below:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="a8c8d3e82c6d44c82b343752305cdc095" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="width: 38.31%; vertical-align: bottom">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom">&#160;</td>
<td colspan="2" style="width: 12.8%; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Shares</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Underlying</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Options</div>
</td>
<td style="width: 1.03%; vertical-align: bottom">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom">&#160;</td>
<td colspan="2" style="width: 12.79%; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Weighted</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Average</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Exercise</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Price</div>
</td>
<td style="width: 1.02%; vertical-align: bottom">&#160;</td>
<td colspan="3" style="width: 13.81%; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Weighted</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Average</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Remaining</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Contractual</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Term (Years)</div>
</td>
<td style="width: 1.04%; vertical-align: bottom">&#160;</td>
<td colspan="3" style="width: 16.12%; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Aggregate</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Intrinsic</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Value</div>
</td>
<td style="width: 1.04%; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom">&#160;</td>
<td colspan="2" style="width: 12.8%; vertical-align: bottom">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom">&#160;</td>
<td colspan="2" style="width: 12.79%; vertical-align: bottom">&#160;</td>
<td style="width: 1.02%; vertical-align: bottom">&#160;</td>
<td colspan="3" style="width: 13.81%; vertical-align: bottom">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom">&#160;</td>
<td colspan="3" style="width: 16.12%; vertical-align: bottom">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Outstanding at January 1, 2016</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.73%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">332,560</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">$</div>
</td>
<td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">35.36</div>
</td>
<td style="width: 1.02%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;&#160;&#160;&#160;&#160;Granted</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 11.73%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">227,000</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 11.72%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">2.89</div>
</td>
<td style="width: 1.02%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;&#160;&#160;&#160;&#160;Exercised</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.73%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">-</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">-</div>
</td>
<td style="width: 1.02%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;&#160;&#160;&#160;&#160;Forfeited</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff">&#160;</td>
<td style="width: 11.73%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">(25,445</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">)</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff">&#160;</td>
<td style="width: 11.72%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">36.30</div>
</td>
<td style="width: 1.02%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.73%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.02%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="3" style="width: 13.81%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="3" style="width: 16.12%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Outstanding at June 30, 2016</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">&#160;</td>
<td style="width: 11.73%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">534,115</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">$</div>
</td>
<td style="width: 11.72%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">21.55</div>
</td>
<td style="width: 1.02%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 11.72%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">8.1</div>
</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.24%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">$</div>
</td>
<td style="width: 13.82%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">140,740</div>
</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.73%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.02%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.72%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.24%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 13.82%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="width: 38.31%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Exercisable at June 30, 2016</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">&#160;</td>
<td style="width: 11.73%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">331,427</div>
</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.03%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">$</div>
</td>
<td style="width: 11.72%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">32.44</div>
</td>
<td style="width: 1.02%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 11.72%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">7.1</div>
</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.06%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.24%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">$</div>
</td>
<td style="width: 13.82%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right">23,870</div>
</td>
<td style="width: 1.04%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
</tr>
</table>

</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Schedule of Nonvested Share Activity</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">A summary of the activity of nonvested options under the Plan to acquire common shares granted to employees, officers, directors and consultants during the six months ended June 30, 2016 is presented below:</div>

<div style="margin-bottom: 3pt; text-align: left; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="a803bc49bdf14c89b8c428d6c75c12ef" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Nonvested Shares</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Nonvested</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Shares</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Underlying</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Options</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Weighted</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Average</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Exercise</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Price</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Weighted</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Average</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Grant Date</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Fair Value</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom"></td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 58%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Nonvested at January 1, 2016</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">33,336</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">15.54</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">11.41</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 58%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;&#160;&#160;&#160;&#160;Granted</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">227,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">2.89</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">2.13</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 58%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;&#160;&#160;&#160;&#160;Vested</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">(54,028</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">)</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">6.67</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">5.02</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 58%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">&#160;&#160;&#160;&#160;&#160;Forfeited</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">(3,620</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">)</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">15.13</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">10.75</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 58%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 58%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left">Nonvested at June 30, 2016</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">202,688</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">3.75</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">2.73</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>

</div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock', window );">Schedule of Nonqualified Award Activity</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">Following is a summary of outstanding options and warrants that were issued outside of the Plan for the six months ended June 30, 2016:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="c42e36b37b494fd99c6f9c9aaed437d8" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="width: 48.94%; vertical-align: bottom">&#160;</td>
<td style="width: 1.41%; vertical-align: bottom">&#160;</td>
<td colspan="2" style="width: 11.08%; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Shares</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Underlying</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Options / Warrants</div>
</td>
<td style="width: 1.63%; vertical-align: bottom">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom">&#160;</td>
<td colspan="2" style="width: 12.17%; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Weighted</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Average</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Exercise</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Price</div>
</td>
<td style="width: 1.42%; vertical-align: bottom">&#160;</td>
<td style="width: 9.57%; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Weighted</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Average</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Remaining</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Contractual</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Term (Years)</div>
</td>
<td style="width: 1.21%; vertical-align: bottom">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; border-bottom: #000000 2px solid">&#160;</td>
<td style="width: 9.73%; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Aggregate</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Intrinsic</div>

<div style="font: bold 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Value</div>
</td>
</tr>

<tr>
<td style="width: 48.94%; vertical-align: bottom">&#160;</td>
<td style="width: 1.41%; vertical-align: bottom">&#160;</td>
<td style="width: 0.97%; vertical-align: bottom">&#160;</td>
<td style="width: 10.11%; vertical-align: bottom">&#160;</td>
<td style="width: 1.63%; vertical-align: bottom">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom">&#160;</td>
<td style="width: 0.95%; vertical-align: bottom">&#160;</td>
<td style="width: 11.21%; vertical-align: bottom">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom">&#160;</td>
<td style="width: 9.57%; vertical-align: bottom">&#160;</td>
<td style="width: 1.21%; vertical-align: bottom">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom">&#160;</td>
<td style="width: 9.73%; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 48.94%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #cceeff">Outstanding at January 1, 2016</div>
</td>
<td style="width: 1.41%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 0.97%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 10.11%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #cceeff">432,003</div>
</td>
<td style="width: 1.63%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #cceeff">$</div>
</td>
<td style="width: 11.21%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #cceeff">15.47</div>
</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 9.57%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.21%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 9.73%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="width: 48.94%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff">&#160;&#160;&#160;&#160;&#160;Granted</div>
</td>
<td style="width: 1.41%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 0.97%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 10.11%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff">-</div>
</td>
<td style="width: 1.63%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 0.95%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 11.21%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff">-</div>
</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 9.57%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.21%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 9.73%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="width: 48.94%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #cceeff">&#160;&#160;&#160;&#160;&#160;Exercised</div>
</td>
<td style="width: 1.41%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 0.97%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 10.11%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #cceeff">-</div>
</td>
<td style="width: 1.63%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.21%; vertical-align: bottom; background-color: #cceeff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #cceeff">-</div>
</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 9.57%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.21%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 9.73%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="width: 48.94%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff">&#160;&#160;&#160;&#160;&#160;Forfeited</div>
</td>
<td style="width: 1.41%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 0.97%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff">&#160;</td>
<td style="width: 10.11%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff">-</div>
</td>
<td style="width: 1.63%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 0.95%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff">&#160;</td>
<td style="width: 11.21%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff">-</div>
</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 9.57%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.21%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 9.73%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="width: 48.94%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.41%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 0.97%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 10.11%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.63%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 11.21%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 9.57%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.21%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td style="width: 9.73%; vertical-align: bottom; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="width: 48.94%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff">Outstanding and exercisable at June 30, 2016</div>
</td>
<td style="width: 1.41%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 0.97%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">&#160;</td>
<td style="width: 10.11%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff">432,003</div>
</td>
<td style="width: 1.63%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 0.95%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff">$</div>
</td>
<td style="width: 11.21%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff">15.47</div>
</td>
<td style="width: 1.42%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 9.57%; vertical-align: bottom; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center; background-color: #ffffff">1.8</div>
</td>
<td style="width: 1.21%; vertical-align: bottom; background-color: #ffffff">&#160;</td>
<td style="width: 1.42%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: left; background-color: #ffffff">$</div>
</td>
<td style="width: 9.73%; vertical-align: bottom; border-bottom: #000000 4px double; background-color: #ffffff">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: right; background-color: #ffffff">-</div>
</td>
</tr>
</table>

<div style="margin-bottom: 3pt; text-align: left; margin-top: 3pt; line-height: 1">&#160;</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in other outstanding share-based compensation awards other than stock options or nonvested awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6810921456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Animal Health License Agreements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_AnimalHealthLicenseAgreementsAbstract', window );"><strong>Animal Health License Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueByArrangementDisclosureTextBlock', window );">Schedule of Current and Long-Term Deferred Revenues</a></td>
<td class="text"><div><div style="margin-bottom: 3pt; font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify; margin-top: 3pt">A tabular summary of the revenue categories and cumulative amounts of revenue recognition associated with the License Agreement follows:</div>

<div style="margin-bottom: 3pt; margin-top: 3pt; line-height: 1"><br style="line-height: 1" />
</div>

<table id="f2d1a33d3eb548a2afb87d449627c214" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Category</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Totals</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 86%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">License fees and milestone amounts paid / achieved</div>
</td>
<td style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,920,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 86%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Third party obligations recorded, including WU</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">(363,700</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">)</div>
</td>
</tr>

<tr>
<td style="width: 86%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Deferred revenue balance</div>
</td>
<td style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,556,300</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 86%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Revenue amortization to June 30, 2016</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">(345,93<font style="font: 10pt Times New Roman, Times, serif">7</font></div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">)</div>
</td>
</tr>

<tr>
<td style="width: 86%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 11%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 86%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Net deferred revenue balance at June 30, 2016</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">$</div>
</td>
<td style="width: 11%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000">1,210,36<font style="font: 10pt Times New Roman, Times, serif">3</font></div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>

<div>&#160;</div>

<table id="a36bc686410dc4269bd2d2dea3cf0710d" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman; width: 100%">
<tr>
<td style="vertical-align: top; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Commencement of license fees revenue recognition</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Upon signing or receipt</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Commencement of milestone revenue recognition</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">Upon milestone achievement over then remaining life</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: justify">Original amortization period</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1 Times New Roman, Times, serif; color: #000000; text-align: center">197 months</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>

</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_AnimalHealthLicenseAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_AnimalHealthLicenseAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueByArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the type of arrangements and the corresponding amounts that comprise the current and noncurrent balance of deferred revenue as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueByArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6747939392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INTERIM FINANCIAL STATEMENTS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAndCash', window );">Cash and liquid investments</a></td>
<td class="nump">$ 16,147,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_WorkingCapital', window );">Working capital</a></td>
<td class="nump">15,801,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="nump">16,018,544<span></span>
</td>
<td class="nump">$ 16,070,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">105,858,803<span></span>
</td>
<td class="nump">$ 105,582,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_TotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners', window );">Total value of capitalized patent costs that could be impaired due to inability to locate a new strategic target, a partner or other third-party interested in advancing development and commercial activities of the Venaxis appendicitis portfolio</a></td>
<td class="nump">$ 371,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_TotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total value of capitalized patent costs that could be impaired due to inability to locate a new strategic target, a partner or other third-party interested in advancing development and commercial activities of the Venaxis appendicitis portfolio.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_TotalValueOfCapitalizedPatentCostsThatCouldBeImpairedDueToTerminationOfStrategicPartners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Working capital as measured by current assets less current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAndCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of investments and unrestricted cash as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAndCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6747850960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract', window );"><strong>Cash, cash equivalents and short-term investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_PercentageOfInvestmentPortfolioCashAndCashEquivalent', window );">Cash and cash equivalent investment portfolio, percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInvestmentExpense', window );">Management fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Sales</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 24,517<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 35,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Income (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_WeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit', window );">Basic and diluted weighted average number of shares outstanding pre-stock split basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,990,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_BasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis', window );">Basic and diluted weighted average number of shares outstanding post-split basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,876,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares not included in the computation of EPS</a></td>
<td class="nump">966,000<span></span>
</td>
<td class="nump">776,000<span></span>
</td>
<td class="nump">966,000<span></span>
</td>
<td class="nump">776,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_BasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basic and diluted weighted average number of shares outstanding post-split basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_BasicAndDilutedWeightedAverageNumberOfSharesOutstandingPostsplitBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_PercentageOfInvestmentPortfolioCashAndCashEquivalent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of cash and cash equivalents investments held within the entity's investment portfolio.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_PercentageOfInvestmentPortfolioCashAndCashEquivalent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_WeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basic and diluted weighted average number of shares outstanding pre-stock split basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_WeightedAverageNumberOfShareOutstandingBasicAndDilutedPrestockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Antidilution<br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Diluted Earnings Per Share<br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Contingent Stock Agreement<br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInvestmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to the generation of investment income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInvestmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueGoodsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueGoodsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6748108784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Revenue recognition and accounts receivable) (Details) - Net Sales [Member] - Customer Concentration [Member]<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_ConcentrationRiskNumberOfCustomers', window );">Number of customers</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Customer One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Risk percentage</a></td>
<td class="nump">58.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Customer Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Risk percentage</a></td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Customer Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Risk percentage</a></td>
<td class="nump">14.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_ConcentrationRiskNumberOfCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of customers contributing to concentration risk during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_ConcentrationRiskNumberOfCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6351-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13531-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6404-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersAxis=appy_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersAxis=appy_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersAxis=appy_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersAxis=appy_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersAxis=appy_CustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersAxis=appy_CustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6747907824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Feb. 29, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 38,000<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">$ 51,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_SalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty', window );">Sales price of corporate headquarters, land and building to a third party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,749,484<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on sale of property and equipment (Note 2)</a></td>
<td class="nump">$ 912<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,920,273<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_SalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales price of corporate headquarters, land and building to a third party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_SalesPriceOfCorporateHeadquartersLandAndBuildingToThirdParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3179-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6747892640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and equipment (Schedule of Property and Equipment) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">$ 64,619<span></span>
</td>
<td class="nump">$ 5,116,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="nump">64,080<span></span>
</td>
<td class="nump">3,162,037<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">539<span></span>
</td>
<td class="nump">1,954,496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember', window );">Land and improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,107,508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,589,231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">253,526<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember', window );">Laboratory equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">848,014<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office and computer equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">$ 64,619<span></span>
</td>
<td class="nump">$ 318,254<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6748170688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other long-term assets (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Patents, trademarks and applications, net of accumulated amortization</a></td>
<td class="nump">$ 943,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 943,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,136,410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">387,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">387,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">387,239<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total other long-term assets</a></td>
<td class="nump">1,330,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,330,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,523,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived assets, accumulated amortization</a></td>
<td class="nump">554,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">554,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 548,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Future amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2016</a></td>
<td class="nump">81,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2017</a></td>
<td class="nump">81,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2018</a></td>
<td class="nump">81,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2019</a></td>
<td class="nump">81,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2020</a></td>
<td class="nump">81,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment charges</a></td>
<td class="nump">$ 34,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 168,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6748011664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes and Other Obligations (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Future Maturities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">Remainder of 2016</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember', window );">Mortgage Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_DebtInstrumentAmortizationPeriod', window );">Amortization period</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_DebtInstrumentMaturityPeriod', window );">Balloon maturity period</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=appy_NotesPayableToBankMember', window );">Commercial Banks [Member] | Mortgage Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate</a></td>
<td class="nump">3.95%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Periodic payments, principal and interest</a></td>
<td class="nump">$ 11,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentInterest', window );">Periodic payments, interest</a></td>
<td class="nump">$ 4,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=appy_UnitedStatesSmallBusinessAdministrationMember', window );">U.S. Small Business Administration [Member] | Mortgage Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate</a></td>
<td class="nump">5.86%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Periodic payments, principal and interest</a></td>
<td class="nump">$ 9,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentInterest', window );">Periodic payments, interest</a></td>
<td class="nump">$ 3,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_DebtInstrumentAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period for amortization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_DebtInstrumentAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_DebtInstrumentMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balloon maturity period for a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_DebtInstrumentMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6479336&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=appy_NotesPayableToBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=appy_NotesPayableToBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=appy_UnitedStatesSmallBusinessAdministrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=appy_UnitedStatesSmallBusinessAdministrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6815952656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Notes and Other Obligations (Schedule of Long-Term Debt) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Mortgage notes</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,997,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherShortTermBorrowings', window );">Other short-term installment obligations</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">142,328<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes and other obligations</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,140,029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Less current portion</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">301,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes and other obligations, noncurrent</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,838,779<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6822916608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock options and warrants (Stock incentive plan options) (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Sep. 01, 2015</div></th>
<th class="th"><div>Aug. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares reserved under the Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">709,141<span></span>
</td>
<td class="nump">459,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=appy_StockIncentivePlanMember', window );">Stock Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Incentive stock options exercised to purchase common shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="nump">227,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted, exercise price</a></td>
<td class="nump">$ 2.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options forfeited</a></td>
<td class="nump">25,445<span></span>
</td>
<td class="nump">24,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Options expired</a></td>
<td class="nump">21,825<span></span>
</td>
<td class="nump">4,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Options forfeited, unvested</a></td>
<td class="nump">3,620<span></span>
</td>
<td class="nump">20,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Options forfeited, exercise price</a></td>
<td class="nump">$ 36.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Options expired, exercise price</a></td>
<td class="nump">39.81<span></span>
</td>
<td class="nump">$ 98.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options forfeited, unvested, exercise price</a></td>
<td class="nump">$ 15.13<span></span>
</td>
<td class="nump">$ 16.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of options vested</a></td>
<td class="nump">$ 271,000<span></span>
</td>
<td class="nump">$ 449,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Expected to vest</a></td>
<td class="nump">162,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 339,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, period for recognition</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Awards outstanding</a></td>
<td class="nump">534,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">332,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=appy_StockIncentivePlanMember', window );">Stock Incentive Plan [Member] | Independent Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="nump">77,000<span></span>
</td>
<td class="nump">43,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted, exercise price</a></td>
<td class="nump">$ 2.89<span></span>
</td>
<td class="nump">$ 15.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_VestingPeriodSixMonthAnniversaryPercentOfSharesVesting', window );">Percent of shares vesting on the six month anniversary from grant date</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=appy_StockIncentivePlanMember', window );">Stock Incentive Plan [Member] | Independent Directors [Member] | Vesting in Period One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=appy_StockIncentivePlanMember', window );">Stock Incentive Plan [Member] | Independent Directors [Member] | Vesting In Period Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=appy_StockIncentivePlanMember', window );">Stock Incentive Plan [Member] | Independent Directors [Member] | Vesting In Period Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=appy_StockIncentivePlanMember', window );">Stock Incentive Plan [Member] | Independent Directors [Member] | Vesting In Period Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=appy_StockIncentivePlanMember', window );">Stock Incentive Plan [Member] | Officers and Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="nump">93,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted, exercise price</a></td>
<td class="nump">$ 2.89<span></span>
</td>
<td class="nump">$ 15.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=appy_StockIncentivePlanMember', window );">Stock Incentive Plan [Member] | Officers and Employees [Member] | Vesting in Period One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=appy_StockIncentivePlanMember', window );">Stock Incentive Plan [Member] | Officers and Employees [Member] | Vesting In Period Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rate</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=appy_StockIncentivePlanMember', window );">Stock Incentive Plan [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=appy_StockIncentivePlanMember', window );">Stock Incentive Plan [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=appy_NonqualifiedMember', window );">Nonqualified [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Incentive stock options exercised to purchase common shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted, exercise price</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Options forfeited, exercise price</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Awards outstanding</a></td>
<td class="nump">432,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">432,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=appy_NonqualifiedMember', window );">Nonqualified [Member] | Non-compensatory Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted, exercise price</a></td>
<td class="nump">$ 15.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Awards outstanding</a></td>
<td class="nump">429,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentOptionsExpirationDate', window );">Expiration Date</a></td>
<td class="text">May 31,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=appy_NonqualifiedMember', window );">Nonqualified [Member] | Compensatory Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted, exercise price</a></td>
<td class="nump">$ 27.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Awards outstanding</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentOptionsExpirationDate', window );">Expiration Date</a></td>
<td class="text">Dec. 31,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_VestingPeriodSixMonthAnniversaryPercentOfSharesVesting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percent of shares vesting on the six month anniversary from grant date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_VestingPeriodSixMonthAnniversaryPercentOfSharesVesting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_InvestmentOptionsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of the option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 12<br> -Section 13<br> -Footnote 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invest_InvestmentOptionsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>invest_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=appy_StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=appy_StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_IssuanceTypeAxis=appy_IndependentDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_IssuanceTypeAxis=appy_IndependentDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=appy_ShareBasedCompensationAwardTrancheFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=appy_ShareBasedCompensationAwardTrancheFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_IssuanceTypeAxis=appy_OfficersAndEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_IssuanceTypeAxis=appy_OfficersAndEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=appy_NonqualifiedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=appy_NonqualifiedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_IssuanceTypeAxis=appy_NonCompensatoryRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_IssuanceTypeAxis=appy_NonCompensatoryRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_IssuanceTypeAxis=appy_CompensatoryRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_IssuanceTypeAxis=appy_CompensatoryRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6743249712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock options and warrants (Schedule of Stock-based Compensation) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">$ 176,388<span></span>
</td>
<td class="nump">$ 347,581<span></span>
</td>
<td class="nump">$ 224,272<span></span>
</td>
<td class="nump">$ 780,983<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">176,388<span></span>
</td>
<td class="nump">303,644<span></span>
</td>
<td class="nump">221,712<span></span>
</td>
<td class="nump">696,006<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 43,937<span></span>
</td>
<td class="nump">$ 2,560<span></span>
</td>
<td class="nump">$ 84,977<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6811040432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock options and warrants (Schedule of fair value assumptions) (Details)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected price volatility</a></td>
<td class="nump">99.00%<span></span>
</td>
<td class="nump">93.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.39%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6748213184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock options and warrants (Schedule of Award Activity) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=appy_StockIncentivePlanMember', window );">Stock Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares Underlying Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning</a></td>
<td class="nump">332,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">227,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited</a></td>
<td class="num">(25,445)<span></span>
</td>
<td class="num">(24,742)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending</a></td>
<td class="nump">534,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable</a></td>
<td class="nump">331,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning</a></td>
<td class="nump">$ 35.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">2.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited</a></td>
<td class="nump">36.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending</a></td>
<td class="nump">21.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable</a></td>
<td class="nump">$ 32.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_WeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted Average Remaining Contractual Term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
<td class="text">8 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable</a></td>
<td class="text">7 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_AggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="nump">$ 140,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable</a></td>
<td class="nump">$ 23,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=appy_NonqualifiedMember', window );">Nonqualified [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares Underlying Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning</a></td>
<td class="nump">432,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending</a></td>
<td class="nump">432,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning</a></td>
<td class="nump">$ 15.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending</a></td>
<td class="nump">$ 15.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_WeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted Average Remaining Contractual Term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_AggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_AggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_AggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_WeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_WeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=appy_StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=appy_StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=appy_NonqualifiedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=appy_NonqualifiedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6747938624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock options and warrants (Schedule of Nonvested Awards) (Details) - Stock Incentive Plan [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward', window );"><strong>Nonvested Shares Underlying Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Beginning balance</a></td>
<td class="nump">33,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">227,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Vested</a></td>
<td class="num">(54,028)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Forfeited</a></td>
<td class="num">(3,620)<span></span>
</td>
<td class="num">(20,614)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Ending balance</a></td>
<td class="nump">202,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice', window );">Beginning balance</a></td>
<td class="nump">$ 15.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">2.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice', window );">Vested</a></td>
<td class="nump">6.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited</a></td>
<td class="nump">15.13<span></span>
</td>
<td class="nump">$ 16.48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice', window );">Ending balance</a></td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance</a></td>
<td class="nump">11.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted</a></td>
<td class="nump">2.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Vested</a></td>
<td class="nump">5.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Forfeited</a></td>
<td class="nump">10.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance</a></td>
<td class="nump">$ 2.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of share-based payment awards that vested during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of nonvested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=appy_StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=appy_StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6810014992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Animal Health License Agreements (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_AnimalHealthLicenseAgreementsAbstract', window );"><strong>Animal Health License Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInNextTwelveMonths', window );">Annual royalty commitment</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee', window );">Prior written notice period for termination of license agreement by the licensee</a></td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_LicenseAgreementMaximumMilestonePayments', window );">Aggregate milestone payments, maximum</a></td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_AdditionalMilestoneMaximumPayments', window );">Additional milestone payments, maximum</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_DeferredRevenueGross', window );">Original amount of deferred revenue</a></td>
<td class="nump">1,556,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">96,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,698<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue, noncurrent</a></td>
<td class="nump">1,113,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,162,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecognitionOfDeferredRevenue', window );">Recognition of license fee revenue</a></td>
<td class="nump">48,350<span></span>
</td>
<td class="nump">$ 48,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_LicenseFeesAndMilestoneRevenue', window );">License fees and milestone revenue</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_AdditionalMilestoneMaximumPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional milestone payments up to a certain amount as part of a license agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_AdditionalMilestoneMaximumPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_AnimalHealthLicenseAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_AnimalHealthLicenseAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_DeferredRevenueGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue, net of deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_DeferredRevenueGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_LicenseAgreementMaximumMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum aggregate milestone payments receivable as party of a license agreement with a third party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_LicenseAgreementMaximumMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_LicenseFeesAndMilestoneRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License fees and milestone revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_LicenseFeesAndMilestoneRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The prior written notice period for termination of license agreement by the licensee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(c).Q3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(c).Q3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment maturing in the next fiscal year following the latest fiscal year for commitments not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in this taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecognitionOfDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of previously reported deferred or unearned revenue that was recognized as revenue during the period. For cash flows, this element primarily pertains to amortization of deferred credits on long-term arrangements. As a noncash item, it is deducted from net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecognitionOfDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6745162736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Animal Health License Agreements (Schedule of Revenue Recognition Associated with the License Agreement) (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_AnimalHealthLicenseAgreementsAbstract', window );"><strong>Animal Health License Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_LicenseAndMilestonePaymentsRevenue', window );">License fees and milestone amounts paid / achieved</a></td>
<td class="nump">$ 1,920,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCurrentAndNoncurrent', window );">Third party obligations recorded, including WU</a></td>
<td class="num">(363,700)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_DeferredRevenueGross', window );">Deferred revenue balance</a></td>
<td class="nump">1,556,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_DeferredRevenueAccumulatedRecognition', window );">Revenue amortization to June 30, 2016</a></td>
<td class="num">(345,937)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Net deferred revenue balance at June 30, 2016</a></td>
<td class="nump">$ 1,210,363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Original amortization period</a></td>
<td class="text">197 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_AnimalHealthLicenseAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_AnimalHealthLicenseAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_DeferredRevenueAccumulatedRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from deferred revenue arrangements as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_DeferredRevenueAccumulatedRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_DeferredRevenueGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue, net of deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_DeferredRevenueGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_LicenseAndMilestonePaymentsRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net amount of license and milestone payments made and received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_LicenseAndMilestonePaymentsRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6726507168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($) </div>
<div>Officers</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems', window );"><strong>Purchase Commitment, Excluding Long-term Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_appy_NumberOfOfficersUnderEmployementAgreements', window );">Number of officers | Officers</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=us-gaap_EmploymentContractsMember', window );">Employment Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems', window );"><strong>Purchase Commitment, Excluding Long-term Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted', window );">Annual commitment amount | $</a></td>
<td class="nump">$ 655,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_appy_NumberOfOfficersUnderEmployementAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of officers of the entity under employment agreements. Renew of the agreements is automatic in nature and termination can be executed by either party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">appy_NumberOfOfficersUnderEmployementAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>appy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=us-gaap_EmploymentContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=us-gaap_EmploymentContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>48
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MSD_@'.B#HYSF/CC:UX.+$SC-\^#HU&'=#\]__1U_]VH'^_\VPS]02P,$%
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MTJ[#?Z?Q)\Y&I&WCF:D[.<)TCL):W-V365!KTXBV"SS>0K%/()0OV2T63NV
M+0X6X,6NIM3;-"+NE:DJZ3OAPG1RTV88](OTIM3;-"9NGRGIA**HN6E$W;@K
M;(!E2H&CQSNE^J81?^/:1%%4X#1B<(]!@4=1U.4T(O-E"]J94135.HUXW:L"
M']%22-WF$;?[*@8;7%,4U9S'-.^3@7.*.JG0$=?[41E%4==YQ/5+7JW#YGM)
M4=1V'K']$FJ#/4G1*(JBMO.([9<4O08OI*)GD%/;><3V7D775%%.;>>OM7V3
M4Q2UG;_2=GQ&4=1V'K&]%Y67]'M-;<\N5?)+J"RE*&I[]JJB'E#4]HS:GL5L
M[T51V[.3CB1B>V]ER,8416W/(K;WHVAMSZCM6<3VWN\-&U 4M3V;/G68/YM*
M[*NEAB*TW*X=!GO6//3A^--]1<>34#[#]1WVYO,D--#8*S=*7>&]>WUK1-MF
M=N3GSOO#/U!+ P04    " !DA@I)8..0#TP"  "-!P  &    'AL+W=O<FMS
M:&5E=',O<VAE970Q+GAM;'V578^C(!2&_PKQ!XR*7VUC3:;=;'8O-IG,Q>XU
M55K-B+A Z^R_7S[4X@2]4<'W/0\'#I /E'WP&F,!/DG;\:-7"]$??)^7-2:(
MO] >=_+/E3*"A&RRF\][AE&E3:3U81"D/D%-YQ6Y[GMC14[OHFTZ_,8 OQ."
MV+\3;NEP]$)OZGAO;K50'7Z1^[.O:@CN>$,[P/#UZ+V&AW,8*8E6_&[PP*UO
MH 9_H?1#-7Y61R]08\ M+H4*@>3K@<^X;54D2?X[!GTRE='^GJ)_U^G*X5\0
MQV?:_FDJ4<O1!AZH\!7=6_%.AQ]XS"%1 4O:<OT$Y9T+2B:+!PCZ-.^FT^_!
M_(FCT>8VP-$ 9P-,-PW1:(AF0QCK3,W(=%[?D$!%SN@ F%F,'JDU#P^1G+D2
M<-W)S'3)S+CL?11![C]4F%$!M>)D*\)9X<O8,P"Z *,=6G;H IQM1>0&1"Y
M9#*(+'OLML<N>VSLL65/EN,SBI.M2-V 9 .06/9L"4@-P"@Z,\-AFL7AWHU)
M-S"IA=DY\[ 5*X!L Y#9=1 X"0O)2JWL-A [VP^=B(5DI5KV&XB][8^=B(4D
M<2/4 ;'*4#^?$=(E)!EWU4*3K5"<.W>B+#;FSEE9H\:4%@S"E?(-G1MXXMC[
MTZI,>\H6&ABL4)R[>*+8VQB&KFS.H\9D$^VR=)]^+3+?.OT(9C=]*W!0TGNG
M+R&K=[YY7J$^/9_R(N_1#?]"[-9T'%RHD&>P/C"OE HL1Q*\R%6LY=TX-UI\
M%>HS4\MK;@O3$+2?+K_Y!B[^ U!+ P04    " !DA@I)JXQ?5<D#   L$
M&    'AL+W=O<FMS:&5E=',O<VAE970R+GAM;(V878_:.!2&_TK$_38^_LZ(
M02JIJMV+2E4O=J\S8 ;4A- D,[3_?IT/Z#%[;.W-D(3WV(^3^,&>];7MOO='
MYX;L9U.?^^?5<1@N3WG>[XZNJ?H/[<6=_3>'MFNJP9]VKWE_Z5RUGXJ:.N>,
MZ;RI3N?59CU=^]IMUNW;4)_.[FN7]6]-4W6_MJYNK\\K6-TN?#N]'H?Q0KY9
MY_>Z_:EQY_[4GK/.'9Y7'^&IY'J,3(F_3^[:H^-LA']IV^_CR5_[YQ4;&5SM
M=L/81.4_WEWIZGILR??\8VGT=Y]C(3Z^M?YY&J['?ZEZ5[;U/Z?]</2T;)7M
MW:%ZJX=O[?5/MXQ!C0WNVKJ?_F:[MWYHFUO)*FNJG_/GZ3Q]7N=O+%O*Z *^
M%/![ <AD@5@*Q$-!/I--X_I4#=5FW;77K)L?QJ4:GSD\"7_G=ED_7>SFV^5'
MUONK[QO.U_G[V,X2X5-D&T2H1!DDQ#V2^_[O$)R"$#,$Q_62KA=4O9SK!:Y7
M(:*9!S%'SE-$2EM85E"Y$N<X \YM9#PRP2,QCP[[T3./1/T :&4D<"I8!D$)
MTA0%T$0J0:0PD2&)5$ $3-(\.,85&&-I&IV@T9C&DC0:TVBN+->"Y F#_BXR
MQ6DBDR RF*@@B0SJ2 DR4^(,%$K*0M,L-L%B$8M@83]S9!M$@$2Q"*4P7MZ,
M)BD2) 7NAGP=M@4>L1#,@"1Q@ISB0LN"YAG5&P4:O_Q-1+X0VR6S=&64+120
M<[ ,DIQ9S:$P$2K2H8N^ /M/1/P%I !OX\(&%(H>%P]>+JD*^AT,<H8!TS&B
ME%(!.U70#@,1/'S)R*E<0NC>PIJ(4B'E5,!2%;3"0(9OF6:TPX(<EV!M1!F0
M<BI@J0I+3M0P0\]4P$H5_C='1:8JI)P*6*JTGK: 95EH740>6#P6\J2,"EBI
MDM$\V)=2&:\/&BCPJBF8T;%YFA(K8&U*H!_8_U K8+>"%=:8F,Q2=@6L5_K7
M=@N!-P&$UJ0=RH>@]FL713/QE& Y%JRD!<L#P2K#_,\+R10$_<(%E(XL73BI
MUQL3UJN4Y&,+,H^/32XXD4Q(DERG8DW+V/U-:95CK4I:JSS0*@?_>@E)3XS'
MJ%9^"L6X4G;EV*YT9UN.K?D',&65M8Q>E?TGZQ=P4D1F"4]9EF.#2GJQR(.U
MJV9@U>-[<N-Z2!JF162)QE.VY=BVDMQ*;'FP-"47(LNF(TA&%B(YVM==JE?W
MI>I>3^<^>VD'OT6<]G.'MAV<;X]]\*,\^JW[_:1VAV$\-/ZXFS>S\\G07FY[
M\_L_"#;_ E!+ P04    " !DA@I)ZG6Z8]8!  !<!0  &    'AL+W=O<FMS
M:&5E=',O<VAE970S+GAM;(V4WXZ<(!3&7\7X (N*LNW$,>G8;-J+)IN]:*\9
MQ=$LB O,N'W[\L>QN*&F7@@<O^^<W\% .7/Q*GM"5/3.Z"B/<:_4= ! -CUA
M6#[PB8SZ2\<%PTHOQ07(21#<6A.C($L2!!@>QK@J;>Q95"6_*CJ,Y%E$\LH8
M%K]/A/+Y&*?Q/? R7'IE J JP>IK!T9&.? Q$J0[QE_20XV,P@I^#F26WCPR
M[&?.7\WB>WN,$X- *&F4R8#U<",UH=0DTH7?EIQ_2QJC/[]G?[+=:OHSEJ3F
M]-?0JE[#)G'4D@Y?J7KA\S>RM%"8A VGTKZCYBH59W=+'#'\[L9AM./LOA1H
ML84-V6+(5D.:[QK@8H ?#,"1V;Z^8H6K4O Y$NY?3-C\\O0 ]<XUD;1!X;9+
M=R9U]%8520EN)L\BR:SDY$NRD*+>*. J ;K^"I&%(*"#R'R(-.R'(7_N_-#W
M?T!TDI,O@6E(4O]#LJ'(=RARGP)N2R!'X22CE:#$/2%AO2O<$!4[1(5/E >)
M"J\0_/2(/J,T"+2GV_"@'1[D\Q1!'O2?/'LZQP.\@S#A"_F!Q648973F2I\I
M>P ZSA71V9('W5ZOK[IU04FGS/11SX4[_6ZA^'2_R]8+M?H#4$L#!!0    (
M &2&"DEUQ'<F*@0  "L2   8    >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL
MC5C9DJ,V%/T5RN_=:)=PN5TU!E+)0ZJFYB%YIFUYJ6%Q +<G?Q^QV'WE7'#[
MP8 X=SE7RQ%:7:OZ9W.TM@U^%7G9O"V.;7M>AF&S/=HB:UZKLRW=FWU5%UGK
M'NM#V)QKF^UZHR(/&2$J++)3N5BO^K;O]7I57=K\5-KO==!<BB*K_]W8O+J^
M+>CBUO#C=#BV74.X7H5WN]VIL&5SJLJ@MONWQ3>Z3!GI(#WBKY.]-N ^Z))_
MKZJ?W<,?N[<%Z7*PN=VVG8O,73YL;/.\\^0B_S,Z_8S9&<+[F_??>KHN_?>L
ML7&5_WW:M4>7+5D$.[O/+GG[H[K^;D<.LG.XK?*F_P^VEZ:MBIO)(BBR7\/U
M5/;7Z_!&\]$,-V"C ;L;W./@!GPTX)\&8M9 C ;BJQ'D:" ?(H0#][YR2=9F
MZU5=78-ZZ.YSUHTJNI2N;[9!TS?60X>XVC6N]6,MU2K\Z/R,$-9#-AY$8Y $
M0N@=$;KX]R08EL08@0%SA@6((4(:-(>G3M())UZ:'$N3#[7BT#["[05F+P9[
M >P5\5,<(!L(X=2'Z*$4 Z0<> I)->8H>>XHA8ZX-$3BC.0,(PD94921G$E$
M#8PD2,202*&$GOM)H1_**.$X(35#2$%"#"6DGA-2,!$E&%J9Y+FC%#IB7!.&
M,](SC#1DQ+$H&^V-**H%2NI+J 2BA.$B0GE-HSQ>9F8R&LA+X/;13%TB:"_1
MND1P7#)F. J+(8P*PQ0Q:&D\G)$L>IPQ8W$@CA-JQ-1:T^G@)+_NY2=!A1(<
M,4,HS8G!"7HP*9F8(.CAA)!*XP0]''7UHI),,$2EZ\80JH[2.$,*^S"2$2,X
M18ACA$M"T9(E/I!%1G&&DX1 P;119*H;46F\D82BI="Z;T;,$.K%:#<WT>1C
M'TBC2/QO;;K1])",2>*&/\[30PI&E)S25CHGKA2JJYHJU9R\4JAY&NWG#86B
M%U%TA8_IG'C>"@0=43>LF.:8LW3*F<]K3F0IE#Y\2FVH]'I6H ,E]E%N$8_0
M"9\\X.3$>$I]G(C8Y$HUI[D4"J%&9].&0B7DDA)TNL<>S)5!451_$@^G(QY-
MS&$OJF*3,WA.@"E4X,=!<J.G/7H&[^78@[UP8R@NPAZ.1II'>!U2WR'E9'(A
M1J7XQA!J\>.^0(\,C;=&=1PE!HQ]H%N*.7O473VR])%:<87&3GV@6_(B*-$^
MS[DM X5[AL?TS<@3JO<+>64,@\6/,(G"DD<8T<3[4<PJ]:WHZ]2P97/[!P;W
M#QK?/S HY-QH-;&EB;\*3+X*3&>! \L0? D7MC[T9Q!-L*TN9=O)#FB]GW-\
M8]V7]$/[ABYCBK0G=)D.IQB?[M>K<W:P?V;UX50VP7O5NN_W_F-[7U6M=9F[
MOEX$1YOM[@^YW;?=K7;W]7"6,3RTU?EV-',_'UK_!U!+ P04    " !DA@I)
M.GO\+$D$  #*$@  &    'AL+W=O<FMS:&5E=',O<VAE970U+GAM;(V8R8[;
M.!"&7T7PO6.R2'%IN W$&@29PP!!#C-GM4TOB!:/I&YGWGZHS5UTBD(NED3_
M1?XEBA^7S:UN?K1GY[KD9UE4[<OJW'77Y_6ZW9]=F;>?ZJNK_#_'NBGSSC\V
MIW5[;5Q^&(+*8@V,J7697ZK5=C.4?6NVF_JM*RZ5^]8D[5M9YLU_.U?4MY<5
M7\T%WR^G<]<7K+>;]3WN<"E=U5[J*FG<\67UF3]G0O220?'WQ=U:=)_TYE_K
M^D?_\.?A9<5Z#ZYP^ZZO(O>7=Y>YHNAK\BW_.U7ZT68?B._GVK\,Z7K[KWGK
MLKKXYW+HSMXM6R4'=\S?BNY[??OJIAS2OL)]7;3#;[)_:[NZG$-629G_'*^7
M:KC>QG^TFL+H )@"X!YP;X<.$%. ^ B00Z:CLR&O/_(NWVZ:^I8T8V=<\[[/
M^;/P;VZ?M$-A,[XNGUGK2]^W6F_6[WT]DP0&R0Y+^%VQ]I7?6P"JA2D<4#A0
M#618D1JZ!4&U(,8<!,XA$B^I>#G&2QPO0XMZ3&*45(/D";02BM1E@4X"MXI%
M#*4+":78D*7CU4)""L4;%AI58T(*&060H(&295BF#;-&T&[T@AN-W7#2C4;-
M2,4$J<JPBH/55M)FS((9@\V0.>],T(=&I.0;S!YE,M)1=L&-Q6X$Z<;BI)5A
MCX-T<F.#-R@U[:7G6M1,_^>'&TFZF313UMP" _W@>ZPM"VH3$6YP$DW3*. 8
M/":-U$"B9\X(D\4H.B- &=$]'4B>! /%(F9(2LUF,*8,V8N[23/UMA561!QA
M'0A@/$(9OL0]CL$G4MI10+24*:E(818*N13:1EC!2?3-GC#[1*3+TF#HB;BG
M0)A*K5AL8"SAE&.>BDC/85+:-$*P0,4U5[%QL<13'@#5T'8P*Y\@]5#5Y,O,
M0J4PD#(>X2HGP3J/UH"L$1;R)1AR3$-+3UO<!E^9MVHMW2/9@U0!5SHV3&")
MBX!)9ND)## 7N5 <4DZ_[T#I/:6@> 0G0-)Q=H7I:.F9;-+,GYNT\A'K$ZR#
MRF*PAB74 D:MI:<R@$=$D!]O%NJD9@ 11TN\!<Q;2T]G@#F:<JN5H4D2"H4Q
M1L<ZC23N-$@ $]=&IC18XB-@/EJ:CQ!@S_<[H]<662@$D5H1\[3$1\!\M#0?
M0?VN)_7;GI8@"1B2EH8D8/2!U-J/1=I3L/(4H"W$QLC2VA,P(JVE/>%EI9_7
M 6+O"0M%*JSE,4]+T 4,7<YHZD*PNI3&^IT ;2H0&J6-B Q=01)WWM"QP%0D
M+[&$1Q'L6AG-1X'Y*#RV'V33IBZ02>N_W8@A$I!S3A 8BJR-Q!+1A BJH'>J
M(E@:^O6:_F5+O49'!*5K3L/129OLZ[>JZS?EJ/1^//,9^B.&A_(=?\[&0Y:/
M:K:;:WYR?^7-Z5*UR6O==74YG#8<Z[ISWB'[Y*ES=OGA_E"X8]??:G_?C$<M
MXT-77^>3H_OQU?9_4$L#!!0    ( &2&"DFYNU/WH0$  +$#   8    >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL?5/+;MLP$/P5@A\0RK*=%(8L($X1M(<"
M00[MF996$A&2JY"4E?Y]^9 5.1!Z$7=7,[.S?!0CFC?; 3CRH:2V1]HYUQ\8
MLU4'BML[[$'[/PT:Q9U/3<ML;X#7D:0DR[/LGBDN-"V+6'LQ98&#DT+#BR%V
M4(J;OR>0.![IAEX+KZ+M7"BPLF SKQ8*M!6HB8'F2!\WA],N("+@MX#1+F(2
MO)\1WT+RLS[2+%@ "94+"MPO%W@"*8.0;_P^:7ZV#,1E?%5_CM-Z]V=NX0GE
M'U&[SIO-**FAX8-TKSC^@&F$?1"L4-KX)=5@':HKA1+%/](J=%S'].=;-M'6
M"?E$R+\06&H4;7[GCI>%P9&8M+4]#R>X.>1^(RIB8]&DZ;U1ZZN7<I/M"W8)
M0A,FCYC3#69&,*\^M\C76DST?$'/U^G;-?HV.=S>.+Q?%]BM">R2P.Y_(R;,
MZ1;S\*4)6^RI M/&JV-)A8..%W51G6_G8Q[/Y!->%CUOX1<WK="6G-'YDXW'
MT" Z\":RNSTEG7\_<R*A<2%\\+%)5RHE#OOK YE?:?D/4$L#!!0    ( &2&
M"DE+>CW4I $  +$#   8    >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL?5/;
M;IPP$/T5RQ\0@W?3IBL6*9NJ:A\J17EHG[TP@!6;H;99TK^O+RQA(]07/#.<
M<^:,+\6$YM5V (Z\:=7;(^V<&PZ,V:H#+>P=#M#[/PT:+9Q/3<OL8$#4D:05
MXUGVB6DA>UH6L?9LR@)'IV0/SX;846MA_IY X72D.;T67F3;N5!@9<$67BTU
M]%9B3PPT1_J8'T[[@(B 7Q(FNXI)\'Y&? W)C_I(LV !%%0N* B_7. )E I"
MOO&?6?.]92"NXZOZMSBM=W\6%IY0_9:UZ[S9C)(:&C$J]X+3=YA'N ^"%2H;
MOZ0:K4-]I5"BQ5M:91_7*?W9\9FV3> S@2^$ARP:3XVBS:_"B;(P.!&3MG80
MX03S _<;41$;BR9-[XU:7[V4>?90L$L0FC$\8DXWF 7!O/K2@F^UF.E\1>?;
M]-T6?9<<[FX<?MD6V&\)[)/ _G\C)LSI!I-G'YJPU9YJ,&V\.I94./;QHJZJ
MR^U\C(?(WN%E,8@6?@K3RMZ2,SI_LO$8&D0'WD1V=T])Y]_/DBAH7 @_^]BD
M*Y42A\/U@2ROM/P'4$L#!!0    ( &2&"DGI]!;*H@$  +$#   8    >&PO
M=V]R:W-H965T<R]S:&5E=#@N>&UL?5/;;IPP$/T5RQ\0@Y>TT8I%RJ:*FH=(
M41[:9R\,8,478ILE_?OXPA*VHGW!,\,Y9\[X4D[:O-D>P*$/*90]X-ZY84^(
MK7N0S-[H 93_TVHCF?.IZ8@=#+ FDJ0@-,N^$<FXPE49:R^F*O7H!%?P8I =
MI63FSQ&$G@XXQY?"*^]Z%PJD*LG":[@$9;E6R$![P/?Y_E@$1 3\XC#958R"
M]Y/6;R%Y:@XX"Q9 0.V" O/+&1Y B"#D&[_/FE\M W$=7]0?X[3>_8E9>-#B
M-V]<[\UF&#70LE&X5SW]A'F$VR!8:V'C%]6C=5I>*!A)]I%6KN(ZI3]%/M.V
M"70FT(5PET7CJ5&T^8,Y5I5&3\BDK1U8.,%\3_U&U,C&HDG3>Z/65\]5GN<E
M.0>A&4,CYGB%61#$JR\MZ%:+F4Y7=+I-WVW1=\GA[LKA/P2*+8$B"13_&S%A
MCM>8W5]-R&I/)9@N7AV+:CVJ>%%7U>5VWM-X)E_PJAQ8!\_,=%Q9=-+.GVP\
MAE9K!]Y$=G.+4>_?SY((:%T(O_O8I"N5$J>'RP-97FGU"5!+ P04    " !D
MA@I)T3 >RZ,!  "Q P  &    'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;'U3
MVVZ<,!#]%<L?$(.73:,5BY1-%:4/E:(\M,]>&,"*+]0V2_KW\84E;(7Z@F>&
M<\Z<\:6<M'FW/8!#'U(H>\2]<\.!$%OW()F]TP,H_Z?51C+G4],1.QA@321)
M06B6W1/)N,)5&6NOIBKUZ 17\&J0':5DYN\)A)Z..,?7PAOO>A<*I"K)PFNX
M!&6Y5LA >\2/^>%4!$0$_.(PV56,@O>SUN\A^=$<<18L@(#:!07FEPL\@1!!
MR#?^,VM^M0S$=7Q5?X[3>O=G9N%)B]^\<;TWFV'40,M&X=[T] +S"/L@6&MA
MXQ?5HW5:7BD82?:15J[B.J4_^]U,VR;0F4 7PD,6C:=&T>9WYEA5&CTAD[9V
M8.$$\P/U&U$C&XLF3>^-6E^]5'E>E.02A&8,C9C3#69!$*^^M*!;+68Z7='I
M-GVW1=\EA[L;A_MM@6)+H$@"Q?]&3)C3+>;^GR9DM:<23!>OCD6U'E6\J*OJ
M<CL?:3R3+WA5#JR#G\QT7%ETULZ?;#R&5FL'WD1VM\>H]^]G202T+H3??&S2
ME4J)T\/U@2ROM/H$4$L#!!0    ( &2&"DF"OCWCHP$  +$#   9    >&PO
M=V]R:W-H965T<R]S:&5E=#$P+GAM;'U3VVZC,!#]%<L?4(.3MMF((#6MJO9A
MI:H/N\\.#&#5%VJ;T/W[]850LD+[@F>&<\Z<\:48M?FP'8!#7U(H>\"=<_V>
M$%MU()F]T3TH_Z?11C+G4],2VQM@=21)06B6W1')N,)E$6MOIBSTX 17\&:0
M':1DYL\1A!X/.,>7PCMO.Q<*I"S(S*NY!&6Y5LA <\ /^?ZX#8@(^,5AM(L8
M!>\GK3]"\EH?<!8L@(#*!07FES,\@A!!R#?^G#2_6P;B,KZH/\=IO?L3L_"H
MQ6]>N\Z;S3"JH6&#<.]Z?(%IA-L@6&EAXQ=5@W5:7B@82?:55J[B.J8_=#?1
MU@ET(M"9L,NB\=0HVGQBCI6%T2,R:6M[%DXPWU._$16RL6C2]-ZH]=5SF>?W
M!3D'H0E#(^9XA9D1Q*O/+>A:BXE.%W2Z3M^LT3?)X>;*X6Y=8+LFL$T"V_^-
MF##':\R/?YJ0Q9Y*,&V\.A95>E#QHBZJ\^U\H/%,ON%ET;,6?C+3<F7123M_
MLO$8&JT=>!/9S2U&G7\_<R*@<2&\][%)5RHE3O>7!S*_TO(O4$L#!!0    (
M &2&"DG:R$V2H0$  +$#   9    >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM
M;'U3VVZ<,!#]%8L/B,&[::L5BY1-%;4/E:(\M,]>&,"*[2&V6=*_KR\L82O:
M%SPSG'/FC"_EA.;5]@".O"NI[3'KG1L.E-JZ!\7M'0Z@_9\6C>+.IZ:C=C#
MFTA2DK(\_T05%SJKREA[-E6)HY-"P[,A=E2*F]\GD#@=LR*[%EY$U[M0H%5)
M%UXC%&@K4!,#[3%[* ZG?4!$P$\!DUW%)'@_([Z&Y'MSS/)@ 234+BAPOUS@
M$:0,0K[QVZSYT3(0U_%5_2E.Z]V?N85'E+]$XWIO-L]( RT?I7O!Z1O,(]P'
MP1JEC5]2C]:ANE(RHOA[6H6.ZY3^L&*F;1/83& +X4L>C:=&T>97[GA5&IR(
M25L[\'""Q8'YC:B)C463IO=&K:]>JH+E);T$H1G#(N9T@UD0U*LO+=A6BYG.
M5G2V3=]MT7?)X>[&X3_Z[[<$]DE@_[\1$^9TB_G;)5WMJ0+3Q:MC28VCCA=U
M55UNYP.+9_(!K\J!=_"#FTYH2\[H_,G&8V@1'7@3^=U]1GK_?I9$0NM"^-G'
M)EVIE#@<K@]D>:75'U!+ P04    " !DA@I))J<X$:,!  "Q P  &0   'AL
M+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q]4]N.FS 0_16+#U@3AW2KB"!MMJK:
MATJK?6B?'1C 6MM#;1.V?U]?"$LJU!<\,YQSYHPOY83FS?8 CKPKJ>TIZYT;
MCI3:N@?%[0,.H/V?%HWBSJ>FHW8PP)M(4I*R//]$%1<ZJ\I8>S%5B:.30L.+
M(794BIL_9Y XG;)==BN\BJYWH4"KDBZ\1BC05J F!MI3]K0[GHN B("? B:[
MBDGP?D%\"\GWYI3EP0)(J%U0X'ZYPC-(&81\X]^SYD?+0%S'-_6O<5KO_L(M
M/*/\)1K7>[-Y1AIH^2C=*T[?8![A$ 1KE#9^23U:A^I&R8CB[VD5.JY3^O-8
MS+1M IL);"%\SJ/QU"C:_,(=KTJ#$S%I:P<>3G!W9'XC:F)CT:3IO5'KJ]=J
MQ_8EO0:A&<,BYGR'61#4JR\MV%:+F<Y6=+9-WV_1]\GA_LYAL2U0; D42:#X
MWX@)<[[''/YI0E=[JL!T\>I84N.HXT5=59?;^<3BF7S JW+@'?S@IA/:D@LZ
M?[+Q&%I$!]Y$_G#(2._?SY)(:%T('WULTI5*B</A]D"65UK]!5!+ P04
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M'WULTI5*B</A^D"65UK]!5!+ P04    " !DA@I)O=S)7*0!  "Q P  &0
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M_$$4*7+!)R3FJQV(^8+1,=8742)I@V*N7B<J=?1:1$F<XZL16C"QQ9P=S(K
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MBW'<-.0@U!+)-3-WA=D(VE]OOO'ZS?\#4$L#!!0    ( &2&"DG'RA9LG (
M #8*   9    >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;(V6RXZ;,!2&7P7Q
M (-OW$8)4I.J:A>51K-HUT[B)&@ I[:33-^^-H;4'AF&#6#SG\/G'Q_;JSL7
M;_+,F(K>VZ:3Z_BLU.4Y2>3^S%HJG_B%=?K-D8N6*MT4IT1>!*.'/JAM$@1
MEK2T[N)JU?>]B&K%KZJI._8B(GEM6RK^;EC#[^L8QF/':WTZ*].15*OD$7>H
M6];)FG>18,=U_ 4^;Q$PDE[QJV9WZ3Q'!G['^9MI_#BL8V 86,/VRJ2@^G9C
M6]8T)I/^\I\AZ?]OFD#W><S^K1^NQM]1R;:\^5T?U%G3@C@ZL".]-NJ5W[^S
M80RI2;CGC>ROT?XJ%6_'D#AJZ;N]UUU_O]LW!1C"P@%H"$"/ $AF _ 0@#\$
M)):L']=7JFBU$OP>"?LS+M3\<_B,M7/[2/:=PMJE1R9U[ZV"9;I*;B;1H$&]
M9N-J4$BQ]13X(4DTP(,"A2BPI4 >119.@$,)B$V W000^I"Y'8;5=+TF(QDL
M0ZJMJTHAS%(\,1XR@T.\\>3^AS*+0SP<4("0:NNJ,,P0P'D8)YW!23V<(HB3
MNN/&91#&U>C)0LC4K\IF8#(/I@PGR&<F2[YDLA0S!,7<9+&:C:O!,.A&X;H!
M09Z"(LQ2SK"4;N4 $$Y@EJ-).\S+S_V P45@@(!P@2.>:,*206,]06E1(D?H
M\P27@Y$'>:Y,I0@N"*,K>)$K<T4,R1)7R )7B.<*3M$4SEP1P]0S!4VD");>
M:$JVR)1@\8T4^1)3\@6FY(XI!2D )!,X<Z4,"\^4B:4:!BMP-*5<8@H*EN!
M@<""[6<0?;;_>#(,"Y1^]"5Q=O@+/;&?5)SJ3D8[KO1AH=_9CYPKIK.!)SUI
MSOH0]V@T[*C,8ZZ?A3W6V(;BE_&4]C@J5O\ 4$L#!!0    ( &2&"DE5R22\
MY0(  , +   9    >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;(V6P7*;,!!
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MIY0>*6=*!99NA$^R?I7\&9@.#3X+M4WDGIGQ: Z"=N.TGWXY\K]02P,$%
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MDFNF+S6]$;2]WM'C/PK9?U!+ P04    " !DA@I),6/+Q/H!  #<!0  &0
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M3;L'>!)"@PF7/IG[:DRKG18,3MI."S.7OOOXA1;]K9=.#;WZ#U!+ P04
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M^)0^2=F*+KA@V>76163'QT,A3FU_&W?W]7B.,#ZT\JJ.11YG,]O_4$L#!!0
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M.7H"Z99 :@52K\B=7V1AL[0^@X64ZM>-HFU0]@"4>:#2!^46E#F@+TF>%/=
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MA@&JH"8#U:]B_ Y3A,02EH(J]XO*06G!9DB &'GW8\?=./HOZ0S;!T03(%H
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M1@1O\+\W'YZ_?_G:>_'RS<6;RY<7K[RK#Q<?GK]^_N;#58.<99L@$=+G>Y>
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MAV+:29FPNQ##>2*Q3FF#&]]M4EJ6.B*8M04=]?@;&7SHX>CI KF5T QB_V+
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M552LGG%TP201B&W NSA2SR+MOHKP6Z"3C)QB$M\7",&V*'5]'6J;A -)+0B
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MF_$(_U49%E6(0U:@^B2#'I+0[A>9=9/4G%W=DOM2QU#57P\21J[NMPB:+MR
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ME].HM?%!%U)[KQ9/SQ$G]C7<*?5!E8/$?6ZI<[&-.P0R61%V8THT4K46CUW
M"PY//=3D)<D[['C<HAS36,%!+XV+(-0' (&XIP7B-E+!*WVM$QD:;)7URI6I
M*-/@_<K=P@MNPQ%T%6&% LGM.'@;+YJR;X-^BM&RR:!!&:)@8\GA='=OZ7UI
M1,"G0?+)8G?_YAVYSQ<4PE\QPM:;C'KS29/T2W$3JPA=-3U=#7E$Q[:FG*ZQ
MP_RJIZJ$SX7EQK"X]_$;GO1FT\9N#B)ONR_Q*"I?]>^Y:='=[KWV%3<\DTYF
M47,!WF,X#)5.I/M]W(.'WM8]O:^,<!7N>UY?7*:-^U=N>MJ?ZA11'4X?N_0=
MQBK9[=[)2_%LM3M.[!/I6<PL]<=<W("K.2C:4-8TJ[[B8CT>D)H'=2KFY :Z
M5=\9NN.S7WM,H:VY?GZMK0'7?6_];#W?IMY..Z+I<6N3J>^]%;.4N[I6T[[5
MX;BW\;SVS%B#Y!U\JNE^K7T5,;5FDY#2H1J\B9A+XU+=4 "XI0W>"X>!(+^T
M\H!-N%\;DO])WF=T,\#GYBF"%@;;=[/(=ZQ*63=4/P295,W?GOVJ) 6QFW<E
M&[K4Q*4._3R 0 ,% U"AF4T>5!55:Q?/GCCM'E]M@2_U @]IG+_$= >UU%]@
MPA>8E?FE\[VU7UI]KE]:;=70W2C\,V>Y-UY]O?F^#IJ\EG(T;?U'7P:VUU*6
MIFW8BO_N7HU@\#?U]Z/>\SL$;>-8].V9XSICU@X(.)U?_0J?;3IV$9?W6,"S
M<-D[,,5!0<^2C]M";(X3\GZNJ.97NUWBZX:'I+>KEOB8IO1Y?$!5NV7OK@"J
M.R[(W<"W*ZN90*$#*G<U@*?^U<E"6H-[Z@WG<U?W^<CU:TLT4(/']X;-OA@J
MU+Y*5*F^%)Q5G_WQ&.SRE3?$32-6^299J6$9<DOIVH?=D$1;Y7![NM IS5D1
M-O5/=SCW[VS>[NL_L,[ZIYE$?0U$6IO2TR;U5F='M6J-+'"+QMY<N3$',^=X
MQV*4B2]AZ;J*4X<95M=[[#UIT>J."-5I&)YT@ISXI%W2I0/UV"_4TN>X<)_&
M:=P9(7$_6\&%_738K54[NVE_;SZ+8^M,M:H"^CFX^BLL\J&)/?+^3COZ-1]$
M\%6YO$8G\Y[!/7K9_GDI+5</2FA* O?[?L@^9"?N5@,9VD8_$ 32TN-N]+&O
MH"NE^.*8N)4#;/3^@2L-4_^]8E?N.I&VZWE4$$N#MMPGCN40^MUI(M?1(BXS
M=VME_OLY%)3NTB %RGIFYO+YC36"^2OM?C'?C[0+ZC+_1G%J$%7S4(!)HV\3
M!H6Z&:JFKO:_>8]-VR=Y7GS[_P%02P$"% ,4    " !DA@I)YW\Q-[D!  "=
M%P  $P              @ $     6T-O;G1E;G1?5'EP97-=+GAM;%!+ 0(4
M Q0    ( &2&"DE(=07NQ0   "L"   +              "  >H!  !?<F5L
M<R\N<F5L<U!+ 0(4 Q0    ( &2&"DD,==)IC@$  *D6   :
M  "  =@"  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M &2&"DD3GZN&O (  'X*   0              "  9X$  !D;V-0<F]P<R]A
M<' N>&UL4$L! A0#%     @ 9(8*2:+NEHL_ 0  :0,  !$
M ( !B <  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 9(8*29E<G",0
M!@  G"<  !,              ( !]@@  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    " !DA@I)*QSBQ#D"  """0  #0              @ $W#P
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( &2&"DGJ_$ QL0,  ,(,   /
M          "  9L1  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !DA@I)
M8..0#TP"  "-!P  &               @ %Y%0  >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ 9(8*2:N,7U7) P  +!   !@
M     ( !^Q<  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    (
M &2&"DGJ=;ICU@$  %P%   8              "  ?H;  !X;"]W;W)K<VAE
M971S+W-H965T,RYX;6Q02P$"% ,4    " !DA@I)=<1W)BH$   K$@  &
M            @ $&'@  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#
M%     @ 9(8*23I[_"Q)!   RA(  !@              ( !9B(  'AL+W=O
M<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( &2&"DFYNU/WH0$  +$#
M   8              "  >4F  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q0
M2P$"% ,4    " !DA@I)2WH]U*0!  "Q P  &               @ &\*
M>&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ 9(8*2>GT%LJB
M 0  L0,  !@              ( !EBH  'AL+W=O<FMS:&5E=',O<VAE970X
M+GAM;%!+ 0(4 Q0    ( &2&"DG1,![+HP$  +$#   8              "
M 6XL  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " !DA@I)
M@KX]XZ,!  "Q P  &0              @ %'+@  >&PO=V]R:W-H965T<R]S
M:&5E=#$P+GAM;%!+ 0(4 Q0    ( &2&"DG:R$V2H0$  +$#   9
M      "  2$P  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%
M  @ 9(8*22:G.!&C 0  L0,  !D              ( !^3$  'AL+W=O<FMS
M:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " !DA@I)4^X5 *,!  "Q P
M&0              @ '3,P  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+
M 0(4 Q0    ( &2&"DF]W,E<I $  +$#   9              "  :TU  !X
M;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ 9(8*25=[=''<
M 0  104  !D              ( !B#<  'AL+W=O<FMS:&5E=',O<VAE970Q
M-2YX;6Q02P$"% ,4    " !DA@I)/XA?R*4!  "Q P  &0
M@ &;.0  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( &2&
M"DGH&HY2I@$  +$#   9              "  7<[  !X;"]W;W)K<VAE971S
M+W-H965T,3<N>&UL4$L! A0#%     @ 9(8*22RE2V>F 0  L0,  !D
M         ( !5#T  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4
M    " !DA@I)T%:=!=P!  !%!0  &0              @ $Q/P  >&PO=V]R
M:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( &2&"DE3=)3XI@$  +$#
M   9              "  41!  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL
M4$L! A0#%     @ 9(8*20;J_HCS 0  B04  !D              ( !(4,
M 'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " !DA@I)'F[G
M*)L"  !\"0  &0              @ %+10  >&PO=V]R:W-H965T<R]S:&5E
M=#(R+GAM;%!+ 0(4 Q0    ( &2&"DF"YU#A!P(  ' &   9
M  "  1U(  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @
M9(8*23SX$Q-7 @  B@<  !D              ( !6TH  'AL+W=O<FMS:&5E
M=',O<VAE970R-"YX;6Q02P$"% ,4    " !DA@I)Q\H6;)P"   V"@  &0
M            @ 'I3   >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4
M Q0    ( &2&"DE5R22\Y0(  , +   9              "  ;Q/  !X;"]W
M;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ 9(8*28F1WA)8 @
M?@@  !D              ( !V%(  'AL+W=O<FMS:&5E=',O<VAE970R-RYX
M;6Q02P$"% ,4    " !DA@I)L>-=W/H!  #@!0  &0              @ %G
M50  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( &2&"DG
MX]IIN@4  "@A   9              "  9A7  !X;"]W;W)K<VAE971S+W-H
M965T,CDN>&UL4$L! A0#%     @ 9(8*28O>VVMW @  - @  !D
M     ( !B5T  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &2&"DEKP)CL"0(  , %   9              "
M ?QK  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ 9(8*
M2?+W4F#. 0  FP0  !D              ( !/&X  'AL+W=O<FMS:&5E=',O
M<VAE970S-BYX;6Q02P$"% ,4    " !DA@I)1+Q<\>LU  #B]   %
M        @ %!<   >&PO<VAA<F5D4W1R:6YG<RYX;6Q02P4&     "T +0 M
)#   7J8

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.5.0.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>68</ContextCount>
  <ElementCount>181</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>28</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-daei</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-bs</Role>
      <ShortName>Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-bsp</Role>
      <ShortName>Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-soo</Role>
      <ShortName>Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-socf</Role>
      <ShortName>Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Disclosure - INTERIM FINANCIAL STATEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-ifs</Role>
      <ShortName>INTERIM FINANCIAL STATEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-sap</Role>
      <ShortName>Significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Property and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-pae</Role>
      <ShortName>Property and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Other long-term assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-ola</Role>
      <ShortName>Other long-term assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Notes and Other Obligations</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://venaxis.com/role/appy-naoo</Role>
      <ShortName>Notes and Other Obligations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Stockholders' equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-se</Role>
      <ShortName>Stockholders' equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Stock options and warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-soaw</Role>
      <ShortName>Stock options and warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Animal Health License Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-ahla</Role>
      <ShortName>Animal Health License Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Commitments and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-cac</Role>
      <ShortName>Commitments and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-sapp</Role>
      <ShortName>Significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Property and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-paet</Role>
      <ShortName>Property and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-pae</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Other long-term assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-olat</Role>
      <ShortName>Other long-term assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-ola</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Notes and Other Obligations (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://venaxis.com/role/appy-naoot</Role>
      <ShortName>Notes and Other Obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-naoo</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Stock options and warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-soawt</Role>
      <ShortName>Stock options and warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-soaw</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Animal Health License Agreements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-ahlat</Role>
      <ShortName>Animal Health License Agreements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-ahla</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - INTERIM FINANCIAL STATEMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-ifsd</Role>
      <ShortName>INTERIM FINANCIAL STATEMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-ifs</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Significant accounting policies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant accounting policies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-sapp</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Significant accounting policies (Revenue recognition and accounts receivable) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/SignificantAccountingPoliciesRevenueRecognitionAndAccountsReceivableDetails</Role>
      <ShortName>Significant accounting policies (Revenue recognition and accounts receivable) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-sapp</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Property and equipment (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/PropertyAndEquipmentNarrativeDetails</Role>
      <ShortName>Property and equipment (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-paet</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Property and equipment (Schedule of Property and Equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/PropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>Property and equipment (Schedule of Property and Equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-paet</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Other long-term assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-olad</Role>
      <ShortName>Other long-term assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-olat</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Notes and Other Obligations (Narrative) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://venaxis.com/role/appy-naoond</Role>
      <ShortName>Notes and Other Obligations (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-naoot</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Notes and Other Obligations (Schedule of Long-Term Debt) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://venaxis.com/role/appy-naoosoldd</Role>
      <ShortName>Notes and Other Obligations (Schedule of Long-Term Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-naoot</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Stock options and warrants (Stock incentive plan options) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/StockOptionsAndWarrantsStockIncentivePlanOptionsNarrativeDetails</Role>
      <ShortName>Stock options and warrants (Stock incentive plan options) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-soawt</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Stock options and warrants (Schedule of Stock-based Compensation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfStock-basedCompensationDetails</Role>
      <ShortName>Stock options and warrants (Schedule of Stock-based Compensation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-soawt</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Stock options and warrants (Schedule of fair value assumptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfFairValueAssumptionsDetails</Role>
      <ShortName>Stock options and warrants (Schedule of fair value assumptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-soawt</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Stock options and warrants (Schedule of Award Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfAwardActivityDetails</Role>
      <ShortName>Stock options and warrants (Schedule of Award Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-soawt</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Stock options and warrants (Schedule of Nonvested Awards) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/StockOptionsAndWarrantsScheduleOfNonvestedAwardsDetails</Role>
      <ShortName>Stock options and warrants (Schedule of Nonvested Awards) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-soawt</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Animal Health License Agreements (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-ahland</Role>
      <ShortName>Animal Health License Agreements (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-ahlat</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Animal Health License Agreements (Schedule of Revenue Recognition Associated with the License Agreement) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/appy-ahlasorrawlad</Role>
      <ShortName>Animal Health License Agreements (Schedule of Revenue Recognition Associated with the License Agreement) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-ahlat</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="appy-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Commitments and contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://venaxis.com/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>Commitments and contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://venaxis.com/role/appy-cac</ParentRole>
      <Position>36</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>appy-20160630.xml</File>
    <File>appy-20160630.xsd</File>
    <File>appy-20160630_cal.xml</File>
    <File>appy-20160630_def.xml</File>
    <File>appy-20160630_lab.xml</File>
    <File>appy-20160630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>54
<FILENAME>0001079973-16-001107-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001079973-16-001107-xbrl.zip
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MNH95$9:Z^ D+R2$&&3*'94]N7U>MH6 &EF'2M)*]<*";$XBJHE*3<AY*E[2
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M=!OO=&>\14NQ-HX3OH6@OOG&.L12^0)O2X/,TT!36NM$_ J;S*$17=#HZQS
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MT7\X#F.9MI*ID._\C";NPZ?A-FP2?P<//:3 )(Z0F;!VH==TQX-_:8@-K-G
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M3FFX^:H**R1K$#[P81D,HQ2?&K_C+6+[0JK:DRIC).E:Y\N48HP5M2UA KK
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M,5D?2?\@T0)4.@9!_^K#MV'DQD^H&W?Q6/HU2-Q(>IFM :K\TS^^YG\H/_W
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M9%/J\,H@S'AR$!V>8G$3=BD>YBJU9;%"PXA)+ZC0VM I UBNP+]$T$Z&&5
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MA\J+0WKBF6> \*0LB><HL(3KS'M<ER"#;V%K2',+"*XA/(<J30OG1XG[#__
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M*MX3\UI<H8XFA0W1T:M']=!<P9?::*+V$&"KF%8U&+YT8"H*I1-*EQ_I]A&
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M#ZAC597Z ;N%8,/J84QS<*G*@@9_0%\V'N>F:&G,+EA\8E+<>=:PZZN@U)-
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M_,'XQ6F5-\T; '7%WB(U[J-WBZD;-D0@,.([)'GF+@!:4#;MD%:;DK?9YL0
ML77GX^20[WG8US".HZ/63YCA7]HQ$^(^T31H[1'&^I=:;8BMU:ZC/ >-K[\+
MXQ/1$Z5^X'5:PQV[UX\"Q=XR<^=<2J((SN;PU0N+"0,L+RL%/A^>&<.*=PX%
M'==VQ_O6,GO%IA2^@X:07'KCRK_[2!S<;TG.=,^%R; F);)@YT#(*G&!X% ^
M<R6I8M5UX4<M1,#V*=9S^)8G[0X=B!W>(!TL#8E)G']S[&3: UE<7!"#%.BA
MPD"[+V_SZ6A0XGL=_QD_/</X?=38FPH#O+_G.[D5B"V:Z84_7,EPVJ_;$-4;
M#W>#4TY7X.*6"L,QC&H?\-B&3,5&=S'#2NR%6>]J)6O H9XX[$RBD92^@.P9
M>(NI]P#D9>A]C93OX?DM+K]B#!T,T,M:L+[TQ\G)<# <G[B>($+G\'ES.QBL
MK-K>X)C8[<GAJ/UF7E;^JVT.U)OW:+U$,]WT-,0(O+=;-EW^=B'_?A15+#<N
MA_LC+C8NAXW+X5$2]L;EL'$Y;%P.]\;ET N5OA3T=$&3-1*_TP+B=XF1-LZ(
M>\W^-\Z(C3-BXXQX  =UXXS8.",VSHB-,V+CC'B$S'WCC-@X(S;.B&_HC/B,
MAMQ5J-\6YV&FM3J>D9Q!Y57^XS2+WWE:S=NI2^!VYA3^GJ(.MZ2!K\M OWVL
MX>HK\Z_>?'CQ_M7KX.6K-Z=OGKTZ_24X^W#ZX<7K%V\^G&TDRUI^BU9.U%X;
M.AWJ_S59^"FA'E]ET>X2#U5&/_ 8I\=1O!>O3/\[@$'-6]I92WEOF!R=]+E5
M'T-&H*QMNDNR<IL\$NQ'O.^/.B3E55P X)?,!E[FQ8P6=^=_=B4=#7'G>9(I
MNVLN^@TXN[VP+\W:H4EF19>BIJC=C!IC[HU[SPV_XP^>D.J"U.1(2$R#4>C*
MZ3E249B:)>>L\@P_13W@E>_8"+T+BLL?+A7D%+,B8#1-PX*V)CMNLZBS,#:[
MP3-UKB39%%-R"N(TSZL,]VTY-5(S(3:L(M%(UU;3-S1):]XS+;EKB1YAY!8K
M35^^Q;[$C(K=/V8)_F(N*FD<9@8BU9LAKG,BLRN;-'*Q#-/FLSN-G4\T &"C
M\W-)]&NM%:7I/Q033GL;Z^A_JS,%5)8,RWK&6:@A$:\OX\%+@^5E<NWM3,DM
MODY7/<W@="31RJ# H_'_=J*5$P2+8%UAWN[?H35$L]6K+'$@V0,G]HYM(M&F
M24Z1+?W8EJ=U*L;Y1Z$/W(55^W7_;>1Y&BJG$!QDT\OKX;RYT?MN8AK6J IZ
M'\;93=< SUR1 +G'GAC0)/M\O,VYI,J6"A7(CRINS^:4]6H:IU7WJF_5ZCIN
M)7URM4LT1Y@F%5PJRD*/D1![M'\D2;&1$I>O-H><CT*>'PR.AR-Y+A=\67]2
MW="C.5M#0QL=CDY<UNV0);3D"3<Q)^B-1#W\;C2D]@_XU=W>7..\KK"'T?(;
MI/V'NY0]@,1+M$OEE;C7K(4SVEZUKKVNN?OM'*D:K6$T,WY=V%WK[([C5*CF
M(.FX-$50:>PG[G:^Q_#9E(3B#8;S!&EA!S'%AV69$Z=G5X:F'5=QDAE/FI (
M+1/.-H^: .8<F5M\7S'1LW&)>X7<V#\M*G[)>?8-^# )XM)+J&_KA-B^!\&\
MGJ3<NN:AYE@AE C@GB73>_N;0 W+G/"E[2%5QZ@:7+$QMG)$E]P<1F"7*=:O
MGH)2C"3K@T&#OV]R13!Q9\;$I:C[\!>OVFQ8MVF#H!'/<L().9]-'@]:L6=F
MX#>JB9VY,.[UN<P>E%RZ;6^A9$,("8<0\!D?6I:E>%[)*UW87-D69245<S+#
M*>34@!/R:(25N4PXY4"1D!13>!V6\-2?VL<#@;IJ"E('77,2EM26,SQL'99E
M?Z&^\TLR-<%9E(AQYEV17(+?_H*"'FKG 4&U['#;2SVML"O9/KAP!3><+G90
M;$8B((0'@;T07;3-1,0<)Z7#P,A4)I$-I-/$23C0[$#,'W%VL&@0".&DB5"Q
M+WMLB8YG&N]<$7^Q"9%Z!GL1BBT/?D(M_@#-X%/EBM; XB:18>AX^\U_GCV1
M#"[$YL'3*_P?B88JV<$G--HPVXEP%N$)",^SG(8<X5>#](+(PP035F_&IL .
MR63GA(IX#1*$_ZBMWHY259JF,%*?_K YZFMDTK6VS-&H>\JQ%4HDG1/]NJZ@
MH7SP,@*YL\N>='T@P31]Y]\GQ'<UTI0U^5RO:WT06$<)JS$$)CC%,B=+8RD5
M2X8S0C'$HLY5DHIS>PY9ZQ*U-GD#N]S'.T$^T^D?_ L,!^-8:+V9LNDJ%:]?
M4I6>!\5O<Z<KA3<4NT:=$I<!3X()(UN<J).<:EDH+,/2B3FO,P>Z6)6WGL$&
MHX6I,JI+TTGPIO!ST%,@C&BYKA+P4Z%4+67E,O6QJ"R]2@]<X8=^U<$8R53'
MC)C(<Z[N S>H>4@RC:CK2B+4U%:!2EEB^")%(OD3,Y+4L98.?<'&68]"U>!=
MR*]".TUJ7=$?"J,0B\96):FAY\0@CH'O8N6L7@O%GORJEU:YC24E5AC)J+7;
M=,%^Q8H#6]C5,@?,18UAMJ_X,0O>7FZ.S8W-#!Z9<XB[9.JV 29LT7'GK3D<
MZI%_X)%WZZQ=_\AL!UIH+?YI*QH.]\*3$S,ZF)K]T20*)R8<[P]/#O;"H^E^
M.-R29.<_;3T_>_?R%]+#/N!3^A5)*>G@T/K^M#64O^=A'-N_/^OU?TJG/ZXN
M\'#X?6=T[5KE305Y_6(\W!T?>)=05I><7S?HP UF?(2EZY99IT7M4K!O+3K>
M^]K#".LJ7VL8O<0@@1F?YJEHF@()>I1X%Y^R@CUY1V@M.=6["I^K/'\?#L'T
M) S')V9O?+0?[4>3X^/]H^'>:'H8Q<.C\;&)-X?@H1Z"!B%98H<])\\,BD\-
M& !GB!I ,82(K2WM*SUMRY4F"'46K =+\.'P,!Y/1B?#X[V3P_V#<#39/QX?
M[8VB\>0D.AB>F W%/U"*5W.RFJ1%"/"5-J?'*<WSF;!D+P?$AZP,S27<B_.B
MPY'8QK3@_:C11@,[1YDO5X'I(9Z'X_'T:!+O'8>3D[U]<S@*HW@<30[C*"9$
M=&A&F_/P*,Z#BXVC[\O*7O%42QTKRNJ2D?S0,,COWB5-WPOUXJY,]>Q2NR92
MDY@67/F\;UR0;KKH0['*SWA,EUQ@7JR[MG"R?)IX$15-G5.Y'<TF#&T9]I5+
ML>Y/4-L) ^#R=7[8_J2I7".F7JV$PP"#.:>U1<)^X=1/CANQ69Q;O!>#:D&-
MD(LT[;IV8'-!B(QG5":F'&EJ?CMQ6<RR,3#2TIV'];F]S^UJY+!+R=6KEB;Y
MBC[-E6/^H]HK'O8U+E^=OGOW?ZU8[G$08Q"YI.NW\WU]C<G%3]7N-'JU]TBD
M?GL-X7)P[E5[B[.5'/Z5BRO#U.O,ZD!I'L$('.I]2DMI0E<#A' VN-$644J*
M>$?LJ6W2".-+=1&WYBOU5=4OX#L$]$ X8W:OZW2@%P;8?<F^#_"S\KIJ;YUB
MXRMN#'RW=Z0N][Z"7=8%'49UU2'8>5BQ9Q]&,5KF&";GF&UK2='-#=\;XOJU
M8U;_^>__]H\?/DV*-/D1_Z8__Q]02P,$%     @ 9(8*2<OD/TT%#0  Q7$
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M\7O_D>(_?.QX%^R[4@P N=0Q3WC0:V;4$]-#G%#JN"?6?)Q0[L@GUGZ"4NX
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M &4"Y$D:Y!VVV1PS-MA<S0:<!Z9IBLQF>PL4ODP S<POZU(&?FI\.$P$-A/
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MM;T.W(B9T*DEZ#E<>M).^<*/6?B%'8Q87_8HGLYC"Y^)2^;"<@YE2H0XBBN
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M[;SM\G2CLU]]8_VU>N0QF.>_HU?>^1_(5^3 Y^TY/42NRL-:V@>((';IWE5
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MG/OSP9SXW"KY]U[18V:5J^JV"6S$M<"*#O+=A)_S']RSQ#[Y?U!+ P04
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M>,C* '5S_):Z*K2IV4'#&7["8<QGA/,7%IR/C?;6BM/MOJ:U*LV=S4XV:%Z
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M*]_Y&Y+P[:!V [N2X#6WL)PG'[2O_@!W#R=0?L"N(J )ICL_J]!YYOS#O80
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M@.(OR78H+F?+E%HZ/TX"'!PA$OGAEA^(_?QQCAL_P[<$W+K569QYH?8NC5'
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M;M?+TSBAB*9+E+]C+Z"^5$(U2"_I2*%C[61+0A:Y?1_SN\<W;.*2X+-/8;"
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MYR'=[0F($<>0+ *-,4M3&9I K6C$><CW ?'6\@X)Z/65[(SS/YI3?K+6&:T
M59W'B!]NQ9?Q:?RK/9QG5@X:X':=Q[6W)DQV.+RG!XTR;)F5@X:R+><A].T=
M-  \P['=7)-EN9!>SF#)8N0UG$?2[P%&W9-&S96]W5-:6&5E3P&WZSQBOS49
MLL/AL>\I@@4BGXCP/^)JV@-7Q<55$8DI"^KF8KE4F;6"(%. \3[2A4_[*1M3
M/FWB^(G/!ET$;%AU!%D)+$F#A#.=Q6"92Q<?7IP^#V'XXRV"Y 5#B8,@SHI
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M$)R,P1>J+=3A6$9S83=21^0U,)R-S=Y%P?22D;YKK%[2R.'<+H7AC V&L(W
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MA\JZA@KI\[OB ..V'V*Z4\'L)8I[>(/1'1M$PM=#'[E@T4.NDFS//5+S_AO
M9&0Z *B0/J-KCFX8(A+<(3<)-P?[GL.""OF(;G%P,'94HJ^[5M^=M%L?"53
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M^'>GO\-1O/Q&_!".^?R3_P]02P$"% ,4    " !DA@I)0R:N2$V(   I50<
M$0              @ $     87!P>2TR,#$V,#8S,"YX;6Q02P$"% ,4
M" !DA@I)R^0_304-  #%<0  $0              @ %\B   87!P>2TR,#$V
M,#8S,"YX<V102P$"% ,4    " !DA@I)^<1! @X.   4J0  %0
M    @ &PE0  87!P>2TR,#$V,#8S,%]C86PN>&UL4$L! A0#%     @ 9(8*
M2;M0S<$7&   (I,! !4              ( !\:,  &%P<'DM,C Q-C V,S!?
M9&5F+GAM;%!+ 0(4 Q0    ( &2&"DDGC<%:/T<  $8@!  5
M  "  3N\  !A<'!Y+3(P,38P-C,P7VQA8BYX;6Q02P$"% ,4    " !DA@I)
MD+]%]'@L  #.!0, %0              @ &M P$ 87!P>2TR,#$V,#8S,%]P
<<F4N>&UL4$L%!@     &  8 B@$  %@P 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
